




In science we resemble childeren collecting  a few pebbles at the beach of knowledge,                       
while the wide ocean of the unknown unfolds itself in front of us 
In de wetenschap gelijken wij op kinderen, die aan de oever der kennis hier en daar een steentje 
oprapen, terwijl de wijde oceaan van het onbekende zich voor onze ogen uitstrekt 
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The present study focuses on Chlamydia psittaci (C. psittaci), which is an obligate intracellular Gram-
negative bacterium causing respiratory disease and mortality in many bird species (Kaleta & Taday, 
2003). C. psittaci can be transmitted through inhalation of aerosols of nasal secretions and feces from 
infected birds (Burkhart and Page, 1971; Cole, 1990). Initially, the respiratory tract is colonized, from 
where the disease further spreads to other organs, leading to a systemic infection. C. psittaci is 
responsible for huge economical losses in the poultry industry resulting from lowered egg-production 
and the need of antibiotic treatment (Grimes & Wyrick, 1991). Moreover, C. psittaci can be transmitted 
to humans causing psittacosis, the clinical outcome ranging from inapparent to severe flu-like 
symptoms or pneumonia (Andersen and Vanrompay, 2000). Especially, people in close contact with 
birds such as poultry workers, pet bird owners and veterinarians are at risk for this zoonotic agent.  
The first objective of this thesis was: a) to determine how widespread C. psittaci  and atypical 
Chlamydiaceae (ACC) were among chickens in Flanders and b) to investigate their zoonotic 
transmission.  
After infection, the primary replication of C. psittaci takes place in the epithelial cells and macrophages 
of the respiratory tract. Subsequently, the bacteria can be found in macrophages of the vascular 
system. It is believed that C. psittaci uses these macrophages as a vehicle to spread throughout the 
body to start replication in epithelial cells and macrophages of various tissues and establish a systemic 
infection. Because C. psittaci can survive and even replicate within a cell which is part of the innate 
immune system, the macrophage, and the fact that this bacteria is widespread among chickens, the 
second objective of this thesis was to examine the innate immune response elicited by C. psittaci in 
chicken macrophages.  
As C. psittaci possesses a huge zoonotic potential, the third objective aims to determine the 
relationship between C. psittaci and the human macrophage, with the emphasis on internalization, 
survival and replication and on the innate immune system.  
Treatment with antibiotics can easily resolve a C. psittaci infection. However, tetracycline resistance 
has already been reported for C. suis through horizontal gene transfer (Dugan et al., 2004; 2007). 
Antibiotics, especially tetracyclines are widespread in the poultry industry, creating the risk for 
tetracycline resistance among C. psittaci strains. This calls for research on creating an effective vaccine 
against C. psittaci. Therefore, a good understanding is needed of the mediators, the PRRS and the cells 
involved in the host immune response during a C. psittaci infection and how these factors interact with 
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each other. The fourth objective of this thesis was to investigate the in vivo innate immune response 
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1.    Introduction 
Chlamydia psittaci (C. psittaci) is an obligate intracellular bacteria causing respiratory disease in a wide 
variety of domestic and wild birds (Grimes, 1994). It has been shown , that C. psittaci is endemic in 
many species of wild birds, but also in poultry like chickens, turkeys, geese and ducks (Newman et al., 
1992; Vanrompay et al., 1997b; Verminnen et al., 2008; Lagae et al., 2014). Furthermore, this 
bacterium is a zoonosis that causes psittacosis in humans. As transmission occurs through inhalation 
of pathogen-containing aerosols from faeces and nasal tract exudates, people in close contact with 
birds are at risk like farmers, pet keepers, employees of abattoirs and taxidermists. 
2.    History 
In 1879, Jacob Ritter associated for the first time a strange form of pneumonia in Switzerland with the 
importation of infected psittacine birds (Ritter, 1880). Three years later, after an outbreak in Paris, the 
disease was called ‘psittacosis’ after the Greek word for parrot ‘psittakos’ as parrots showed to be the 
source of the infection (Morange, 1895).   
Halberstaedter and van Prowazek described for the first time in 1907 intracytoplasmatic inclusions 
containing a large number of micro-organisms derived from conjunctival scraping of patients suffering 
from trachoma. Because a classical Giesma staining showed a blue matrix or mantle surrounding the 
particles, these organisms were wrongly assumed to be protozoa, named ‘Chlamydozoa’ after the 
Greek word ‘Chlamys’ for mantle (Halberstaedter and von Prowazek, 1907a; Halberstaedter and von 
Prowazek, 1907b). However, later studies revealed that these micro-organisms were bacteria instead 
of protozoa. This was the beginning of a long and confusing process of chlamydial classification.  
During the winter of 1929-1930, a pandemic outbreak of psittacosis was reported due to the shipment 
of green Amazon parrots from South America to the United States and Europe (Coles, 1930). Bedson 
and Western managed successfully to isolate the causative agent in 1930 (Bedson and Western, 1930). 
Until 1930, it was commonly believed that only psittacine birds were the source of avian chlamydiosis 
infections. Although, later on, other animals like chickens, pigeons and ducks were shown to transmit 
psittacosis to humans (Meyer and Eddie, 1932; Pinkerton and Swank, 1940; Wolins, 1948). In the same 
period, researchers were able to isolate the causative agent of lymphogranuloma venereum (LGV) 
from human tissue, which is a serious genital infection (Hellerström & Wassén, 1930). Both particles 
were classified as viruses belonging to the psittacasosis-LGV group. Two years later, the developmental 
cycle, like it is known today, was for the first time described. Beside the previously identified 
elementary body, a novel form of the organism was discovered: the reticulate body (Bedson and Bland, 
1932). 
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Finally, 20 years after the first classification, in 1966, Chlamydiae were recognized as Gram-negative 
bacteria. Because of new techniques like electron microscopy and cell culture, research revealed that 
these organisms have a Gram-negative-like envelope, a distinct developmental cycle with EBs and RBs 
containing both DNA and RNA and prokaryotic ribosomes susceptible to antibiotics (Moulder, 1966). 
The organisms causing psittacosis, LGV and trachoma were combined into one single genus: Chlamydia 
(Page, 1966). 
3    Taxonomy 
Originally, the order Chlamydiales has one family, the Chlamydiaceae, containing one genus, 
Chlamydia and just two species, Chlamydia trachomatis and Chlamydia psittaci (Page, 1968). Due to 
the development of DNA-based classification methods during the 1980s, two additional species, 
Chlamydia pneumonia (Grayston et al., 1989) and Chlamydia pecorum (Fukushi and Hirai, 1992) were 
introduced. In 1999, Everett et al. (1999) proposed a new classification based on phylogenetic analyses 
of 16S and 23S rRNA genes, and on phenotypic, morphologic and genetic information. This information 
showed that the order Chlamydiales contains at least four distinct groups at the family level: the 
Chlamydiaceae, the Parachlamydiaceae, the Simkaniaceae and the Waddliaceae. The Chlamydiaceae 
were divided into two genera, Chlamydia and Chlamydophila, comprising nine species (Everett et al., 
1999). The order of Chlamydiales was further extended with four new families of chlamydia-like 
bacteria, Piscichlamydiaceae, Clavochlamydiaceae, Rabdochlamydiaceae and Criblamydiaceae (Horn, 
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Fig. I-1: Overview of the new classification as proposed by Everett et al. (1999) versus the old classification 




However, regarding the taxonomy proposed by Everett et al., there are still a lot of issues that need 
to be addressed. One of them is the proposal to split the genus Chlamydia in two genera, Chlamydia 
and Chlamydophila, which has led to significant controversy (Schachter et al., 2001; Stephens et al., 
2009). Due to these issues, a subcommittee of the International committee on systematic 
prokaryotes (ICSP) on the taxonomy of Chlamydiae was formed in 2009. This subcommittee decided 
that a single genus, Chlamydia, will be used. To support this proposal, a working group will analyze 
the data derived from all recently available genome sequences of the members of the family 
Chlamydiaceae. The new classification will be applied in this thesis. 
Recently, a new member of Chlamydiaceae, named atypical Chlamydiaceae (ACC), was isolated from 
a group of poultry slaughterhouse workers in France who suffered from atypical pneumonia. 
Phylogenetic analysis based on 16S rRNA showed a seperate position of ACC among other Chlamydia 
species within the family of Chlamydiaceae (Zocevic et al., 2012).  
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3.1.    Chlamydiaceae 
Today, the Chlamydiaceae have one genus, Chlamydia with nine species (Table I-1). The nine species 
differ in inclusion morphology, pathogenicity and host specificity (Everett et al., 1999). 
Table I-1: The family Chlamydiaceae (Kerr et al., 2005) 
Species Host Clinical signs 
Chlamydia trachomatis Humans Chronic conjunctivitis and blindness (trachoma) 
Sexually transmitted disease (STD) 
Infection of the urogenital tract, infertility 
 
Chlamydia muridarumc Mice 
Hamsters 
Respiratory tract infection 
Genital tract infection 
 
Chlamydia suisc Pigs Diarrhea, pneumonia, conjunctivitis, reproductive 
disorders 
 
Chlamydia pneumoniae Humans 
Koala 
Pneumonia, bronchitis, encephalomyelitis, 
laryngitis, atherosclerosis, reactive arthritis 
 
Chlamydia psittacia Humans 
Birds 
Respiratory tract infection 
 
 
Chlamydia abortusa Ruminants 
Pigs 
Reproductive disorders, abortion and bad semen 
quality 
 
Chlamydia pecorumc Ruminants 
Pigs 
Koala 
Reproductive disorders, infertility, infection of the 
urine tract (koala) and abortion, enteritis, 
polyarthritis, encephomyelitis, metritis, 
conjunctivitis and pneumonia (other animals) 
 
Chlamydia felisb Cats Conjunctivitis and respiratory tract infections 
 
Chlamydia caviaeb Guinea pigs Ocular and urogenital tract infection 
aZoonotic pathogen (multiple case reports) 
bZoonotic pathogen (a few case reports) 
cZoonotic potential cannot be excluded (not yet investigated) 
 
3.1.1.    Chlamydia trachomatis 
C. trachomatis infections are the leading cause of bacterial sexually transmitted disease (STD) in 
industrialised countries and of infectious blindness (trachoma) in Africa, the Middle East, Asia and 
South-America. STDs caused by C. trachomatis are strongly associated with urethritis, cervicitis, pelvic 
inflammatory disease and, at later stage, chronic pelvic pain, ectopic pregnancy and tubal factor 
infertility in women. In men, symptoms include urethritis, epididymitis, prostatitis and infertility. In 
both sexes, it can cause mucosal inflammation of the throat and rectum (Spiliopoulou et al., 2005).  C. 
trachomatis is divided in two biovars: trachoma and lymphogranuloma venereum (LGV) (Longbottom 
and Coulter, 2003). The trachoma biovar is comprised of 14 serovars (A to K, Ba, Da and Ia) which 
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primarily infects columnar epithelial cells of mucous membranes: serovars A to C were specially 
associated with trachoma, while D to K were associated with sexually transmitted infection (Wang and 
Grayston, 1970). The LGV biovar consisted of four serovars (L1, L2, L2a and L3) which proliferated in 
lymphatic and subepithelial tissues and caused systemic infections (Schachter, 1999). The reference 
strains for the trachoma and LGV biovar are C/PK-2 and L2/434/BU (ATCC VR 902B), respectively. 
3. 1. 2.    Chlamydia muridarum 
Two strains of C. muridarum, MoPn and SPFD have been respectively isolated from mice and hamsters 
(Fox et al., 1993; Stills, 1991). MoPn (mouse pneumonitis) was isolated in 1942 from the lungs of 
asymptomatic albino Swiss mice and was subsequently shown to be capable of producing pneumonia 
in mice (Nigg et al., 1942). MoPN have been shown to be sensitive to sulfadiazine and harbors and 
extrachromosomal plasmid (Moulder et al., 1965). It is also the type strain for C. muridarum (ATCC VR 
123T). SPFD obtained from a hamster, is known to cause asymptomatic infection (Fox et al., 1993).  
3. 1. 3.    Chlamydia suis 
C. suis has only been isolated from swine, in which it may be endemic (Zahn et al., 1995; Szeredi et al., 
1996; Schiller et al., 1997) causing conjunctivitis, enteritis, pneumonia and a high incidence of 
apparently asymptomatic infections (Rogers et al., 1996; Rogers and Andersen, 1996; Rogers and 
Andersen, 1999). C. suis often appears as a mixed infection with C. abortus (Hoelzle et al., 2000). 
Several strains of C. suis are known to have an extrachromosal plasmid, pCS. Some strains have 
enhanced resistance to sulfadiazine and/or tetracycline, which is alarming for human health as C. suis 
is closely related to C. trachomatis (Everett, 2000; Lenart et al., 2001). Isolate S45T (ATCC VR 1474T) is 
the reference strain. 
3. 1. 4.    Chlamydia pneumoniae 
C. pneumoniae is comprised of three biovars, one human Taiwan acute respiratory agent (TWAR) and 
two animal biovars, Koala and Equine infecting horses and frogs respectively (Berger et al., 1999). 
TWAR causes about 10% of all community-acquired pneumonia in adults and 5% of bronchitis and 
sinusitis (Grayston et al., 1993). It is the third most common cause of pneumoniae and most infections 
are asymptomatic, especially in children. Transmission is person to person by respiratory particles. 
Furthermore, it has been associated with atherosclerosis (Grayston, 1999; Sessa et al., 2009), 
Alzheimer’s disease (Balin et al., 1998; Honjo et al., 2009), asthma (Clementsen et al., 2002; Newcomb 
and Peebles, Jr., 2009) and multiple sclerosis (Stratton and Wheldon, 2006). The Koala biovars isolates 
are commonly obtained from ocular and urogenital sites. All five Australian free-ranging koala 
populations are infected with C. pneumonia inducing respiratory illness (Everett, 2000). The Equine 
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biovar includes one respiratory isolate, N16, isolated from a nasal swab of a horse and contains an 
extrachromosomal plasmid (Wills et al., 1990). The type strain for C. pneumoniae is TW-183T (ATCC VR 
2282T). 
3. 1. 5.    Chlamydia pecorum 
C. pecorum has been isolated from mammals like ruminants (cattle, sheep, goats) (Fukushi and Hirai, 
1992), koalas (Girjes et al., 1993) and swine (Kaltenbroeck and Storz, 1992; Anderson et al., 1996). In 
koalas, clinical manifestations of C. pecorum include ocular infection leading to conjunctival scarring 
and blindness, respiratory tract infections, urinary tract infections causing incontinence, and genital 
tract infections potentially leading to infertility. In other animals, C. pecorum causes abortion, 
encephalomyelitis, conjunctivitis, pneumonia, enteritis and polyarthritis. The reference strain is E58T 
(ATCC VR 628T). 
3. 1. 6.    Chlamydia abortus 
C. abortus is endemic among sheep, goats and ruminants and has been associated with abortion, 
premature or full-term delivery of stillborn, moribund or weakly animals failing to survive beyond 48h. 
The disease among sheep is also known as ovine enzootic abortion (OEA) or enzootic abortion of ewes 
(EAE). OEA is recognized as a major cause of lamb loss in sheep throughout Europe and is encountered 
in most sheep-rearing areas of the world, including Africa and North-America. Cattle, pigs and horses 
are also infected, but it is thought to occur to a much lesser extent (Longbottom and coulter, 2003). C. 
abortus is well known as a zoonotic pathogen with the biggest threat to pregnant women, because of 
the ability of C. abortus to colonize the placenta. The outcome of human infection in the first trimester 
of pregnancy is likely to be spontaneous abortion, whereas later infection causes stillbirths or preterm 
labour (Hyde and Benirschke, 1997). The type strain for C. abortus is B577T (ATCC VR 656T). 
3. 1. 7.    Chlamydia felis 
C. felis is endemic among domestic cats worldwide, primarily causing inflammation of feline 
conjunctivae, rhinitis and respiratory problems (Gaillard et al., 1984). Transmission requires close 
contact between cats and ocular secretions are the most important body fluid for infection (Gruffyd-
Jones et al., 2005). There is evidence that C. felis may occasionally cause keratoconjunctivitis in humans 
and sporadically pneumonia, due to close contact between cats and their owners (Hartley et al., 2001; 
Browning, 2004). The type strain for C. felis is FP BakerT (ATCC VR 120T). 
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3. 1. 8.    Chlamydia caviae 
C. caviae primarily infects the mucosal epithelium of the conjunctivae of guinea pigs, resulting in ocular 
inflammation and eye discharge. It can also infect the genital tract of guinea pigs where the disease 
has many similarities with a human genital infection. There are six strains of C. caviae or guinea pig 
inclusion conjunctivitis (GPIC) isolated from guinea pigs, which share an identical ompA sequence 
(Zhao et al., 1993). The reference strain for C. caviae is GIPCT (ATCC VR 813T), which harbors an 
extrachromosomal plasmid pCpGP1 (Lusher et al., 1989). 
3. 1. 9.    Chlamydia psittaci 
C. psittaci causes worldwide respiratory diseases in pet birds and poultry. The infection is often 
systemic and can be unapparent, severe, acute or chronic with intermittent shedding. The symptoms 
include conjunctivitis, anorexia, nasal discharge, rhinitis, diarrhea, polyuria, dyspnea and dullness 
(Vanrompay et al., 1995a). Transmission of C. psittaci occurs by inhalation of aerosols created from 
respiratory tract exudates and faecal material of birds. The transmission can also be vertical through 
the egg (Wittenbrink et al., 1993). C. psittaci compromises nine known genotypes (A-F, E/B, M56 and 
WC) and is a well-known zoonotic pathogen. In humans, the disease can vary from mild flu-like 
symptoms to severe pneumonia (Beeckman and Vanrompay, 2009). Several strains harbor an 
extrachromosomal plasmid. The reference strain for C. psittaci is 6BCT (ATCC VR 125T). A more detailed 
discussion can be found in paragraph 6 and 7 of this chapter. 
3. 1. 10.    Atypical Chlamydiaceae 
In 2008, atypical Chlamydiaceae were detected for the first time in chickens during a psittacosis 
outbreak in Germany (Gaede et al., 2008). Subsequently, they were isolated from chickens in France, 
while atypical pneumonia were simultaneously reported among slaughterhouse workers in France 
(Larouceau et al., 2009). In 2012, ACC have also been detected in Australian, German, Greek, Croatian, 
Slovenian and Chinese chicken flocks (Robertson et al., 2010; Zocevic et al., 2012). These data suggest 
that ACC could be distributed worldwide among chickens. Interestingly, atypical strains of 
Chlamydiaceae were also indentified in turkeys and pigeons (Gasparini et al., 2011).  
3. 2.    Parachlamydiaceae 
The Parachlamydiaceae are Chlamydia-like endosymbionts that naturally infect free-living amoebae, 
specifically Acanthamoeba and Hartmanella (Amann et al., 1997; Horn et al., 2000). They have a 
Chlamydia-like cycle of replication and 80% to 90% homology of ribosomal genes. The 
Parachlamydiaceae family compromises two genera, of which the type strains are the Parachlamydia 
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acanthamoebae and the Neochlamydia hartmanellae (Greub and Raoult, 2002). It has been shown 
that P. acanthamoebae can induce respiratory disease in humans (Marrie et al., 2001). Moreover, 
experimental models have demonstrated the ability of P. acanthamoebae to enter and replicate within 
human macrophages (Greub et al., 2005) and pneumocytes (Casson et al., 2006) and to cause 
pneumonia in mice (Casson et al., 2008). In 2008, Parachlamydiaceae was linked to bovine abortion 
cases in Switzerland as the organism was detected by 16S rRNA PCR and within placental lesions by 
immunohistochemical analyses. Thus caution should be taken when handling bovine abortion material 
because of the potential zoonotic risk (Ruhl et al., 2008). Genome analysis showed that strain UWE 25 
contains no homologues of the major outer membrane protein (MOMP) or of the family of 
polymorphic outer membrane proteins (POMPs), but it does encode a complete Type III secretion 
system (T3SS) and some effector proteins (Horn et al., 2004). 
3. 3.    Waddliaceae 
The family of the Waddliaceae comprises a single genus, the type genus Waddlia and two species. The 
first species, Waddlia chondrophila currently includes only the type strain, WSU 86-1044T (ATCC VR 
1470T), which was isolated from the tissues of a first-trimester aborted bovine fetus (Dilbeck et al., 
1990). Waddlia was also demonstrated by PCR and serology in women with sporadic and recurrent 
miscarriages. Waddlia seropositivity was associated with animal contact suggesting that Waddlia may 
be zoonotically transmitted, but infection through contaminated water, uncooked meat, milk or sexual 
contact might also be the mode of transmission to humans (Corsaro et al., 2002; 2003; Baud et al., 
2007; 2008). In 2005, the second species, Waddlia malayensis was isolated from urine samples from 
fruit bats in Northern Malaysia. They are resistant to penicillin and streptomycin, but sensitive to 
tetracyclin (Chua et al., 2005). 
3. 4.    Simkaniaceae 
The family Simkaniaceae currently includes two genera: Simkania and Fritschea. The type species is 
Simkania negevensis, originally discovered as contaminant in a human cell culture (Corsaro et al., 2003; 
Kahane et al., 1995). Its original host is unknown, but it grows well in Acanthamoeba spp. and other 
amoeba (Kahane et al., 2001). On the basis of molecular and serological data, Simkania negevensis has 
been associated with bronchiolitis and community-acquired pneumonia in children and with 
exacerbation of chronic obstructive pulmonary disease in adults (Kahane et al., 1998; Lieberman et al., 
1997; 2002). Simkania negevensis has a longer developmental cycle when compared to other 
chlamydiales (7-12 versus 2-3 days) (Kahane et al., 1999; 2002). The type strain ZT does not possess an 
extrachromosomal plasmid (Everett et al., 2000). Fritschea are endosymbionts of the plant-feeding 
whitefly Bemisia tabaci and scale insect Eriocococcus spurius. In the gut of Bemisia tabaci, these 
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bacteria live within bacteriocytes transmitted directly from the parent to the oocytes (Everett et al., 
2005). 
4.    Morphology 
4. 1.    Developmental forms 
Chlamydiaceae are obligate intracellular pathogens with a unique biphasic developmental cycle, in 
which it alternates between two distinct morphological forms, the small extracellular infectious 
elementary body (EB) and the intracellular, non-infectious, metabolically active reticulate body (RB), 
as well as by intermediate forms (IBs) (Vanrompay et al., 1996). 
Elementary bodies are small, spherical or occasionally pear shaped electron-dense structures with a 
diameter of 0.2-0.3 µm. It is characterized by a dense, eccentric core of condensed DNA and chromatin 
and it has a granular appereance due to the presence of 70S ribosomes (Fig. I-2A/C). The EB is the only 
infectious stage of the chlamydial developmental cycle. It functions as a tough ‘spore-like’ body whose 
purpose is to permit chlamydia survival in the non-supportive environment outside the host cell. This 
resistance to both physical and chemical factors in the extracellular environment is a consequence of 
the rigidity of the cell envelope, which is both osmotically stable and poorly permeable, and also of the 
greatly reduced surface area of the EB (Longbottom and Coulter, 2003). The EB is thought to be 
metabolically inert until it attaches to, and is endocytosed by, a susceptible host cell. It contains only 
small amounts of the bacterial cell wall strengthening substance, peptidoglycan (Everett et al, 1994). 
Instead it derives its strength from cross links (S-S bridges) formed between the sulphur atoms of its 
sulphur amino acids (cysteine and methionine) rich proteins in the outer envelope, the cysteine rich 
proteins (Newhall and Jones, 1983).  
The non-infectious reticulate bodies have a diameter of 0.5-1.6 µm and are responsible for 
intracellular replication. They are metabolically active and as a consequence their cytoplasm is rich in 
ribosomes and RNA, which are required for protein synthesis (Longbottom and Coulter, 2003). They 
possess a fragile membrane lacking the extensive disulfide bonds characteristic of the EB, resulting in 
a more permeable membrane to facilitate nutrient uptake (Newhall and Jones, 1983). Their nucleoid 
acid appears diffuse and fibrillar. The differentiation of EB to RB involves an expansion to a diameter 
ranging from 0.5 to 1.6 µm, resulting in a less electron dense cytoplasm in which the nucleus can no 
longer be distinguished (Fig. I-2D). 
During the developmental cycle, RBs begin to differentiate again into EBs inside the chlamydial 
inclusion. The initial sign of this differentiation is the re-condensation of chlamydial nucleic acid in to 
histone protein. This stage is called the intermediated body with a diameter of 0.3 to 1.0 µm and a 
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central electron dense core (Fig. I-2B) (Litwin et al., 1961; Costerton et al., 1976; Vanrompay et al., 
1996). 
    Fig. I-2: Overview of C. psittaci and C. trachomatis developmental forms.  
 
A. Transmission electron microscopic picture of a section throough an EB of C. psittaci. Note the projections 
extending from the outer membrane. The bar represents 0.15 µm. Adapted from Matsumoto (1988). 
B. An intermediate body of C. trachomatis undergoing differentiation. Two points of condensation of DNA 
into electron dense nucleoids (n) can be observed as well as the inner cytoplasmic membrane and the outer 
envelope (env). The bar represents 0.25 µm. Adapted from Ward (1988). 
C. Stereographic viewing of a purified EB surface. The bar represents 0.1 µm. Adapted from Matsumoto 
(1982) 
D. Transmission electron microscopic picture of a section through an RB of C. psittaci. Surface projections 
penetrating the inclusion membrane can be observed. The bar represents 0.1 µm. Adapted from 
Matsumoto (1988).   
 
4. 2.    Outer membrane composition 
The cell envelope of Chlamydiaceae consists of a cytoplasmatic inner membrane and an outer 
membrane separated by a periplasmatic space. The outer membrane contains proteins, phospholipids, 
lipopolysaccharides (LPS) and lipids. The most striking feature of the chlamydial envelope is the 
presence of negligible amounts of peptidoglycan (Hatch, 1996; Moulder, 1993). This is in contrast to 
other Gram-negative bacteria where a part of the cell wall contains peptidoglycan, covalently bound 
A B
C D
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to lipoproteins, which is insoluble in ionic detergents like sacrosyl. However, a part of the cell wall of 
Chlamydiaceae is still insoluble in ionic detergents, called the Chlamydia Outer Membrane Complex’ 
or COMC. This complex consist of the ‘Major Outer Membrane Protein’ (MOMP), Polymorphic 
membrane proteins (Pmps) and two cysteine rich proteins (CRP): Outer membrane complex A protein 
(OmcA or Omp3) and Outer membrane complex B protein (OmcB or Omp2) (Hatch et al., 1984; Sardinia 
et al., 1988; Stephens et al., 2001). The outer membrane is further composed of Omp85, PorB, LPS and 
the heat shock proteins hsp60 and hsp70. A schematic overview of the chlamydial envelope is given in 
Figure I-3. 
A combination of the double-layer membrane and efficient efflux pumps present in Chlamydiaceae 
prevent effective translocation across the membrane of these bacteria. Multidrug efflux mechanisms 
are broadly conserved in bacteria. In Chlamydia spp., efflux is the predominant mechanism of 
tetracycline resistance (Dugan et al., 2004; Pool, 2005). 
Fig. I-3: Schematic overview of the envelope of chlamydial EBs. In the outer membrane, MOMP, both CRPs 




4. 2. 1.    Major outer membrane protein 
The chlamydial major outer membrane protein (MOMP) was discovered in 1981 by three independent 
laboratories, due to relatively new techniques of SDS-PAGE electrophoresis (Hatch et al., 1981; 
Caldwell et al., 1981; Salari and Ward, 1981). The 40 kDa MOMP is one of the predominant proteins at 
the surface of EBs and RBs, where it covers 60% of the total outer membrane protein (Caldwell et al., 
1981).  MOMP is critical for its chlamydial function because it functions as a structural protein (Hatch, 
1996), a general porin (Bavoil et al., 1984; Wyllie et al., 1998; Jones et al., 2000) and a potential 
chlamydial cytoadhesin (Su et al., 1990; Swanson and Kuo, 1994). The most widely studied and 
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accepted function of MOMP is that of a porin. Exposure to thiol reducing agents lead to reduction in 
disulfide bridges, opening up its pore structure for the uptake of nutrients and partly triggering the 
early differentiation of EBs after entry in the host cell. These porin characteristics were also confirmed 
by electrical studies of native and recombinant MOMP in planar lipid bilayers (Wyllie et al., 1998; 
1999). Like other bacterial porins, MOMP has predominantly β-sheet content (62%) (Wyllie et al., 
1998). Four variable domains (VD1 to 4), located on the outer loops (i.e. exposed on the surface) are 
flanked by highly conserved regions (Baehr et al., 1988; Yuan et al., 1989). These variable domains 
contain genus-, species-, subspecies- and serovar-specific antigenic determinants (Caldwell et al., 
1981; Everett, 2000; Kim and DeMars, 2001). The serovar- and subspecies-specific epitopes are 
surface-exposed and act as targets for neutralizing antibodies, while the species- and genus-specific 
epitopes are inaccessible to antibodies and therefore non-neutralizing (Batteiger et al., 1986; Kuo and 
Chi, 1987; Zhang et al., 1987). Since MOMP is immunodominant and generates host antibodies which 
are protective, there was much interest in MOMP as a candidate for vaccine development. 
4. 2. 2.    Cystein-rich proteins: OmcA and OmcB 
Apart from MOMP, the major proteins in the COMC are the two cysteine-rich proteins (CRPs) OmcA 
and OmcB. OmcB or Omp2 is the largest of the two CRPs with a molecular weight of 60 kDa. The amino 
acid sequence reveals a protein containing 24 cysteine residues, where the position of these residues 
is highly conserved (Allen and Stephens, 1989). OmcB is highly conserved among chlamydia species. It 
is a structural protein involved in the conversion of the RB to the EB (Mygind et al., 1998) and believed 
to contribute to the cell-wall rigidity and osmotic stability of the EB (Newhall, 1987). Furthermore, it is 
highly immunogenic (Sanchez-Campillo et al., 1999), carries genus-specific epitopes (Watson et al., 
1994) but it is thought not to be surface accessible to antibody binding (Watson et al., 1994; Everett 
and Hatch, 1995). OmcB seems to be located in the periplasm (Everett and Hatch, 1995). However, a 
few reports have suggested that it plays a role in attachment and invasion of the host cell (Ting et al., 
1995; Stephens et al., 2001). Later studies indicate that OmcB from C. trachomatis serovar LGV1 
functions as an adhesion and is indeed surface exposed (Fadel and Eley, 2007; 2008). OmcA or Omp3 
has a molecular of 9-12 kDa. This cysteine rich lipoprotein is anchored to the outer membrane by its 
lipid moiety with a hydrophilic peptide extending to the periplasm (Everett and Hatch, 1995). 
The CRPs of the COMC are present in the outer membrane of the EBs. They do not appear in RBs, only 
during the differentiation from RB to EB (Newhall, 1987; Sardinia et al., 1988; Everett and Hatch, 1995; 
Sanchez-Campillo et al., 1999). It has been proposed that disulphide cross-linked polymers of OmcB 
were the functional equivalent of peptidoglycan forming a disulphide cross-linked network with the 
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perisplasmic domains of OmcA and other membrane protein like MOMP. This might account for the 
structural stability of EBs (Hatch et al., 1986; Hackstadt et al., 1985; Everett and Hatch; 1995). 
4. 2. 3.    Lipopolysaccharide 
According to other gram-negative bacteria, the chlamydial outer membrane contains an antigenically 
important lipopolysaccharide (LPS) with a molecular weight of 10 kDa. Chlamydial LPS harbors a genus-
specific epitope composed of a 3-deoxy-D-mannose-oct-2 ulopyranosonic acid (Kdo) trisaccharide with 
the sequence αKdo-(2→8)-αKdo-(2→4)-αKdo which is surface exposed and highly immunogenic 
(Brade et al., 1986). The structure is unique to Chlamydiaceae because two of the Kdo residues are 
linked through a 2→8 linkage (Brade et al., 1987). 
4. 2. 4.    Polymorphic membrane proteins 
In 1996, the group of David Longbottom has identified and isolated a group of proteins of 
approximately 90 kDa present in the outer membrane of C. abortus strain S26/3, called the 
polymorphic membrane proteins or pmps (Longbottom et al., 1996; 1998). Genome sequencing of 
chlamydial genomes revealed a pmp family unique to Chlamydiales that plays an important role in the 
biology and disease pathogenesis. There are 17 pmp genes identified for C. Caviae (Read et al., 2003), 
21 for C. pneumonia (Kalman et al., 1999), 9 for C. trachomatis (Stephens et al., 1998), 12 for C. felis 
(Harley et al., 2007) and 18 for C. abortus (Thomson et al., 2005). The pmp genes encode large proteins 
of 288 to 582 amino acids. These proteins are polymorphic in both amino acids and predicted size. 
However, they all encode repeats (2-13 copies) of the amino acid sequence GGAI and FXXN in the 
amino-terminal of the protein (Kalman et al., 1999; Grimwood et al., 2001). They also have the amino 
acid phenyl-alanine at the amino terminus and most have signal peptides indicating that they are likely 
membrane proteins. By protein structure analysis, they are predicted to be autotransporters that 
mediate the translocation of the N terminus to the bacterial surface (Vandahl et al., 2001; Henderson 
and Lam, 2001). They also contain multiple GGAI motifs, which have been associated in other 
organisms with adhesion to the host cell (Grimwood and Stephens, 1999). 
4. 2. 5.    PorB 
Genome sequence has revealed a predicted protein CT713 with weak sequence homology to MOMP 
and a molecular weight of 37 KDa (Stephens et al., 1998). Functional analysis showed pore-forming 
capabilities when tested in a liposome-swelling assay, but they were different from the porine 
capabilities of MOMP. Therefore this protein was named PorinB (PorB) because it was the second porin 
characterized in Chlamydia (Kubo and Stephens, 2000). PorB is localized in the outer membrane 
complex of Chlamydia and it is surface accessible but it is present at much lower amounts than MOMP 
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in the COMC (Kubo and Stephens, 2000). PorB and MOMP are both porins facilitating the diffusion of 
solutes through the outer membrane. MOMP is a general porin, permitting the diffusion of a wide 
variety of compounds, like polysaccharides and amino acids including glutamate. In contrast PorB is a 
more specific porin, transporting dicarboxylic acids such as 2-oxoglutarate in order to complete the 
tricarboxylic acid (TCA) cycle and providing carbon and energy production intermediates (Iliffe-Lee and 
McClarty, 2000; Kubo and Stephens, 2001). 
4. 2. 6.    Omp85 
Omp85 is a conserved outer envelope protein found in a number of Gram-negative bacteria, including 
N. gonorrhoeae, T. pallidum and H. influenza (Stephens and Lammel, 2001). Omp85 is present in the 
chlamydial outer membrane complex but no porin activity has been detected so far. Because Omp85 
is surface-accesible, antibodies against Omp85 can neutralize chlamydial infection in vitro, which make 
Omp85 a valid candidate for vaccine development (Kubo and Stephens, 2001). Omp85 proteins have 
been shown to be essential for bacterial cell viability, lipid transport to the outer membrane (Genevrois 
et al., 2003) and the assembly of outer membrane proteins (Voulhoux et al., 2003). 
4. 2. 7.    Heat shock proteins 
Heat shock proteins (HSP) are highly conserved intracellular proteins. Their amino acid composition 
has not changed very much throughout evolution and they are expressed in both prokaryotes and 
eukaryotes. Different chlamydial heat shock proteins have been identified: Hsp10, Hsp60 and Hsp70 
(Kornak et al., 1991; Brunham and Peeling, 1994). HSP functions as chaperone proteins concerned with 
the intracellular folding and refolding, assembly and translocation of proteins. Their expression is 
increased when cells are exposed to stress like elevated temperature, protein degradation, mechanical 
stress and chemical stress (Van Eden et al., 1998). In Chlamydia, Hsp60 facilitates protein folding (Fink, 
1999; Hartl and Hayer-Hartl, 2002; Tsan and Gao, 2009) and antibodies against C. trachomatis Hsp60 
have been correlated with severe outcome of chlamydial infections in women (Zhong and Brunham, 
1992). The chlamydial Hsp70 has been best studied, has a molecular weight of 75 kDa, and prevents 
the misfolding and aggregation of polypeptides (Fink, 1999; Hartl and Hayer-Hartl, 2002; Tsan and Gao, 
2009). This protein shares approximately 50% sequence homology with other species. It is also a 
potential vaccine candidate as antibodies to the protein can neutralize the organism in cell culture 
(Danilition et al., 1990). However, the homology between chlamydial and human Hsp is so high that 
antibodies may crossreact resulting in an auto-immune disease (Capello et al., 2009). 
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5.    Developmental cycle 
Chlamydiaceae are obligate intracellular bacteria which means that they can only replicate inside 
eukaryotic host cells. The chlamydial development cycle is a complex multi-stage process characterized 
by the entry, the early differentiation, the exponential growth and inclusion expansion, detachment 
and late differentiation and finally, cell lysis or exocytosis (Figure I-4). Chlamydiaceae have a unique 
biphasic developmental cycle which involves predominantly two alternating morphological forms, the 
EB and the RB. The EBs have the ability to attach and invade susceptible host cell, whereas the RBs 
carry out bacterial multiplication within the cells (Stagg, 1998; Abdelrahman and Belland, 2005).  
The acute infection starts with the attachment of EBs to the cytoplasmatic membrane of a susceptible 
host cell inducing its own internalization in membrane bound vacuoles termed inclusions. These 
inclusions avoid phagosome-lysosome fusion. EBs differentiate into metabolically active RBs and 
undergo repeated cycles of binary fision leading to secondary differentiation back to EBs. Eventually, 
EBs and some non-differentiated RBs are released from the host cell through lysis or exocytosis. Under 
certain conditions like nutrient deprivation, antibiotics or immune factors (IFN-γ), the developmental 
cycle is disrupted, resulting in the appearance of large, aberrant RBs. This phenomenon is known as 
persistence, in which no visible growth of the chlamydial organism can be observed (Mpiga and 
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Fig. I-4: Schematic representation of the development cycle of Chlamydiaceae (Beeckman, 2009). 
 
5.1    Attachment and internalization 
Attachment of EBs to the host cell occurs in a two-steps process. The initial attachment happens via 
reversible electrostatic interactions of the bacteria with heparin sulfate containing glycosaminoglycans 
(GAGs) (Zhang and Stephens, 1992). Second, an irreversible, temperature-dependent receptor-ligand 
binding was demonstrated that induces internalization (Fudyk et al., 2002). So far, the receptor 
responsible for the binding has yet to be identified. Possible bacterial adhesion candidates include 
MOMP, OmcB, Hsp70 and PmpD (Raulston et al., 1993, Ting et al., 1995; Wehrl et al., 2004; Hackstadt, 
1999). MOMP has also been implicated in the entry of chlamydiae into their host cell. It promotes non-
specific electrostatic interactions followed by more specific hydrophobic interactions acting as an 
adhesion (Su et al., 1990). 
Ultrastructural studies have shown that chlamydiae preferentially bind to the host cell near the base 
of microvilli. This might be advantageous since the membrane regions at the bases of the microvilli are 
areas of active transport of extracellular material into the cell, possibly facilitating rapid and efficient 
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entry (Hodinka and Wyrick, 1986; Doughri et al., 1972; Wyrick and Richmond; 1989; Vanrompay et al., 
1996; Hodinka et al., 1988). Electron microscopic studies suggest two possible mechanisms for 
chlamydial internalization. The first one involves a sequential zipper-like microfilament-dependent 
process of phagocytosis requiring drirect contact between bacterial adhesins and host cell receptors 
(Byrne and Moulder, 1978). The second one involves uptake into clathrin-coated vesicles by receptor 
mediated endocytosis (Hodinka et al., 1988; Vanrompay et al., 1996). Following the attachment, the 
type III secretion system (T3SS) is also activated and effector proteins are secreted into the host cell, 
including the bacterial protein Tarp (Translocated Actin-Recruiting Phosphoprotein), resulting in actin 
rearrangements and active uptake of the bacteria by means of an endocytotic vacuole (Abdelrahman 
and Belland, 2005). Chlamydiaceae are able to inject Tarp and other effector proteins because EBs 
have a preformed T3SS loaded with bacterial effector proteins (Bavoil and Hsia, 1998).  
5.2 Inclusion forming and proliferation 
After internalization, chlamydiae modify the properties of its inclusion; thereby preventing normal 
trafficking through the host endocytic pathway, effectively dissociating it from late endosomes and 
lysosomes.  In normal conditions, lysosomes fuses with pathogen-containing phagosomes, releasing 
acidic hydrolases in the resulting phagolysosomes in order to eradicate the pathogen. Chlamydiaceae 
have developed mechanisms to avoid this phagolysosomal fusion. Many theories have been evoked 
that attempt to explain this inhibiton and these are summarized in a review by Escalante-Ochoa et al. 
(1998). However, in vitro analyses show that not every inclusion escapes fusion with lysosomes 
depending on the kind of host cell, chlamydial strain and the conditions (Moulder, 1991). Within a few 
hours post infection, the inclusions are trafficked to the perinuclear region of the host cell using 
microtubules (Scidmore et al., 1996). This migration brings the inclusion in close proximity to the Golgi 
apparatus to acquire endogenously synthesized spinghomyelin and cholesterol (Hackstadt et al., 1995; 
Rockey et al., 1996; Wolf and Hackstadt, 2001). These processes occur early in the developmental cycle 
and are necessary for successful replication of Chlamydiaceae within a host cell.  
Meanwhile, by 8 hours post infection, primary differentiation from EBs into metabolically active RBs 
takes place. Subsequently, these RBs migrate to the periphery of the inclusion and start replication by 
binary fission resulting in exponential growth of the pathogen and increase in inclusion size. At the 
beginning of the reproductive stage, the chlamydial inclusion is closely associated with mitochondriae, 
facilitating the transfer of ADP and ATP to the bacteria. Remarkably, this association is only seen in 
infections with C. psittaci (Matsumoto et al., 1991). The T3SS remains active in RBs and continues to 
secrete effectors into the host cytoplasm. An important group of proteins secreted by the T3SS are the 
Inc proteins which insert into the inclusion membrane and are thought to interact with host proteins. 
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They share a common hydrophobicity motif that span the inclusion membrane (Rockey et al., 2002). 
Interestingly, the inclusion must be actively modified otherwise the chlamydiae will be degraded.  
Following the bacterial replication, RBs will re-differentiate into EBs, termed secondary differentiation. 
From 24 hours post infection, asynchronous replication occurs resulting in RBs that continue to 
replicate and RBs that will differentiate into infective EBs (Dunn and Valdivia, 2010). The signal for this 
secondary differentiation is unknown, but speculative mechanisms have been proposed that the 
dissociation of dividing RBs from the inclusion membrane could be a trigger. The removal of the T3SS 
from the inner surface of the inclusion membrane has been suggested as a critical event in this process 
(Bavoil et al., 2000). This hypothetical mechanism could also explain the asynchronous nature of 
secondary differentiation. 
5.3    Exit from the host cell 
After secondary differentiation, the newly formed EBs and some non-differentiated RBs will exit the 
host cell at 24 to 72h post infection through several mechanisms: 1) host cell lysis (Rockey et al., 1996; 
Campbell et al., 1989), 2) exocytosis (Todd and Caldwell, 1985), 3) caspase-independent apoptosis 
(Perfettini et al., 2002) and 4) extrusion (Hybiske and Stephens, 2007). In this way, EBs will infect 
neighbouring cells, thereby spreading the bacterium, and consequently the disease, and enabling 
further proliferation of the bacteria in the host. Because Chlamydiaceae reside within an inclusion, it 
needs to traverse two membranes to escape the host cell. Lysis of the host cell is a destructive mode 
of release leading to rupture of the inclusion and cellular membrane, resulting in the death of the host 
cell. Upon lysis, EBs can diffuse outward and infect new cells. In contrast, extrusion represented a 
packaged release process in which a portion of the chlamydial inclusion was released by membrane 
protrusion. This process left the original cell and residual inclusion intact. But the consequence of 
extrusion-mediated release is less clear. It is possible that rupture and release of EBs occur after they 
have moved to a safer location, away from preexisting local immune responses. Alternatively, these 
extrusions could also be engulfed by macrophages, in which secondary infection and dissemination in 
the host are facilitated (Hybiske and Stephens, 2007). 
5.4    Persistence 
Chlamydiaceae have the ability to interrupt the developmental cycle, resulting in a persistent infection. 
A persistence infection is determined as a long-term relationship between Chlamydia and their host 
cell in which these bacteria remain in a viable but culture-negative state. In vitro, persistence can be 
induced by iron deficiency (Raulston, 1997), monocyte infection (Koehler et al., 1997), continuous 
culture (Kutlin et al., 2001), penicillin treatment (Matsumoto and Manire, 1970), phage infection (Hsia 
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et al., 2000), amino acid starvation (Coles et al., 1993) and IFN-γ exposure (Beatty et al., 1993). The in 
vitro persistence systems are characterized by altered Chlamydial growth, describing enlarged and 
pleomorphic RBs that neither undergo binary fission, nor differentiate to EBs, but nevertheless 
continue to replicate their chromosomes. These RBs are called aberrant RBs.  
6.    Type III secretion system in Chlamydiales 
6. 1.    Introduction 
The type III secretion system (T3SS) has been described in a wide variety of Gram-negative pathogens 
including Yersinia, Salmonella, Shigella, Escherichia, Pseudomonas, Bordetella, Burkholderia, 
Chlamydiaceae and a number of plant pathogens (Cornelis and Van Gijsegem, 2000; Hueck, 1998). This 
system functions as a kind of ‘molecular syringe’, enabling Gram-negative bacteria to translocate 
virulence-related proteins into the cytoplasm of host cells (Hueck, 1998). The injected proteins subvert 
the functioning of the host cell or destroy its communication, favoring the entry or survival of the 
invading bacteria.  
There are seven major classes of protein secretion systems, which can be divided into Sec-dependent 
and Sec-independent systems. The Sec-dependent secretion systems deliver proteins into the 
periplasmic space from which the proteins are transported across the outer membrane. Sec-
independent secretion systems, as the T3SS, deliver proteins directly from the bacterial cytosol across 
the bacterial membranes (Thanassi et al., 2000; Economou et al., 2006). 
Decades before the first visualization of a T3SS in Salmonella, electron microscopic observations 
revealed the presence of many hexagonally organized surface projections arranged regularly with a 
center to center spacing of approximately 50 nm of both EBs and RBs of different chlamydial species. 
These structures have a rotational symmetry corresponding to a 9-subunit composition (Matsumoto, 
1973; 1982; Matsumoto et al., 1976), which were later assumed to be the T3SS of the bacteria (Fields 
et al., 2003). 
Genome sequencing showed that Chlamydiaceae possesses most of the genes for a functional T3SS 
(Stephens et al., 1998), which are scattered throughout chlamydial genomes in four main clusters 
(Fields and Hackstadt, 2006) arranged into multiple operons (Hefty and Stephens, 2007). The molecular 
G+C content of each chlamydial T3S cluster is similar to the roughly 40% level found in the remainder 
of respective genomes (Stephens et al., 1998). This is in contrast to T3S genes of other Gram-negative 
bacteria which are clustered in pathogenicity islands (PAI) on a plasmid or the bacterial chromosome, 
suggesting that they have been acquired by horizontal gene transfer (Mecsas and Strauss, 1996). 
Furthermore, the nucleotide content of these T3SS coding sequences are often denoted by a low G+C 
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ratio (Tampakaki et al., 2004). However, some of the chlamydial T3S clusters lack gene arrangements 
consistent with horizontal gene transfer or PAIs and are flanked by tRNAs and insertion elements. 
These observations have provided the basis for hypothesis stating that the T3SS of Chlamydiaceae 
represent an ancestral or primordial system (Stephens et al., 1998; Kim, 2001), which is functionally 
adapted to the developmental cycle of Chlamydiaceae and the need of these bacteria to survive host 
defenses on both sides of the eukaryotic plasma membrane. 
6. 2.    Composition of the chlamydial T3SS 
The basal structure of a T3SS consists of a basal body and an external hollow needle through which 
effector molecules are transported. The basal body connects both the inner and outer membrane and 
forms the base for the needle structure. At the tip of the needle, adaptor proteins are assembled which 
are involved in host cell sensing. Upon contact with the target cell, a pore is formed in the host cell 
membrane by translocon proteins. In that way, effector molecules can be transported from the 
bacteria into the host cell cytoplasm.  
The T3SS is regulated in two important ways. Firstly, the assembly of the T3SS is tightly controlled at 
transcriptionally, translationally and post-translationally level in a yet undefined manner. Secondly, 
the secretion of effector molecules is controlled by a blocking plug, the SctW protein. Activation of the 
T3SS results in the secretion of a this blocking plug along with the translocon proteins. The blocking 
plug is able to block the T3S channel in order to control the secretion of effectors proteins (Lara-Tejero 
et al., 2011; Osborne and Coombes, 2011).  
The channel of the needle is too small (2-3 nm) to allow folded proteins to pass through the needle. 
Therefore, effector molecules need to be (partially) unfolded for translocation (Stebbins and Galan, 
2003; Parsot et al., 2003). Generally, chaperones aid the non-covalent folding or unfolding and the 
assembly or the disassembly of other macromolecular structures. They play an important role in the 
T3S function via their interaction with effector and translocator proteins. T3SS chaperones can be 
separated into five classes based on their substrate specificity and structural features. Class I 
chaperones assist the effector proteins, while chaperones of Class II interact with the translocator 
proteins. Chaperones of the related bacterial flagellar apparatus belong to Class III. Class IV has only 
one member, CesA which accompanies the EspA filament protein of enteropathogenic E. Coli (Yip et 
al., 2005). Yersinia YscE and its Pseudomonas homolog PscE with their co-chaperones YscG and PscG 
group together in Class V (Wilharm et al., 2007). Only Class I and Class II will be highlighted as they are 
well characterized. Class I chaperones interact with effector proteins, directing them to the ATP-ase, 
which unfolds effector proteins and detach the chaperone (Galan, 2008). As the hydrophobic 
translocator proteins possess toxic properties for the bacteria, they are protected by class II 
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chaperones (Menard et al., 1994; Wattiau et al., 1994; Neyt and Cornelis, 1999). The concentration of 
free chaperones is an indication if the pore of the T3SS is made (Page and Parsot, 2002). 
The discovery of different genes encoding proteins involved in T3SS led to the exception that 
Chlamydiae possess a T3SS (Hsia et al., 1997). The chlamydial T3S model was described by Beeckman 
and Vanrompay (Beeckman and Vanrompay, 2010), classifying the T3SS into several components: the 
exporter, the basal body, the secreton, the needle and the translocon (Figure I-5).  
 
Fig. I-5: Schematic representation of Type III secretion system in Chlamydiaceae as suggested by Beeckman 
and Vanrompay (2010). On the left side is an inactive T3SS shown, while the right side represents a T3SS 
after activation. Legend: IM, bacterial inner membrane; OM, bacterial outer membrane; IncM, Inclusion 
membrane. 
 
The exporter surrounds the basal body and consists of several proteins (SctR, SctS, SctT, SctU, SctV and 
SctN) located in the inner membrane at its cytoplasmic face. The exporter is responsible to mediate 
active transport of effector proteins to the periplasmic space. The proteins SctR, SctS, SctT and SctU 
are membrane proteins. The protein SctV forms a channel though which effector proteins can cross 
the inner membrane (IM). The protein SctN uses ATP to give energy to the T3SS and it also plays a role 
in the interaction with effector proteins through ATP-dependent unfolding and chaperone release 
prior to translocation (Akeda and Galan, 2005; Sorg and Cornelis, 2009). The proteins SctJ, SctD, SctQ 
and SctL form the basal body which is needed for the correct anchoring of the needle complex. The 
secreton consists of the proteins SctC and SctW and is involved in the transport of effector molecules 
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across the outer membrane. SctD and SctC are connected by the lipoprotein SctJ that bridges the outer 
and the inner membranes (Allaoui et al., 1992; Hueck, 1998). The protein StcQ is responsible for 
shuttling chaperone/effector complexes to the protein SctN (Stone et al., 2008) for unfolding and 
chaperone release. The proteins SctF and SctP make up the hollow needle, where T3SS proteins can 
travel to cross the membranes. As mentioned above, the translocon pore is built into the host cell 
membrane upon host cell contact sensed by a multimeric protein complex of LcrV at the needle tip, 
which are also known as adaptor proteins (Blocker et al., 2008). CopB and CopD form a heterodimeric 
translocon in the host cell membrane that enables the needle to dock and subsequently deliver 
effector molecules in the cytoplasm of the host cell. 
As opposed to the conserved feature of the T3SS, effector proteins are highly divergent in sequence 
and function between bacterial species. Most of these effector molecules mimic the host cell proteins 
to utilize and manipulate the host cell. There are able to interact with the host without significant 
harm, to modify the cellular targets to alter their activity and to evade and escape the host cell immune 
response. Effector proteins can act in concordance with other effector proteins to result in a highly 
complex field of interactions (Galan 2009; Shames and Finlay, 2010, Brodsky and Medzhitov, 2009). 
The secreted T3S effector proteins and their possible function are summarized in table I-2. 
Table. I-2: Overview of chlamydial T3S effector proteins and their possible function (Beeckman and 
Vanrompay, 2010; Peters et al., 2007; Betts et al., 2009; Betts-Hampikian and Fields, 2010).  
 














Inclusion membrane protein 
Inclusion membrane protein 
Inclusion membrane protein 
Invasion, recruitment and nucleation of actin at the site of entry 
Modulation of host cell apoptosis 
Induction of cytokine response 
CD8+ T-cell antigen 
Ser/Thr protein kinase activity 
Ruler protein involved in determination of needle length 
Circumvent lysosomal fusion 
Unknown 
Interaction with human AHNAK 
Interaction with human GCIP 
 
 
6. 2.    Role of T3SS in the chlamydial lifecycle 
The T3SS plays a pitoval role in the chlamydial developmental cycle. It modifies the intravacuolar 
environment to favor the different stage of the chlamydial lifecycle. 
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During adhesion and entry in the host cell, the effector molecule Tarp (translocated actin-recruiting 
phosphoprotein) is translocated within minutes following attachment and induces actin recruitment 
to invade the host cell. During infection, Chlamydiaceae have developed mechanisms to avoid the 
phagolysosomal fusion, which is most likely accompanied by an active modification of the inclusion 
membrane by chlamydial Incs (Hackstadt et al., 1997; Wyrick, 2000). Furthermore, the inclusion of 
Chlamydiaceae mimicks the phospholipid composition of the host cell. In this way, there are able to 
intercept nutrient and essential molecules from the eukaryotic trafficking pathways of the host cell like 
sphingomyelin, glycerophospholipids and other lipids (Hatch and Mc Clarty, 1998). Later on, physical 
detachment of RBs from the inclusion membrane provokes T3S downregulation with upregulation of 
the SctW protein expression, which is the signal for the differentiation from RBs into EBs (Hackstadt et 
al., 1997; Bavoil and Hsia, 1998; Bavoil et al., 2000). 
7.    Avian chlamydiosis 
7. 1.    Classification of avian strains 
All known avian strains belong to the species Chlamydia psittaci within the order of Chlamydiales. C. 
psittaci can be further classified with serovar-specific monoclonal antibodies against serovar-specific 
epitopes of the MOMP into six avian serovars (serovar A to F) along with two mammalian serovars (WC 
and M56) (Andersen, 1991; Vanrompay et al., 1993; Vanrompay et al., 1997b). Progress in the field of 
molecular techniques has led to the sequencing of the ompA gene -encodes the major outer 
membrane protein MOMP-, which allow to classify avian C. psittaci strains into genotypes. These 
genotypes are largely congruent with the known serovars, which can be characterized by sequencing 
(Everett et al., 1999), genotype-specific real-time PCR (Geens et al., 2005) or micro-arrays (Sachse et 
al., 2008). However, sequencing of the ompA gene has revealed a new genotype, namely genotype 
E/B. As genotype E/B reacts with the serovar-specific monoclonal antibodies E and B, it is impossible 
to distinguish this genotype with monoclonal antibodies. 
Table. I-3: Overview of C. psittaci genotypes 
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The currently known genotypes tend to be relatively host-specific. Genotype A has been shown to 
infect psittacine birds, whereas genotype B is most prevalent in pigeons. Genotype C has been 
primarily isolated from waterfowl such as ducks and geese and genotype D has the highest prevalence 
in turkeys. Genotype E has the most diverse host range infecting pigeons, ratites, ducks and turkeys. 
Genotype F has been detected in in psittacine birds and turkeys and genotype E/B has been so far 
mainly isolated from ducks. WC and M56 has been shown to occur in Wolfsen cattle and muskrats, 
respectively. All genotypes should be considered as a zoonotic risk as they are readily transmissible to 
humans. 
7.2.     Epidemiology 
From 1938, it became clear that C. psittaci not only infects psitaccine birds but also other bird species 
like poultry such as chickens, turkeys, ducks and geese but also wild birds (Vanrompay et al., 1995a). 
In the early 1950s, C. psittaci could be isolated from turkeys and humans due to a severe respiratory 
outbreak in the turkey industry in the US (Meyer, 1967). Psittacosis outbreaks were also reported in 
the European poultry industries in the 1990s (Ryll et al., 1994; Vanrompay et al., 1997; Sting et al., 
2006). Recent publications show considerable evidence that C. psittaci is nearly endemic in the poultry 
industry in Belgium and other European countries (Sting et al., 2006; Van Loock et al., 2005; Verminnen 
et al., 2008; Dickx et al., 2010; Yin et al., 2013a; Lagae et al., 2013). Nowadays, farm outbreaks seem 
to be associated with mild respiratory signs and low mortality. However, it has been recently reported 
that chlamydiosis increases in people working with poultry (Laroucau et al., 2008; Laroucau et al., 2009, 
Van Droogenbroeck et al., 2009; Dickx et al., 2010, Lagae et al., 2014). At this moment, C. psittaci has 
been found in at least 465 bird species, spanning 30 different bird orders (Kaleta and Taday, 2003). 
7.3.     Transmission 
Transmission of C. psittaci from one bird to another susceptible bird occurs by inhalation of aerosols 
created from respiratory tract exudates, eye and nostril secretions and faecal material containing the 
organism (Burkhart and Page, 1971; Takahashi et al., 1988; Cole, 1990). Shedding occurs intermittently 
and can be activated through stress e.g. sudden change of environment, nutritional deficiencies, 
overcrowding, transport, breeding programs, handling and egg laying (Fudge, 1996). The excretion 
period depends on the immune status of the host, the virulence of the strain and the infection dose, 
but shedding may occur for several months (Gerlach, 1999). Another route to become infected is by 
blood-sucking ectoparasites, like mites, lice and flies (Shewen, 1980; Page, 1975), or less common, 
through bites or wounds (Longbottom and Coulter, 2003). Vertical transmission of C. psittaci through 
the egg is demonstrated in chickens, turkeys, ducks, parakeets, seagulls and snow geese (Wittenbrink 
et al., 1993; Vanrompay et al., 1995a; Lublin et al., 1996). 
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7.4.     Pathogenesis, clinical signs and macroscopic lesions 
After inhalation of C. psittaci–containing aerosols, primary replication starts in epithelial cells of the 
upper respiratory tract (nose, trachea, bronchi). Later on, the bacteria can be found in epithelial cells 
and macrophages of the lower respiratory tract (bronchiole, lungs and airsacs). Subsequently, C. 
psittaci can be demonstrated in plasma- and blood monocytes resulting in a systemic infection 
affecting various organs like the liver, spleen, pericardium, gut and bone marrow (Vanrompay et al., 
1995a). The incubation period varies from three days to several weeks (Page, 1959) and depends on 
the immune status of the host, the virulence of the strain and the infection dose. Common symptoms 
of the infection include sneezing, coughing, ocular and nasal discharge, sinusitis, rhinitis, dyspnoea, 
diarrhea, polyuria, dehydration, watery droppings, fever, anorexia and lethargy (Grimes and Wyrick, 
1991; Longbottom and Coulter, 2003; Vanrompay et al., 1995a). Depending on the age and immune 
status of the host, stress condition, virulence of the strain and the infection dose, symptoms can vary 
from inapparent to severe. Looking at the macroscopic lesions during necropsy, the severeness of the 
infection can be observed. Generally, congestion of conjunctivae, conchae and trachea is present. 
Furthermore, thickened airsacs, grey inflammatory spots in the lungs, fibrinous pericarditis and 
enlarged liver and spleen can be observed (Grimes and Wyrick, 1991; Longbottom and Coulter, 2003). 
7.5.     Diagnosis 
Several techniques are available to detect C. psittaci in clinical samples (Harkinezhad, 2008). These 
techniques include: 1) cell culture for the isolation of C. psittaci, 2) Enzyme-linked immunosorbent 
assay (ELISA) for chlamydial antigen/antibody detection, 3) immunohistochemical staining of 
histological sections, which is based on the presence of the Chlamydiaceae family-specific LPS, 4) DNA-
based detection methods (PCR, real-time PCR and micro-array). 
7.6.     Treatment 
To treat avian chlamydiosis, the antibiotic tetracycline and its derivates are usually used, although 
alternatives like quinolones (enrofloxacin) and macrolides (azithromycin) can also be administered  
(Vanrompay et al., 1995a). At this moment, antibiotics are the only way to manage with C. psittaci 
infections (Van Droogenbroeck, 2010). However, regular and abundant antibiotic use can create 
resistant pathogens, which can lead to huge animal losses but also human disease due to C. psittaci. 
This is already the case for the related organism C. suis causing conjunctivitis and reproductive failure 
in swine, as publications have reported tetracycline resistance and horizontal gene transfer (Dugan et 
al., 2007; Dugan et al., 2004; Schautteet et al., 2010).  
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7.7.     Prophylaxis 
To cope with the problems of antibiotic use, prophylaxis become more and more important. Preventive 
measures must be taken to prevent or reduce transmission of C. psittaci between birds. Firstly, proper 
and regular cleaning and disinfection of the cages is very important, as C. psittaci is able to survive for 
30 days in faeces. Detergents like isopropyl alcohol, lysol, quaternary ammonium compounds, 
chlorophenols and household bleach are very effective in the battle against C. psittaci (Longbottom 
and Coulter, 2003; Smith et al., 2005). Secondly, the development of an effective vaccine would be of 
great importance to prevent avian chlamydiosis. However, at this moment, no commercial vaccine is 
available (see section 9). Thirdly, the natural anti-microbial protein ovotransferrin (OvoTF) has shown 
in vitro and in vivo to have an anti-chlamyial effect (Beeckman et al., 2007; Van Droogenbroeck et al., 
2008).   
8.    Human psittacosis 
8.1.     Public health significance 
Human psittacosis is an infectious disease and therefore designated as a reportable disease. However, 
the incidence of this disease is underestimated because not all infections with C. psittaci cause 
pneumonia and therefore remain unnoticed. Furthermore, psittacosis is challenging to diagnose and 
control. Some birds may be carriers and look healthy but actually they are shedding the C. psittaci 
organism intermittently. Persons at risk include bird fanciers, employees in poultry slaughtering, 
veterinarians, laboratory workers, workers in avian quarantine stations, wildlife rehabilitators, zoo 
workers and pet shop workers (Harkinezhad et al., 2007; Vanrompay et al., 2007). 
8.2.     Transmission 
Humans can become infected with C. psittaci by inhalation of aerosols created from respiratory and 
eye secretions, dried faeces and urine of infected birds. Other sources of exposure include handling of 
the plumage and tissues of infected birds, a bite from an infected bird and in rare cases mouth-to-beak 
contact (Beeckman and Vanrompay, 2009; Smith et al., 2005). Even brief exposures can lead to 
symptomatic infections as well as unrelated activities like gardening or law mowing (Telfer et al., 2005; 
Williams et al., 1998). Person-to-person transmission of the disease is rare (Hughes et al., 1997; 
Williams et al., 1998; Ito et al., 2002). 
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8.3.     Clinical presentation 
Human psittacosis varies in severity from a mild flu-like illness to severe pneumonia. Generally, the 
incubation period is 5 to 14 days, but periods up to 1 month are also possible. Symptoms include abrupt 
onset of fever, chills, headache, malaise and myalgia. Usually, a non-productive cough is developed, 
which can be accompanied with breathing difficulty and chest tightness. Primarily, human psittacosis 
affects the respiratory system but the bacteria may spread throughout the body affecting different 
organs like the liver, the heart, the gastro-intestinal tract and the brain. When the gastro-intestinal 
tract is infected, symptoms like vomiting, abdominal pain and diarrhea are common. In rare cases, 
complications like encephalitis (Carr-Locke and Mair, 1976), hepatitis (Samra et al., 1991), myocarditis, 
endocarditis (Levison et al., 1971), adult respiratory distress syndrome (ARDS) (Yilmazlar et al., 2000), 
arthritis (Gonski and Chan, 2009), keratoconjuntivitis (Dean et al., 1995), ocular adnexa lymphoma 
(Chanudet et al., 2006; Ferreri et al., 2004) and multiple organ failure (Heddema et al., 2006) may 
occur. The outcome of the disease is variable and can be fatal in untreated patients (Kovacova et al., 
2007). 
8.4.     Diagnosis 
A correct anamnesis of the patient’s medical history, professional and free time occupations is a first 
step to link flu-like symptoms to human psittacosis.  If the clinical representation is in concordance 
with human psittacosis, several laboratory tests are available to confirm the disease. First, serological 
tests like microimmunofluorescence (MIF) test, complement fixation test (CFT) and ELISA show cross-
reactivity with other chlamydial species, which makes it difficult to distinguish C. psittaci, C. 
trachomatis and C. pneumoniae antibodies in humans. Furthermore, those tests generate both false 
negative and false positive results (Verminnen et al., 2008). Second, molecular techniques for the 
detection of C. psittaci DNA were developed. Several nested PCRs based on detecting of the 16S rRNA 
and ompA gene are now routinely being used (Sachse and Hotzel, 2003; Van Loock et al., 2005b). 
Moreover, C. psittaci genotyping could be performed using a genotyping real-time PCR (Geens et al., 
2005) or a genotyping micro-array (Sachse et al., 2008; Sachse et al., 2009). Third, the causative agent 
could be isolated from respiratory secretions on cell cultures. Different cell lines such as Buffalo Green 
Monkey (BGM), McCoy, HeLa and African Green Monkey (Vero) are being used, but BGM cells showed 
to be the most sensitive artificial host (Vanrompay et al., 1992). Disadvantages from this technique are 
that the bacteria need 3 to 6 days to grow sufficiently and only a limited of laboratories perform this 
technique because a biosafety level 3 (BSL3) facility is required.  
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8.5.     Treatment  
As in birds, human psittacosis is preferentially treated with antibiotics with tetracyclines such as 
doxycycline or tetracyclinehydrochloride, unless this drug is contra-indicated (pregnant women, 
children < 8 years, allergic reaction). Macrolides such as erythromycin and azithromycin can also be 
used as treatment (Senn et al., 2005). Treatment with antibiotics can easily resolve chlamydial 
infections but resistance can occur through horizontal gene transfer as this is already the case for C.suis 
which has acquired tetracycline resistance (Dugan et al., 2004; Dugan et al., 2007). As the use of 
tetracyclines is widespread in pet birds and poultry, tetracycline resistance can also occur among C. 
psittaci strains.  Moreover, resistance can also take place through point mutations which can alter the 
expression and functionality of the bacteria (Dreses-Werringloer et al., 2003; Roshick et al., 2000). 
Furthermore, antibiotics can induce subclinical persistent infections evolving to chronic disease when 
antibiotic administration is stopped (Hogan et al., 2004). 
9.    Vaccination 
Until today, vaccination is still the most effective way to prevent or even eradicate infectious diseases 
in humans and animals (Bowersock and Martin, 1999; Oshop et al., 2002). The ultimate goal of a 
vaccine is to stimulate the  immune system to develop sufficient amounts of specific antibodies, 
cytotoxic T cells and memory T- and –B cells against a specific pathogen. The need for an efficient 
vaccine against Chlamydiae is huge, as there are some disadvantages linked to the use of antibiotics to 
treat chlamydial infections. First, pathogens can become resistant to antibiotic treatment because of 
the regular and abundant use. Second, chlamydial infections are often asymptomatic and so only those 
with clinical signs are treated which is not the best way to control the infection (Stagg, 1998). Third, a 
persistent infection can be induced due to antibiotic treatment. Fourth, the use of antibiotics does not 
always stop the shedding of the organism which is the case for C. abortion at lambing or oestrus 
(Longbottom and Coulter, 2003). Vaccination would be the best approach to control and prevent 
chlamydial infections. Today, no commercial vaccine against chlamydiosis/psittacosis exists. To make 
an effective vaccine it is important to identify those antigens that elicit a protective immune response, 
to understand the complex immune mechanisms that occur during infection and to develop effective 
methods for vaccine delivery (Longbottom, 2003). 
9.1.     Whole organism vaccines (first generation) 
In the 1950s and 1960s, vaccine studies focused on the use of inactivated or live, attenuated whole 
organisms in order to control both animal and human infections. The first vaccines that were used 
against Chlamydiaceae were live vaccines, which are attenuated or living chlamydial organisms. 
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Generally, developing an attenuated vaccine is done by a number of passages of the pathogen in 
different types of cell cultures. Due to the several passages, one or more mutations occur, resulting in 
a non-virulent attenuated strain of the pathogen. A major advantage is that this live vaccine very 
closely reproduces a normal infection, resulting in a natural stimulus of the immune system (both 
cellular and humoral) against all protective antigens. But live vaccines can revert to its virulent form 
and cause disease or persistent infection, especially in immunosuppressed individuals. Because of the 
unsafety of live vaccines, killed or inactivated micro-organisms were used. These are preparations of 
the wild-type pathogenic micro-organism that have been rendered non-pathogenic using heat or 
chemical treatment.  As the micro-organism cannot replicate, the use of these vaccines are safe but a 
large number of inactivated pathogens are required to stimulate the immune system, which stresses 
the need to revaccinate and to use adjuvantia. Furthermore, only a humoral immune response can be 
induced. As Chlamydiaceae has an intracellular life cycle, a strong cell-mediated immune response is 
needed for the clearance of a chlamydial infection, making killed or attenuated pathogens less suitable 
as vaccine against chlamydiaceae (Van Drunen Little-van den Hurk et al., 2000; Longbottom and 
Livingstone, 2006). Another major disadvantage of whole organism vaccines is that they contain both 
immunogenic and non-immunogenic components and immune answer against non-immunogenic 
components is irrelevant to prevent infection and it even has leads to a reduction of the immune 
response against immunogenic components (Shams, 2005). Undesirable components such as 
endotoxins can result in pathological damage in the host (Wegener et al., 1998). In general, whole 
organism vaccines seems to be more successful in controlling animal infections than human infections. 
The most promising attempts with first generation vaccines have been made to control ovine enzootic 
abortion (OEA) caused by C. abortion in sheep. This formalin-inactivated whole organism vaccine was 
commercialized and successfully applied for 20 years but the re-occurrence of the disease in vaccinated 
animals has led to the withdrawal of the vaccine in 1992 (Littlejohn et al., 1952; McEwen et al., 1951; 
McEwen and Foggie , 1954; Longbottom and Livingstone, 2006). Nowadays, three inactivated vaccines 
and one killed vaccine against OEA  are commercially available in the EU and the USA. Furthermore, 
the only other commercially available vaccines are against C. felis, which include two inactivated- and 
five live attenuated vaccines. These vaccines reduce acute infection but do not always prevent 
shedding of the pathogen or re-infection (Wills et al., 1987). 
9.2.     Subunit vaccines (second generation) 
The second generation– or subunit vaccines contain a part of the pathogen, which are one or more 
defined antigenic determinants playing an important role in the protective immunity. This can be 
antigens or parts of antigens, represented in several forms including purified proteins, recombinant 
proteins and synthetic peptides (Hess et al., 2000). Because the material in a subunit vaccine is not 
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able to replicate, the risk of adverse reactions is very low and safe for use in immunosuppressed 
persons. Despite their safety, subunit vaccines are less successful at inducing long lasting immunity 
against disease and need to be administered repeatedly along with adjuvantia. The main development 
of vaccines against Chlamydiacea is focused on MOMP, a structurally and immunologically dominant 
protein (Caldwell et al., 1981). Initial experiments with MOMP purified from SDS-PAGE failed to induce 
protection against C. trachomatis in monkeys (Taylor et al., 1988). This failure was probably due to the 
denaturation of protective conformational epitopes on the surface of the bacteria during sample 
preparation for gel electrophoresis. Other attempts using detergent extracted COMC preparations 
showed that MOMP offer protection in sheep (Tan et al., 1990), guinea pigs (Batteiger et al., 1993) and 
mice (Sandbulte et al., 1996; Pal et al., 1997). However, purifying MOMP and COMC preparations are 
difficult and expensive because of the problematic bulk growth of Chlamydiaceae. Therefore, 
recombinant proteins could offer a solution to this concern. 
Because of the DNA technology, developing recombinant protein vaccines will be easier and cheaper 
to prepare than the MOMP and COMC preparations which needed large-scale production of 
Chlamydiaceae. However, the expression of the porin MOMP is often toxic in prokaryotic expression 
systems and it is also difficult to produce the native form of rMOMP with intact conformationally 
relevant epitopes (Longbottom, 2003). Moreover, MOMP is also glycosylated (Escalante-Ochoa et al., 
1998; Swanson and Kuo, 1991) and it is possible that export and assembly of MOMP is incompatible 
with other proteins of other gram-negative bacteria as the composition of the cell wall is different 
(Manning and Stewart, 1993). Therefore, it has been showed that the production of rMOMP is easier 
in eukaryotic cells, such as COS7 cells (Vanrompay et al., 1998). A study of Verminnen et al. (2005) 
testing a rMOMP vaccine with and without 1α,25-dihydroxyvitamin D3 in turkeys showed partial 
protection. Furthermore, a rMOMP vaccination study of Tuffrey et al. (1992) did not result in a 
complete protection against C. trachomatis in mice. As most vaccination strategies with subunit 
vaccines are focused on rMOMP, the results are not satisfying. 
9.3.     DNA vaccines (third generation) 
DNA vaccination could be the new strategy to protect humans and animals against Chlamydiaceae. A 
DNA vaccine consists of a plasmid encoding the gene(s) of antigenic component(s) of interest. Injection 
of this plasmid can result in the intracellular production of the chosen antigen(s) in the host cell, 
inducing a protective immune response. By mimicking the natural way of infection, both humoral and 
cellular immune responses may be elicited which is ideal to combat intracellular pathogens like 
Chlamydiaceae. The principle of DNA vaccination is shown in figure I-6.  First, the gene of interest is 
selected, isolated and inserted into a mammalian expression vector system. Once constructed, the 
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DNA vaccine is transformed into bacteria, where bacterial growth generates multiple plasmid copies. 
Afterwards, the plasmid DNA is purified from the bacteria and ready to be delivered in animals (Dufour, 
2001; Oshop et al., 2002).  This DNA vaccine can be injected into the skin or muscle of the host, which 
causes the host cell to produce the introduced gene. This protein is endogenously produced and 
intracellularly processed  into small antigenic peptides by host proteases. Those peptides enter the 
lumen of the endoplasmatic reticulum and are presented by MHC class I molecules. Subsequent CD8+ 
cytotoxic T lymphocytes (CTL) are stimulated which inhibit pathogens through both cytolysis of 
infected cells and noncytolosis mechanisms such as cytokine production (Encke et al., 1999). 
Exogenous antigens can also be presented in association with MHC class II molecules, stimulating CD4+ 
T cells. 
Fig. I-6: Principle of DNA vaccination (Dufour, 2001). 
 
 
DNA immunization has many advantages when compared with other vaccination strategies (Watts and 
Kennedy, 1999). DNA vaccines induce the expression of antigens that resemble native epitopes more 
closely than standard vaccines do since live attenuated  and killed vaccines are often altered in their 
protein structure and antigenicity. Even post-translation modifications are similar as those present 
during infection (Babiuk et al., 2003). Moreover, the plasmid vector can encode several antigens that 
can be delivered to the host in a single dose. Furthermore, rapid and large-scale production is possible 
and the DNA can be easily purified, resulting in lower costs to develop an effective DNA vaccine 
(Dufour, 2001; Longbottom and Livingstone, 2006). DNA vaccines are also temperature stable, which 
makes storage and transport much easier (Ertl and Xiang, 1996). Because of the endogenous 
Chlamydial infection biology  35 
 
production of the antigen(s), a humoral as well as a cellular immune response is evoked and even a 
more balanced Th1/Th2 like immune response, which is very important in the battle against 
intracellular pathogens (Ulmer et al., 1998). DNA vaccines elicit also an immune response in neonates 
and in the presence of maternal antibodies (van Drunen Littlel-van den Hurk et al., 2000; Van Loock et 
al., 2004). This advantage is of very great interest to combat C. psittaci in the poultry, as newborn 
chicks have a poorly developed immune system (Oshop et al., 2002) and high maternal antibody titers 
against C. psittaci have been found in the offspring of most hens. Unfortunately, there are also some 
disadvantages linked to the usage of DNA vaccines. As plasmid vectors often contain nucleic acid 
sequences from oncogenic viruses, the possibility exist that DNA integrate in the host chromosome. 
Although, this has not been proven yet and it is believed that the spontaneous mutations frequency is 
lower (Martin et al., 1999).  There is also a possibility that after injection of bacterial DNA, an immune 
response is evoked generating antibodies against DNA. These antibodies might cross-react with host 
DNA, potentially causing auto-immune diseases in the host (Watts and Kennedy, 1999). Furthermore, 
tolerance can be induced to the antigen (protein) produced. Non-proteins based antigens such as 
bacterial lipopolysaccharides and lipids showed not to be suitable in DNA vaccination strategies (Watts 
and Kennedy, 1999).   
Several studies has investigated the protection of DNA vaccines against Chlamydiaceae. In a murine 
respiratory model, DNA vaccination with the ompA gene induced a protective immune response 
(Zhang et al., 1997) and vaccination with ompA DNA followed by a booster with rMOMP protected 
mice against a swine C. abortus infection (Zhang et al., 2009). However, protection could not be 
induced in mice against C. pneumonia using DNA vectors expressing the cytoplasmic heat shock protein 
60 (Hsp60) or the outer membrane proteins, MOMP and Omp2 (Penttila et al., 2000). The same result 
was obtained after vaccination with the dnaK gene of C. abortus in mice (Hechard et al., 2003a; 
Hechard et al., 2003b). Although, a protective immune response could be induced against C. psittaci 
using a MOMP-based DNA vaccine in turkeys even if maternal antibodies were present (Van Loock et 
al., 2004; Vanrompay et al., 1999a; Vanrompay et al., 1999b; Vanrompay et al., 2001; Verminnen et 
al., 2005; Harkinezhad et al., 2009b; Verminnen et al., 2010). Nowadays, three DNA vaccines for 
veterinary use have been approved. There is one against infectious hematopoietic necrosis in Atlantic 
salmon (Meeusen et al., 2007), one to protect horses against the West-Nile virus (Powell, 2004) and 
one against melanoma in dogs (Bergman et al., 2006). 
9.4.     Adjuvants 
An effective vaccine must stimulate the two arms of the immune system, the innate and the adaptive 
immunity and generate a long-term protection against infection. However, most vaccines developed 
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today include small components of the pathogen. To generate a strong, long-lasting protective 
immune response, molecules such as adjuvants are needed to enhance the specific immune response 
(Shams, 2005; Wilson-Welder et al., 2009). The word ‘adjuvant’ is derived from the Latin word 
‘adjuvare’, which means to help or to enhance (Sanders et al., 2005; Rajput et al., 2007). Different 
adjuvants like alum-based adjuvants, Freund’s adjuvants, immunostimulating complexes (ISCOMs), 
CpG motifs and bacterial toxins can be used, depending on the antigen, the species, the route of 
administration and potential side-effects. An ideal adjuvant should be biodegradable, cheap, promote 
an effective immune response and have a long shelf life (Allison and Byars, 1990). Generally, adjuvants 
can be used for various purposes: 1) boost the immune system against certain antigens or subvert the 
immune response to particular cell types of the immune system, 2) reduce the amount of antigen or 
the number of immunization, 3) act as an antigen delivery system for better uptake of the antigens by 
the mucosa, and 4) to ameliorate the efficacy of vaccines in immunosuppressed people, the elderly 
and newborns (McElrath, 1995; Cox and Coulter, 1997). 
10.    Immune response 
Humans and animals are constantly being exposed to infectious agents and in most cases these 
infections can be resisted. The immune system is composed of the innate or non-specific immune 
system and the adaptive or the specific immune system, both combatting pathogens. Chlamydia is one 
of the many pathogens, able to invade and cause infection in humans and animals. Chlamydia 
possesses a unique developmental cycle, alternating between two morphologic forms – the 
extracellular, metabolically inactive and infectious EB and the metabolically inactive and infectious  RB 
that divides by binary fission within the inclusion. Consequently, the elicited immune response and its 
regulation during infection that contribute to host resistance or susceptibility have not been fully 
elucidated yet. However, understanding the evoked immune response by Chlamydiae is an important 
issue to understand the pathogenesis of acute and persistent infections but also for developing targets 
for effective vaccination and therapeutic strategies for infection.   
10.1.     Innate immune response 
The very first line of defense against Chlamydiae includes physical and chemical barriers such as the 
skin, mucous membranes, hairs and cilia, gastric juice, vaginal secretions, urine, tears, sweat, saliva, 
cerumen, tight junctions of the cells and commensals. Once the outer line of defense is breached, 
innate immune effectors provide the next line of defense. 
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10. 1. 1.    Pattern recognition receptors 
Pattern recognition receptors (PRRs) are on the front line of inducing innate immune response and are 
capable of sensing conserved microbial molecules, referred as pattern associated molecular patterns 
(PAMPs), found on the bacterial surface or inside the pathogen, as well as damage-associated 
molecular patterns (DAMPs). PRRs are located intracellulary or on the plasma membrane of immune 
cells and also on epithelial cells. The different known PRRs can be seen as a network that lead to the 
activation of the same downstream components in response to an infection.  
10.1.1.1     Toll-like receptors 
Toll-like receptors (TLRs) are pattern recognition receptors that recognize highly conserved structural 
motifs expressed by microbial pathogens like lipid, carbohydrate, peptide and nucleic acid structures. 
Stimulation of the TLRs initiates signaling cascades leading to the activation of transcription factors, 
such as AP-1, NF-κB and interferon regulatory factors (IRFs), resulting in a variety of cellular responses 
like the production of cytokines, interferons (IFNs) and effector cytokines that direct the adaptive 
immune response. Chlamydiaceae are classified as gram-negative bacteria, suggesting that LPS plays 
an important role in driving the innate immune response against all types of chlamydial infections. 
However, a study of Tsutsumi-Ishii et al. (2007) showed that Chlamydiaceae LPS has low binding 
affinities for its recognition molecules such as CD14 and LBP (LPS Binding Protein) and exhibit weak 
biological activities like cytokine production against host immune cells including monocytes, thereby 
contributing to the chronic (persistent) inflammatory reactions during infection. However, during a C. 
pneumoniae infection, chlamydial LPS and Hsp60 – both ligands of TLR4 – mediates macrophage foam 
cell formation and DC maturation (Chen et al., 2008; Bulut et al., 2009). Furthermore, TLR4 also 
recognizes C. trachomatis LPS (Prebeck et al., 2003), but a study of Darville et al. showed that TLR2 is 
a more important mediator in the innate immune response to Chlamydial infection. Macrophages from 
TLR2 knock-out (KO) mice produced less TNF-α and IL-6 in response to an active C. trachomatis 
infection. In contrast, macrophages of TLR4 KO mice seemed to produce more TNF-α and IL-6 when 
compared with normal infected mice, suggesting that binding of Chlamydiae by TLR4 may down 
modulate the signaling of other TLRs (Darville et al., 2003). Furthermore, TLR2 seem to be essential for 
bacterial clearance and survival during C. pneumonia infection in vivo (Rodriguez et al., 2006; Beckett 
et al., 2012), because C. pneumoniae do activate NF-κB in a TLR2 dependent manner, leading to 
cytokine production in dendritic cells and macrophages (Prebeck et al., 2001). However, the chlamydial 
pathogen associated molecular pattern (PAMP) that binds with TLR2 still need to be identified 
(O’Connell et al., 2006). In conclusion, it is likely that both TLR2 and TLR4 are necessary to induce a 
cytokine and chemokine response and a protective host defense against chlamydial infections in vivo, 
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with TLR2 playing the greater role. In general, the intracellular TLR9 recognizes unmethylated CpG 
sequences present in bacterial genomes or viral DNA. Han et al. (2004) observed upregulation of mRNA 
TLR9 in dendritic cells during intranasal chlamydial infection. Most probably, TLR9 has a role in 
modulating the immune response towards a Th1 cellular response (Han et al., 2004). 
The myeloid differentiation primary response gene 88 (MyD88) is an universal adaptor protein in the 
downstream signaling pathway of different TLRs (TLR2, TLR4, TLR5, TLR7-9) and the IL-1 receptor 
family. A study of Naiki et al. (2005) demonstrated that after infection with C. pneumonia MyD88-
deficient mice could not upregulate pro-inflammatory cytokines and chemokines, showed a delayed 
recruitment of CD8+ and CD4+ T cells to the place of infection and the bacteria could not be removed 
from their lungs. Furthermore, those mice developed a severe, chronic lung inflammation with 
increased mortality, indicating that MyD88 is essential for the initiation of an effective host immune 
response against the battle of C. pneumoniae and it bridges innate immunity to Th1 responses. 
However, C. pneumoniae was also able to induce TRIF activation, which is a crucial adaptor protein in 
the MyD88-independent signaling pathway. TRIF- as well as MyD88 activation mediates foam cell 
formation in macrophages during C. pneumoniae infection (Chen et al., 2008). 
In summary, both TLR2 and TLR4 signaling via MyD88 control chlamydial infections through the early 
production of cytokines and chemokines. Moreover, activation of TLR-2 and TLR-4 influence their own 
expression as well as those of the cytokine receptors, leading to a strong and well-orchestrated 
immune response. 
10.1.1.2     NOD-like receptors 
The nucleotide-binding oligomerization receptors or NOD-like receptors (NLRs) are intracellular 
receptors of PAMPs, and orchestrate an inflammatory response, autophagy or cell death. The well 
described NOD-like receptors are NOD1 and NOD2 and recognize distinct motifs of peptidoglycan 
(PGN), an essential component of the bacterial cell wall, which is covalently closed , net-like polymer 
in which glycan strands made of alternating N-acetylglucosamine and N-acetylmuramic acid residues 
are cross-linked by peptides. NOD1 recognizes D-γ-glutamyl-meso-DAP dipeptide (iE-DAP), which is 
found in PGN of all Gram-negative bacteria and certain Gram-positive bacteria. NOD2 senses 
intracellular muramyl dipeptide (MDP), found in almost all bacteria (Franchi et al., 2009, Chen et al., 
2009).  
However, Chlamydiae lacks detectable amounts of PGN, but these bacteria do possess PGN synthesis 
and show sensitivity against Penicillin, which is a PGN inhibitor. This paradox is known as the 
Chlamydiae anomaly. Moreover, several studies have reported a significant role for NOD1 induction of 
inflammation during infection with C. muridarum, C. pneumoniae and C. trachomatis (Opitz et al., 
2005; Whitmarsh and Davis, 1996). The endogenous IL-8 production elicited by C. trachomatis in HeLa 
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cells is dependent upon NOD1 signaling through its signaling partner receptor-interacting protein 2 
(RIP2) (Buchholz and Stephens, 2008). Furthermore, a reduced IFN-β expression after infection with C. 
muridarum was observed in HeLa cells treated with NOD1 siRNA (Prantner et al., 2010). Shimada et al. 
(2009) investigated the importance of the NOD/RIP2 pathway in host responses after C. pneumoniae 
infection in mice. NOD1-/-, NOD2-/- and RIP2-/- mice showed a delayed bacterial clearance compared to 
wild-type (WT) mice, suggesting that C. pneumoniae is sensed by both intracellular receptors. In 
conclusion, the NOD/RIP2 signaling pathway plays a significant role in intracellular recognition of the 
different Chlamydiae species, in the innate host immune response and finally in the clearance of the 
bacteria and the survival of the host. However, there must be a perfect coordinated and sequential 
activation of both TLRs and NODs signaling pathways to evoke a well-balanced host immune defense 
against Chlamydiaceae. Probably upon chlamydial infection, TLRs are necessary for the initial 
activation, wheras NODs are responsible for the intracellulary prolonged activation of target cells as 
Chlamydiae is an intracellular bacteria. These data above plus the sensitivity to penicillin suggest that 
Chlamydiae do bear PGN or a PGN-like structure on its cell wall despite the lack of biochemical 
evidence. It is possible that the amount of PGN in Chlamydiae is so low that it is below the detection 
level. Moreover, Chlamydiae do switch between the infectious EB and the non-infectious RB, making 
a biochemical detection of PGN difficult (Hammerschlag, 2002). Penicillin is able to alter the 
morphology of EBs and to stop the devolpmental cycle, indicating that penicillin act on newly 
synthetized structures during maturation from EB to RB (Matsumoto and Manire, 1970). 
10.1.1.3     Inflammasomes 
Danger associated molecular patterns (DAMPs), also known as alarmins are molecules released by 
stressed cells undergoing necrosis that act as endogenous danger signals to promote and exacerbate 
the inflammatory response. Several researchers believe that DAMPs released by injured cells are 
necessary for the host to distinguish pathogenic microorganisms from commensal and other non-
pathogenic bacteria (Matzinger, 2002; Seong and Matzinger, 2004). Some NLRs sense those DAMP 
molecules and form large cytoplasmatic complexes, called inflammasomes. The assembly of 
inflammasomes leads to the production of active caspase-1, which is responsible for the 
transformation of pro-IL-1β and pro-IL-18 to mature IL-1β and IL-18. To generate the immature forms 
of IL-1β and IL-18, NF-κB activation is necessary resulting from signaling such as TLRs. It has been 
reported that C. pneumoniae induce IL-1β secretion in macrophages through the direct activation of 
the NLRP3/ASC inflammasome and subsequently caspase-1 in coordination with TLR2 and MyD88 
which generate pro-IL-1β (Shimada et al., 2011; He et al., 2010). Moreover, caspase-1 deficient mice 
showed a higher bacterial burden in the lungs and an increased mortality during C. pneumoniae 
infection and IL-1β administration diminished those effects, especially during the early stages of the 
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infection (Shimada et al., 2011). It is clear that caspase-1 dependent IL-1β is necessary to initiate a 
proper host immune response against Chlamydiae, whereas NLRP3 inflammasome plays an important 
role in this process. However, as mentioned before, the molecular mechanism for NLRP3 activation 
still need to be unraveled. NLRP3 recognize danger-associated molecules like reactive oxygen species 
(ROS) (TSchopp and Schroder, 2010), lysosomal damage (Hornung and Latz, 2010) and cytosolic K+ 
efflux (Pétrilli et al., 2007), rather than pathogen-associated molecules. As chlamydiae damage the 
mitochondria in macrophages (Shimada et al., 2011), the mtDNA in the cytosol can promote 
inflammasome assembly (Shimada et al., 2012), leading to the production of IL-1β. This mitochondrial 
damage in macrophages causes apoptosis, whereas IL-1β is secreted before cell death, acting as an 
alarming danger signal. However, it has been demonstrated that Chlamydiae also inhibit apoptosis in 
favor of his developmental cycle (Fan et al., 1998; Fischer et al., 2001; Geng et al., 2000). In conclusion, 
these data suggest that Chlamydiae struggle with his host cell the macrophage, 1) resulting in apoptosis 
and subsequently preventing further replication of the pathogen or 2) resulting in inflammasome 
assembly and propagation of pro-inflammation via IL-1β.  However, it is also known that activation of 
inflammasomes also induce cell death known as pyroptosis via activation of caspase-1. Thus, besides 
secretion of pro-inflammatory cytokines such as IL-1β and IL-18, activation of caspase-1 induces pore 
formation in the plasma membrane leading to cell rupture and consequent release of cytosolic 
contents (Martinin et al., 2002; Fink and Cookson, 2006). During C. trachomatis infection, the role of 
inflammasome and subsequently caspase-1 activation is still controversial.  Caspase-1-/- mouse 
fibroblasts are resistant to C. trachomatis infection (Jorgensen et al., 2011), whereas caspase-1 
deficient mice showed a reduced inflammatory damage at the place of infection (Cheng et al., 2008). 
Caspase-1 dependent cell death is regulated by the C. trachomatis T3SS-dependent effector protein 
chlamydial protease-like activity factor (CPAF). However, the inhibition of pyroptosis by CPAF is not yet 
fully understood. It has been suggested that CPAF may function as a proteolyse regulating the pool of 
T3SS effectors in the host cytosol and avoiding accumulation of PAMPs which can be sensed by 
intracellular PRRs (Jorgensen et al., 2011).  
10. 1. 2.    Cytokines/chemokines 
After recognition of different PAMPs and DAMPs by several PRRs, a pro- and anti-inflammatory 
response is mediated by cytokines and chemokines. All families of PRRs activate three major signaling 
pathways: the nuclear factor (NF)-κB, the mitogen-activated protein kinases (MAPKs) and the 
interferon-regulatory factors (IRFs) leading to the induction of inflammatory and antimicrobial 
mediators. The aim of this response is to control the invading pathogen  without generating excessive 
tissue damage and provide an adequate stimulus for the adaptive immune immune system. 
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Chlamydiaeceae infect epithelial cells as well as cells of the immune system like monocytes and 
macrophages. The induced set of cytokines and chemokines and the concentration is dependent on 
the cell type, the route of infection, the dose and the chlamydia species and/or the serovar used. 
Infection with C. trachomatis of epithelial cells causes the induction of IL-8, IL1α, tumor necrosis factor-
α (TNF-α), granulocyte-macrophage colony-stimulating factor (GM-CSF)  and IL-6 (Rasmussen et al., 
1997). It must be noticed that depending on the tissue, several cytokines and chemokines are 
continuously expressed to maintain an innate immune surveillance. Furthermore, Chlamydiales can 
infect immune cells, although not with the same efficiency like epithelial cells. The replication of 
Chlamydiaceae happens in a lower extent in immune cells. This growth inhibition is probably due to 
TNF-α, as treatment with antibodies against TNF-α causes bacterial growth (Haranaga et al., 2003). 
Macrophages infected with C. trachomatis release TNF-α, which induces apoptosis of T-cells together 
with other components. Moreover, the factors released during apotosis of T-cells induce the 
production of transforming growth factor-β (TGF-β) which is an immunosuppressing cytokine, creating 
an ideal environment for chlamydial persistence (Jendro et al., 2002). This controlled apoptosis prevent 
bacterial clearance but provide also enough time to complete the developmental cycle or induce 
persistence. Moreover, a study of Beeckman et al. (2009) showed that C. psittaci infected macrophages 
produce high levels of the anti-inflammatory cytokine IL-10, which can induce deactivation of 
macrophages and suppression of the NF-κB pathway. The cytokine TNF-α is also produced by 
macrophages of aborted ovine placentas (Buxton et al., 2002) and elevated levels has also been found 
in tears of humans suffering from trachoma (Conway et al., 1997). This cytokine can induce an 
imbalance at mucosal surfaces where Th-2-type cytokines such as TGF-β and IL-10 tend to predominate 
(Mowat, 2003). This imbalance can be detrimental to the host, particularly if a persistent infection 
develops that drives an inflammatory loop. However, the cytokines TGF-β and IL-10 are anti-
inflammatory cytokines that can counteract the protective anti-chlamydial Th-1-type response, 
certainly at mucosal sites where those cytokines predominate, resulting in a failure of the host to clear 
the infection and therefore develop chronic disease (Stephens, 2003). The protective Th-1-type 
response against Chlamydiaceae is mediated by IFN-γ, IL-6, IL-1β, IL-8, IL-12 and GM-CSF. The cytokine 
IL-8 is an activator and chemoattractant of neutrophils associated with immunopathology (Mukaida et 
al., 1998; Sansonetti et al., 1999). During a C. trachomatis infection, IL-8 is highly induced and 
dependent upon NOD1 PRR signaling (Bucholz and Stephens, 2008). The cytokines IL-6 and IL-1β 
positively influence each other and are implicated in the acute phase response maintaining the 
inflammation localized to the site of infection, clearing cell debris and attracting other immune  (Kaiser 
et al., 2004; Schneider et al., 2001). Elevation of these cytokines was observed after infection of HD11 
cells (chicken monocytes/macrophages) with C. psittaci (Beeckman et al., 2010), but also after 
infection with C. trachomatis (Rasmussen et al., 1997). Another major inflammatory cytokines 
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produced during chlamydial infection is IFN-γ. The cytokine IFN-γ induces antibody isotype switching 
towards the production of IgG2a, which can be used as a marker of a Th1 response (Snapper and Paul, 
1987). IFN-γ restricts Chlamydiae growth by inducing the host enzyme indoleamine 2,3-dioxygenase 
(IDO) that degrades intracellular pools of tryptophan (Chlamydiae is auxotrophic for tryptophan). 
Besides, IFN-γ downregulate the transferrin receptor on the surface of infected cells, which may also 
limit chlamydial growth by limiting the intracellular stores of iron (Byrd and Horwitz, 1993). In this way 
the developmental cycle of Chlamydiae is delayed, so RBs persist longer which might result in 
persistent unapparent infection and also contribute to immunopathogensis by promoting 
inflammatory damage and fibrosis (Rottenberg et al., 2002). In addition, IFN-γ promote the 
phagocytosis of macrophages, resulting in engulfing and destruction of extracellular EBs (Zhong and 
de la Maza, 1988). Furthermore, IFN-γ triggers the macrophage to release inflammatory mediators 
which promotes the destruction of Chlamydiae and induces fibroblast proliferation and thereby 
enhances the synthesis of collagen (Beatty et al., 1993). It has been shown that early production of IL-
6 prevent IFN-γ like responses in cells. Given that cells almost directly produce IL-6 following infection 
with Chlamydiae and that IFN-γ is a key cytokine for exerting host immune control, this could explain 
the pattern of chronic disease seen in many cases of chlamydial infection.  
10.2.     Adaptive immune response 
The adaptive or the acquired immune system is composed of highly specialized, systemic cells and 
processes that eliminate or prevent pathogen growth. Activation of the adaptive immune system to a 
particular pathogen leads to the creating of immunological memory. The adaptive immune response 
consists out of the cell-mediated immunity and the humoral immunity. 
10. 2. 1.    Cell-mediated immunity 
As Chlamydiae is an intracellular pathogen, it has been suggested that the cell-mediated immunity 
would be more effective than the humoral immunity at conferring protection against disease. It has 
been demonstrated in T cell-depletion and –adoptive transfer experiments that T cells are essential 
for the protection against chlamydial infections (Ramsey and Rank, 1991; Rank et al., 1985). Moreover, 
it has been observed that both CD4+ and CD8+ T cell subsets are present at the place of infection 
(Morrison and Morrison, 2000; Penttila et al., 1998; Rank et al., 2000; Van Voorhis et al., 1996). There 
is evidence that the presence of CD4+ T cells is more important in the resolution of infection and 
orchestrating the activation of other protective immune components (Rank, 2000). B cell knockout 
mice treated with only anti-CD4 antibodies were not able to resolve a chlamydial infection, indicating 
that CD4+ T cells are essential to generate protective immunity in mice both in primary infection and 
reinfection (Su et al., 1997; Morrison et al., 2000). However, there is more and more evidence that 
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CD8+ T cells are also important in the contribution to protection. For instance, depletion of CD8+ T cells 
in mice abrogates protection upon challenge with C. psittaci. Similarly, increased bacterial load and 
disease severity was observed in the absence of CD8+ T cells during a primary and secondary infection 
with C. pneumonia (Penttila et al., 1999; Rottenberg et al., 1999). Nevertheless, CD4+ T cells are needed 
for the induction and preservation of a functional CD8+ T cell response and in their absence, both CD4+ 
and CD8+ T cell effector functions are impaired. The protective cell mediated immune response is 
strongly associated with the production of IFN-γ produced by T cells (Igietseme, 1996). As mentioned 
above, IFN-γ reduces the growth of chlamydiae by altering the cell metabolism and reducing essential 
nutrients such as iron and tryptophan. 
10. 2. 2.    Humoral immunity 
The exact role of antibodies in protection against chlamydial infections is difficult to assess, as it is 
dependent on the site of infection, the chlamydial challenge dose, whether it is a primary or secondary 
infection and whether the infection is acute or persistent. A study of Ramsey et al. (1988) showed that 
B cell-deficient mice were able to resolve a chlamydial genital infection equivalent to controls and they 
were even immune to reinfection, indicating that antibodies are not necessary during primary infection 
or to obtain protective immunity. Of interest, when mice recovered from chlamydial genital infection 
were treated with antibodies against CD4 and CD8 and then reinfected, the infection was prolonged 
in mice treated with anti-CD4-antibodies. However, the infection did not resolve in B cell-deficient 
mice treated with anti-CD-antibodies, indicating that antibodies and CD4+ T cells are necessary to 
resolve a secondary infection (Morrison et al., 2000). B cells seem to have a potential role in building 
up the memory response. There are different mechanisms by which antibodies can resolve a 
chlamydial infection. The first mechanism is neutralization, such that secreting antibodies bind with 
EBs and prevents them from attachment to the host cells. In this way, the developmental cycle is 
abrogated (Howard, 1975; Su and Caldwell, 1991, Peeling et al., 1984; Peterson et al., 1991; Cotter et 
al., 1995). As Chlamydiaceae is an intracellular organism, antibodies can only bind when the bacteria 
is released from the cell or during reinfection of pre-exposed humans/animals. The second mechanism 
is that antibodies can opsonize EBs and enhance uptake, ingestion and destruction of chlamydial 
particles by phagocytes (Moore et al., 2002). The third mechanism is the antibody-dependent cellular 
cytotoxicity (ADCC), which is the destruction of Chlamydiae infected host cells by antibodies (Moore 
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Chlamydia psittaci and atypical Chlamydiaceae infections are (re)-emerging in chickens. We therefore 
examined the prevalence of C. psittaci, atypical Chlamydiaceae and their zoonotic transmission on 19 
Belgian chicken farms. Atypical chlamydiaceae were not detected in chickens but 18 of 19 farms were 
positive for C. psittaci by culture and PCR. C. psittaci ompA genotypes A and D were discovered. None 
of the examined humans (n= 31) was infected with atypical Chlamydiaceae, but 29 (93.5%) of them 
were positive for C. psittaci by culture and PCR. Genotypes A, D and a mixed infection with genotypes 
C and D were found. Humans (n = 2) working in the C. psittaci negative farm never had respiratory 
complaints, while 25 out of 29 (86.2%) positive farmers, reported yearly medical complaints potentially 
related to psittacosis. Four of them currently experienced respiratory disease and one of them was 
being treated with antibiotics. Four farmers (12.5%) mentioned that they had pneumonia after starting 





















1.      Introduction 
The species Chlamydia psittaci (C. psittaci) causes respiratory disease in birds including symptoms such 
as rhinitis, conjunctivitis, nasal discharge, dyspnoea, diarrhoea, polyuria, anorexia, lethargy and 
dullness (Vanrompay et al., 1995). C. psittaci is a well-known zoonotic agent causing psittacosis or 
parrot-fever in humans. During the last 3 decades, psittacosis outbreaks were reported in the United 
States (Grimes & Wyrick, 1991; Newman et al., 1992), China (Ni et al., 1996), India (Chahota et al., 
2000), Australia (Tiong et al., 2007) and European poultry industries (Laroucau et al., 2009; Ryll et al., 
1994; Sting et al., 2006; Van Loock et al., 2005; Vanrompay et al., 1997). Zoonotic transfer occurs 
through inhalation of contaminated aerosols originated from feathers, fecal material and respiratory 
tract exudates. Handling the plumage, carcasses and tissues of infected birds and in rare cases, mouth-
to-beak contact or biting also carry a zoonotic risk (Beeckman & Vanrompay, 2009). Psittacosis in 
humans may vary from unapparent to fatal in untreated patients (Kovacova et al., 2006). Symptoms 
include high fever, chills, headache, myalgia, non-productive coughing and difficult breathing 
(Beeckman & Vanrompay, 2009). 
C. psittaci infections mostly occur on turkey or duck farms. However, C. psittaci infections are emerging 
in European and Asian chickens. Recently, Dickx et al., (2010) examined Belgian broiler breeder, broiler 
and layer farms by a C. psittaci recombinant major outer-membrane protein  (MOMP) -based antibody 
ELISA (Verminnen et al., 2006) and found 98%, 95%, and 95% seropositive layers, broilers, and broiler 
breeders, respectively. Moreover, they demonstrated C. psittaci genotype D in the air of chicken 
hatching chambers and in slaughtered Belgian and French broilers. Zoonotic transmission to hatchery 
and abattoir employees did occur (Dickx et al., 2010; Dickx et al., 2011), albeit without severe clinical 
consequences. Recently, Yin et al., (2012), proved Hill's-Evans’ postulates for C. psittaci genotype B 
and D strains isolated from Belgian and French broilers. 
Larouceau et al., (2009) detected a new atypical chlamydial agent in chickens. The atypical chicken 
Chlamydiaceae (ACC) caused apparently no disease in infected chickens, but the detection of ACC 
coincided with three cases of atypical pneumonia in individuals working in a French poultry abattoir. 
In 2012, ACC have been detected in Australian, German, Greek, Croatian, Slovenian and Chinese 
chicken flocks (Robertson et al., 2010; Zocevic et al., 2012). Importantly, ACC are not detected with C. 
psittaci-specific molecular tools, rendering the need for an ACC-specific PCR. The zoonotic potential 
and the exact taxonomic status of ACC have yet to be defined. 
The aim of the current study was to examine the presence of C. psittaci and ACC on Belgian chicken 
farms, as well as their zoonotic transmission to farmers. 




2.      Material and Methods 
2.1.    Study concept 
We investigated the presence of C. psittaci and ACC, as well as their zoonotic transmission, on 19 
Belgian chicken farms: seven broiler breeder (1600 to 50,000 animals), seven broiler (200 to 150,000 
animals) and five layer (7000 to 22,000 animals) farms from four difference geographical regions 
(Antwerp, East-Flanders, West-Flanders and Limburg). Only one out of 19 farms kept additional birds 
species (ducks and geese). The study was conducted in the summer of 2012. Participating poultry farms 
were randomly recruited by phone. A sampling package was brought to each poultry farm and 
sampling was performed immediately. The package contained a questionnaire designed to asses 
information on: 1) the farmers’ professional and nonprofessional activities, smoking habits, general 
health status, use of medication, influenza vaccination, allergies, clinical signs potentially related to 
psittacosis, 2) the chicken breed, hatchery, housing, feeding, health status, medication, mortality and 
3) the presence of other animals on the farm. The package also contained rayon-tipped aluminium 
shafted swabs (Copan, Fiers, Kuurne, Belgium) for pharyngeal sampling of ten randomly selected 
chickens and the farmers (a maximum of two per farm). Sampling of the chickens was performed by 
one of the researchers. In the meantime, humans sampled themselves at home after informed 
consent. Swabs for culture contained 2 ml chlamydia transport medium (Vanrompay et al., 1992) while 
those for PCR contained 2ml DNA stabilization buffer (Roche, Brussels, Belgium). Packages were 
transported on ice and stored at -80°C until use.  
2.2.    Chlamydia psittaci culture 
Culture was performed using Buffalo Green Monkey (BGM) cells and the organism was identified using 
the IMAGEN direct immunofluorescence assay (Oxoid, United Kingdom) at 6 days post-inoculation 
(Vanrompay et al., 1994). C. psittaci positive cells were monitored using a CX31 fluorescence 
microscope with a x600 magnification (Eclipse TE2000-E, Nikon, Japan) and represented by a score 










Table II-1: C. psittaci culture scores 
Score *Interpretation 
0 Negative (no EB, no IPC) 
1 1-5 EBs 
2 6-15 EBs 
3 15-25 EBs and 1-5 IPCs 
4 25-100 EBs and 6-15 IPCs 
5 1-10 EBs/field and 1-5 IPCs/field 
*EB = elementary body, IPC = inclusion positive cell 
2.3.    Chlamydia psittaci genotyping and PCR detection of atypical 
Chlamydiaceae 
DNA extraction of swabs was performed as described by Wilson et al. (1996). Briefly, specimens were 
centrifuged (13,000 x g), suspended in 198 μl STD buffer (0.01 M Tris-HCl [pH 8.3], 0.05 M KCl, 0.0025 
M MgCl2.6H20, 0.5% Tween20) and 2 μl proteinase K (20 mg/ml stock solution; Sigma Chemical Co.). 
The specimens were incubated at 56°C for one hour and subsequently heated at 100°C for 10 min.  
A C. psittaci-specific nested PCR with internal inhibition control was used (Van Loock et al., 2005b). 
Outer membrane protein A (ompA) genotyping was performed by a C. psittaci genotype-specific real-
time PCR (Geens et al., 2005). The latter PCR distinguishes genotypes A to F and E/B using genotype-
specific primers, genotype-specific probes and competitor oligonucleotides. Samples from chickens 
and humans were also examined for atypical chicken Chlamydiaceae by use of a recently developed 
16S rRNA-based ACC-specific real-time PCR (Zocevic et al., 2013). 
2.4.    Statistics 
Potential zoonotic risk factors were statistically examined using SPSS (Inc., Chicago, Illinois, US). Logistic 
regression was used to search for non-exposure-related risk factors for Chlamydiaceae culture and PCR 









3.      Results 
3.1    Chlamydia psittaci  and atypical Chlamydiaceae in chickens 
Nineteen out of 32 (59%) chicken farms contacted participated, resulting in samples from 190 chickens 
(10 per farm) and 31 humans (a maximum of two per farm).  
Atypical chicken Chlamydiaceae were not detected. Eighteen out of 19 farms (94.7%) were positive for 
C. psittaci by both culture and nested PCR (Table II-2). The percentage of culture-positive chickens per 
farm varied from 60 -100%. C. psittaci genotype D was present in 17/18 (94.4%) of positive farms, while 
a genotype A infection was discovered in 1/18 positive farms (Table V-3). Thus, C. psittaci was found 
in broiler breeders, broilers and layers. According to the questionnaire, respiratory symptoms were 
present in infected broiler breeders (3/7 farms; 42.8%), infected broilers (5/7 farms; 71.4%) and 
infected layers (1/5 farms; 20%). Mean mortality for infected broiler breeders, broiler and layer farms, 
was 5.4%, 2.8% and 9.8%, respectively. One out of six infected broiler breeder, and 2/7 infected broiler 
farms currently used antibiotics (tylosine, Pharmasin®, Eurovet and doxycycline, Soludox®, Eurovet). 
Nevertheless, we were able to detect viable C. psittaci. A high stocking density (number of 
chickens/m2) was significantly related to the risk of acquiring chlamydiosis (p = 0.006). The negative 
farm was the only with no poultry farms nearby (<4 km). Plus, it was the only farm with a very long 
sanitary period (8 weeks), which is the period in-between emptying the barn, cleaning, disinfection 
and restocking (usually 1 to 2 weeks). However, the latter two observations were not significantly 
related to the risk of chlamydiosis in chickens (p = 0.08 and 0.157, respectively). Antibiotics were not 
used at the time of sampling. 
Table II-2: Pharyngeal excretion of viable C. psittaci by poultry (n = 10 per farm) and poultry workers (n = 1 or 

































NA, Not available. 
*Doxycycline. 
t Tylosin. 
C. psittaci in broiler farms (n= 10 per farm) 
Posit ive (%) ~ore (mean ± SD) 
100 2.8±0.8 
100 2.0± 1.2 
60 0.9± 1.0 
100 1.2 ±0.6 
100 2.0± 1.3 
100 1.3 ±0.5 
100 1.7 ±0.9 
C. psittaci in layer farms (n= 10 per farm) 
100 1.8 ± 1.0 
100 1.5 ± 0.8 
100 2.4 ± 1.0 
100 2.1 ± 1.3 
70 1.1 ± 1.4 
C. psittaci in broiler breeder farms (n= 10 per farm) 
100 1.4 ± 0.8 
0 0.0 ± 0.0 
100 2.1 ± 1.2 
100 2.0 ± 0.9 
100 1.8 ± 1.0 
100 1.6 ± 0.5 
100 1.9 ± 1.0 




















Health status of broilers (questionnaire) 
Density Mortality (%) Respiratory symptom s An tibiotic use 
(no. m-2) (% broods) (% broods) 
19.0 2.0 10 10 (doxy*) 
18.0 3.5 25 0 
14.0 3.5 15 0 
20.0 2.8 10 10 (tylot) 
IO.O:j: 3.0 10 0 
20.0 2.0 0 0 
19.5 3.0 0 0 
H ealth status of layers (questionnaire) 
7.0 5.0 0 0 
5.0:j: NA 0 0 
9.0:j: 7!0-30.0 0 0 
9.0:j: 10.0 10 0 
9.CJ!l: 4.0 0 0 
Heal th status of broiler breeders (question naire) 
10.0 2.0 100 0 
7.0 NA 0 0 
16.5 5!0-10.0 0 0 
7.2 10.0 10 0 
6.5 9.3 0 0 
NA 1.5 0 0 
9.0 1.2 10 10 (doxy*) 




Table II-4: C. psittaci perceived health status and psittacosis-compatible symptoms in farm employees 
 
 
Broiler farm employees 
Viabie C. psittaci Personnel data Cur rent health status Yearly medica! complaintst Confirmed 
pneumon ia (no. 
of years ago) 
Score Gen otype Period Time Aves at Current Antibiotic Fl Re GI Ey De 
(h day- 1 home symptoms treatment 
except for *) 
Male s D 27 years 2* - - - Ft:j:, MI NPC1 s t, Dl - - -
I D 20 years 7 Layers - - - - - - - -
I D 2 years 7 Birds - - Ft, M2 - - - - -
I D I S years 2 Layers - - pt,Mt NPC2 - - - -
I D I 2 years I - - - M2 - - - R2 3 
2 D 20 years I - - - F1, M3 - y t Et - -
I D 30 years 2 - - - - PC3 - - - I9 
Female 4 D 2S years 8 - - - FJ, MJ p c t B1, D3 - RI -
3 D I 3 years 3 - - - p2,M2 NPC2 - - - 2 (pleuritis) 
I D 30 years 7 - Cold - Every production round a cold at ± S weeks -
Broiler breeder employees 
Male 2 D IS years 2 - - - - NPC2 - - - -
I D 7 years I - - - pt,Mt pc t v t, s t, D t - - -
2 D I9 years 3 - - - Ft,Mt NPC1 s t - - -
I D 4.5 years 8 - Cold - pi NPC2, B2 - E2 - -
I D 27 years 4 - - - - - - - - 22 
2 D 2S years 8 - - - p2, M2 pc2, B2 v2, s2, D2 E2 - -
0 - 2 years I - - - - - - - - -
0 - I 7 years 3 - - - - - - - - -
Female 3 D IS years 2 - 'AUergic feeling' - TJ NPC2 - - RI -
2 D 7 years 2 - - - Ft, M2 pc2 v t, s t, D t - RI -
2 D I9 years 4 - Cold Augmentin - NPC1 s t - - -
( 4 weeks ago) 
I D 27 years 4 - - - - - - - -
3 D + C 30 years 8 - - p2, M2 pc2 v2, s2, D t - - -



















NA, not applicable. 



















Time Aves at 
(h day- • home 









Layer farm employees 
Current health status Yearly medica] complaintst Confirmed 
pneumonia (no . 
of years ago) 
Curren t Antibiotic Fl Re Gl Ey De 
symptoms treatment 




~ s2. o2 R2 
Ft, Ml NPC1, a• 
F2, Ml El 
t FI, Flu-like; F, fever; M, myalgia; T, tired-fatigue; Re, respiratory; NPC or PC, (non-) productive cough; B, painful breathing; Ex, moming expectoration; Gl, gastrointestinal; V, vomiting; D, 
diarrhoea; S, stomach ache; Ey, eye; E, painful eyes; De, dermatologie; R, non-specific rash. 
:tI, Once or twi ce; 2, repeatedl y; 3, frequent! y. 




3.2    Zoonotic transmissions 
The study population consisted of 11 women and 20 men and the average age was 42 years. Three of 
31 farmers (9.6%) were vaccinated against human influenza. None were infected by ACC. However, 
29/31 (93.5%) of humans were C. psittaci-positive by both culture and the C. psittaci-specific nested 
PCR. C. psittaci genotype D (n=26), genotype A (n=1) and a mixed genotype D plus C infection (n=1), 
was discovered in farmers. Genotyping revealed no result for one sample. This sample originated from 
a female employee of a layer farm which only kept chickens (Table II-4). Thus, C. psittaci zoonotic 
transmission was detected on all but one examined chicken farm.   
Many C. psittaci positives were found, but only four of them (13.7%), who were non-smokers and had 
no allergies, currently experienced respiratory diseases (coughing, n = 3 and/or rhinitis, n = 1; sinusitis, 
n = 1; severe bronchitis, n = 1). They were all infected with genotype D, and the person with bronchitis 
was currently treated with Augmentin® (Glaxo Smith Kline). We informed the farmers and their 
physicians of the diagnostic results. 
Humans (n=2) working in the C. psittaci-negative farm never had respiratory complaints, while 25/29 
positive farmers (86.2%), reported yearly medical complaints potentially related to psittacosis (Table 
II-4). Four out of 31 farmers (12.5 %) mentioned that they had pneumonia after starting to keep 
chickens (Table II-4).  
No potential risk factor like age, gender, living in the direct environment of the farm, number of years 
employed in the sector, daily time in contact with chickens, pet animals, smoking behavior and medical 
complaints was significantly related to psittacosis. 
4.      Discussion 
We examined the occurrence of C. psittaci on 19 Belgian chicken farms, as well as zoonotic 
transmissions of these pathogens to farmers because C. psittaci is now (re)-emerging in chickens. 
Limited reports from 1960 to 2000 suggest that chickens are less sensitive to C. psittaci infections. 
However, during the last decade, C. psittaci has been detected and isolated from chickens raised in 
Australia, Belgium, China, France and Germany (Yang et al., 2007; Gaede et al., 2008; Zhang et al., 
2008; Laroucau et al., 2009; Robertson et al., 2010; Zhou et al., 2010; Dickx et al., 2011). Recently, Yin 
et al., (2012), proved Hill-Evans postulates for C. psittaci genotype B and D strains isolated from Belgian 
and French broilers. Less is known about C. psittaci genotypes infecting chickens. Up




to now, genotypes B, C, D, F and E/B have been found in chickens (Gaede et al., 2008; Zhang et al., 
2008; Dickx et al., 2010; Zhou et al., 2010; Yin et al., 2012).  
C. psittaci is apparently not the only emerging chlamydial pathogen in chickens. Laroucau et al., (2009), 
discovered a new chlamydial agent in chickens raised in France, designated atypical chicken 
Chlamydiaceae (ACC). Remarkably, ACC-positive chickens appeared healthy, but the discovery of ACC 
coincided with three cases of atypical pneumonia in French poultry workers (Laroucau et al., 2009), 
warranting the need for epidemiological surveillance in chickens. Since then, ACC has been found in 
chickens raised in China, Croatia, Germany, Greece and Slovenia (Zocevic et al., 2012). This is why we 
also included the recently developed ACC-specific real-time PCR in our epidemiological study.  
C. psittaci was highly prevalent in chickens and humans. OmpA genotyping revealed the presence of 
genotypes A, C and especially D. To our knowledge, this is the first time that genotype A and only the 
third time that genotype D, has been identified in chickens. Genotype A is most often found in 
Psittaciformes (cockatoos, parrots, parakeets, lories) and is frequently being transmitted from pet 
birds to humans. Genotype A has also been isolated from turkeys and wild birds (Van Loock et al., 2005; 
Verminnen et al., 2006; Geigenfeind et al., 2011; Kalmar et al., 2013). Thus, the pathogen is not 
restricted to Psittaciformes and was probably never noticed before in chickens. However, genotype B 
and D seem to be most prevalent in chickens. Genotype D is most often found in turkeys, but recently 
has been associated with zoonotic transfer from chickens to slaughterhouse employees (Dickx et al., 
2010). Genotype C has primarily been isolated from ducks and geese, but has been found once before 
in chickens, namely in China (Zhang et al., 2008). Atypical chicken Chlamydiaceae were not detected 
in chickens, suggesting that ACC are currently not widespread in Belgian chicken flocks, at least when 
compared to C. psittaci. However, we cannot exclude the absence of this emerging chlamydial agent 
in our chicken flocks. Respiratory disease was present, albeit not on all, C. psittaci-infected farms. 
Respiratory disease was most frequently present on broiler farms, followed by broiler breeder and 
layer farms. Only broiler and broiler breeder farms claimed to use antibiotics (tylosine, Pharmasin, 
Eurovet and doxycycline, Soludox, Eurovet). Antibiotic usage in European poultry has decreased over 
the last few years (Moulin et al., 2008; BelVet-SAC report 2012; http://www.belvetsac.ugent.be/), but 
antibiotics are still frequently used without proper diagnosis; among these are the ones active against 
C. psittaci, with the risk of creating tetracycline resistance as occurred for Chlamydia suis (Dugan et al., 
2004).  
Interestingly, a high stocking density (number of chickens/m2) was the only risk factor that was 
positively correlated with the occurrence of C. psittaci in chickens. This finding was no surprise, as C. 
psittaci transmission most often occurs from one bird to another bird close by. 




As for chickens, ACC were not detected in farmers. However, viable C. psittaci were present in 93.5% 
of the farmers. Genotypes A, C and, as in chickens, especially genotype D were discovered in the 
farmers. In our study, genotype C (most frequently found in Anseriformes; ducks and geese) was not 
detected in chickens, but we cannot exclude the presence of genotype C on the farm, as only 10 
chickens were sampled. Zoonotic transmissions of genotypes A, C and D, and even mixed genotype A, 
C and D infections in poultry workers, have been observed before by Dickx and Vanrompay (2011), 
examining employees of a turkey and chicken hatchery. Thus, C. psittaci-infected chickens present a 
substantial zoonotic risk. One human sample could not be genotyped, which could indicate the 
presence of a new genotype. Attempts to grow the strain to a higher bacterial titre for ompA 
sequencing failed. 
Humans (n= 2) of the C. psittaci- negative farm never had respiratory complaints, while 25/29 (86.2%) 
of humans, all working on C. psittaci-positive farms, reported yearly medical complaints potentially 
related to psittacosis (Table II-4). Four out of 31 farmers (12.5 %) mentioned in the questionnaire that 
they had pneumonia after starting to keep chickens, which was higher than the yearly rate of 8 in 1000 
pneumonia cases in Belgium. It is likely that chicken farmers are regularly infected, creating immunity, 
which protects them against severe disease. However, yearly complaints about fever and respiratory 
disease were of interest (Table II-4). Whether farmers become carriers, clinical consequences and the 
importance of co-infections with other human respiratory pathogens are unknown.  
Preventing avian chlamydiosis in poultry is difficult because of the endemic nature of the bacteria, the 
long-term survival of the bacteria in organic material, the intermittent shedding and the many 
asymptomatic carriers (Pelle-Duporte & Gendre, 2001). An all-in, all-out rearing regime, with thorough 
cleaning and disinfecting between broods is obligatory. C. psittaci is highly susceptible to heat and 
disinfectants (quaternary ammonium compounds, house-hold bleach) but is resistant to drying, acids 
and alkali (Smith et al., 2005). Access of wild birds to the animals or food should be prevented. 
Equipment should be regularly cleaned and disinfected when used for several barns at the farm. 
Personal protective measures involve a good hand hygiene protocol and protective clothing, including 
gloves and an air filter full-face mask. A transition room should be available where protective clothing 
may be kept. The two most important collective protective measures are ventilation and cleaning. 
Natural or mechanical ventilation should try to prevent aerosol accumulation and cross-contamination 
between the different barns. Even continuous disinfection (although expensive) of the air in the barns 
could be considered. Education and training are very important to guarantee that the preventive 
measures are well understood and performed (Deschuyffeleer et al., 2012). 
 




5.      Conclusion 
Despite the governments’ obligation to assess any biohazard in the workplace, knowledge on C. psittaci 
and especially ACC in chickens is still relatively undeveloped and a specific risk assessment in poultry 
production remains to be established. Many health care providers are not familiar with psittacosis, 
especially with its occupational and zoonotic character. An occupational physician assigned to modern, 
vertically integrated poultry farming, covering the complete poultry production ranging from the 
feeding mill to processing facilities, could conduct a campaign to raise general awareness and to inform 
poultry workers on collective and personal protective measures. The occupational physician should 
address local physicians with a written document as this may lead to an early diagnosis and treatment 
in poultry workers (Deschuyffeleer et al., 2012). However, most benefit is to be expected from an 
efficient avian Chlamydia vaccine. 
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Chlamydia psittaci is a gram-negative obligate intracellular bacterium which mainly infects birds and 
mammals. Not much is known on innate immunity initiated by C. psittaci. This study is on chicken HD11 
cell activation and expression of cytokine, chemokine, caspase-1, iNOS and TLR genes during the early 
phase and mid-cycle period of the developmental cycle of the highly virulent C. psittaci strain 92/1293. 
C. psittaci significantly augmented transcript levels for all genes investigated, especially during mid-
cycle. These results demonstrate a robust  innate immune response of chicken macrophage-like cells 




























1.      Introduction 
In birds, C. psittaci replicates in epithelial cells and macrophages of the avian respiratory tract, which 
can result in a systemic infection (Vanrompay et al., 1995). They possess a unique biphasic 
developmental cycle, thereby switching between a metabolically inactive infectious state, the 
elementary body (EB) and a metabolically active non-infectious state, the reticulate body (RB). 
Following attachment of EBs to the host cell membrane and the subsequent internalization, EBs start 
to differentiate into RBs within an inclusion which is derived from the host cell membrane during the 
internalization (Vanrompay et al., 1995). Reticulate bodies start to migrate to the periphery of the 
inclusion whereby the replication starts by binary fission. Afterwards, RBs can re-differentiate into new 
infectious EBs followed  by the  release of those EBs by host cell lysis or reverse endocytosis. In some 
cases, the developmental cycle can be altered in favour of persistence. Persistent Chlamydiaceae or 
so-called aberrant bodies fail to complete their development from RBs into infectious EBs, but retain 
their metabolic activity.  
Not much is known how the innate immune system of the host is influenced by a C. psittaci infection. 
C. psittaci replicates in epithelial cells and macrophages of the avian respiratory tract. Subsequently, 
C. psittaci can be demonstrated in plasma and blood monocytes, resulting in a systemic infection 
(Vanrompay et al., 1995). Monocytes/macrophages are part of the innate immune system and capable 
of engulfing and killing pathogens. But probably their most important function is to recruit other 
myeloid cells, in particular polymorphonuclear phagocytes, to the site of infection by the release of 
chemotactic cytokines. Macrophages can also activate the adaptive immune response by presenting 
antigens to CD4+ T cells via class II MHC antigen (Beuttler, 2004). Although monocytes/macrophages 
play an important role in clearing pathogens, C. psittaci as well as other Chlamydiaceae are able to 
survive and even replicate within those cells. Moreover, C. psittaci uses blood monocytes as vehicles 
to establish a systemic infection in birds. As not much is known how the host innate immune is 
influenced by C. psittaci, Beeckman et al., (2010) demonstrated an  increased expression of IL-1β and 
IL-6,  CXCLi2, CXCLi1 and CCLi2  following inoculation with the highly virulent C. psitaci strain 92/1293 
(ompA genotype D) at 4h post-infection. Interestingly, exceptionally high IL-10 and no TGF-β4 
responses were observed at 4h post inoculation. This could induce macrophage deactivation and NF-
κB suppression (Beeckman et al., 2010) and thereby, could dampen innate immunity and promote C. 
psittaci survival in macrophages. 
Toll-like receptor (TLR) -mediated recognition of components derived from a wide range of pathogens 
and their role in the subsequent initiation of innate immune responses is widely accepted (Kawai and 
Akira, 2011).  




The goal of the present study was to examine the expression of cytokines (IL-1β, IL-6, MIF, LITAF 
(Lipopolysaccharide-induced TNF factor) , IL-12p35, IL-10), caspase-1, GM-CSF, iNOS, chemokines 
(CXCLi1, CXCLi2, CCLi3, IL-16) and TLRs (TLR2, TLR3, TLR4, TLR5, TLR7, TLR21) during an infection of 
HD11 cells with the virulent C. psittaci strain 92/1293 at different time points.  
 
2.      Material  and  Methods 
2.1.    Chlamydia and cell lines 
The well-characterized virulent Chlamydia psittaci strain 92/1293 used in this study was isolated from 
the lung, spleen and cloaca of a diseased turkey (Vanrompay et al., 1993). The bacterium was grown 
in Buffalo Green Monkey (BGM) cells as described previously (Vanrompay et al., 1993) and the median 
tissue culture infective dose (TCID50) was determined using the method of Spearman and Kaerber 
(Mayr et al., 1974). 
The HD11 cell line was derived from chicken myelomonocytic cells transformed by the v-myc encoding 
retrovirus MC29 (Beug et al., 1979). The cells were cultured in Dulbecco’s modified Eagle’s minimal 
essential medium (DMEM) supplemented with 1% L-glutamine, 0.5% gentamicin, 5% Fetal Calf Serum 
(FCS) and 1% sodium pyruvate (Invitrogen, Merelbeke, Belgium) and were incubated in a humidified 
atmosphere at 37°C and 5% CO2.  
2.2.    Chlamydia psittaci infection of HD11 cells 
HD11 cells were seeded in a 25 cm2 tissue culture flask at a concentration of 300 000 cells/ml and 
grown for 24h at 37°C and 5% CO2. The medium was aspirated and 1,5 x 106 HD11 cells were infected 
with C. psittaci at a multiplicity of infection (MOI) of 1. Irreversible attachment and cell entry was 
accomplished by incubating the HD11 cells for 3 hours on a rocking platform at 37°C. The unbound 
organisms were washed away with DMEM (37°C) and culture medium enriched with 5.5 mg/l glucose 
(Sigma) was added to each tissue culture flask. Infected cells were incubated until RNA extraction at 








2.3.    Transcription analysis of cytokine, chemokine, caspase-1, 
iNOS and TLR genes 
We determined the innate immune response following C. psittaci infection of HD11 cells by examining 
gene transcript levels of IL-1β, IL-6, MIF, LITAF, IL-12p35, IL-10, caspase-1, GM-CSF, iNOS, CXCLi1, 
CXCLi2, CCLi3, IL-16, TLR2, TLR3, TLR4, TLR5, TLR7, TLR21 in infected and control HD11 cultures. Specific 
primers (Table 1) were designed using primer 3 (http://frodo.wi.mit.edu/primer3/) and DINA melt 
(http://www.bioinfo.rpi.edu/ applications/hybrid) software programs. Specificity of all RT-PCR primers 
were initially checked by conventional PCR followed by cloning (pGEM-T Easy Vector System, Promega, 
Leiden, The Netherlands) and DNA sequencing of the inserts (LGC Genomics, Berlin, Germany). As we 
were not able to design primers, which were 100% specific for IL10, IL12p35 and GM-CSF, probes, 
kindly provided by P. Kaiser and L. Rothwell (Institute for Animal Health, Compton, Berkshire, UK) were 
needed to verify the specificity of the amplified targets (Table III-1). 
Target Accession No. Primer and probe sequence (5’-3’) Ta 
HD11 28S rRNA X59733 F: TTTGGGTTTTAAGCAGGAGGT 
R: TTGCGACAACACATCATCAGT 
58°C 
C. psittaci 16S rRNA CPU68447 F: GTCAAGTCAGCATGGCCCTT 
R: CCCAGTCATCAGCCTCACCT 
58°C 
MS2 spike Unpublished F: Unpublished 
R: Unpublished 
60°C 
IL-1β Y15006.1 F: CACAGAGATGGCGTTCGTT 
R: GTGACGGGCTCAAAAACCT 
58°C 
IL-6 NM_204628 F: AGAAATGCCTGACGAAGCTCT 
R: CACGGTCTTCTCCATAAACGA 
58°C 
Caspase-1 AF031351 F: TGCCATGAAGACAAAACTTCC 
R: TCTACACATCTCCAGCCATCC 
58°C 
MIF M95776 F: CAGAACAAGACCTACACCAAGC 
R: CTAACAAGGAGCCATCCATC 
58°C 




LITAF AY765397 F: TCCTCACCCCTACCCTGTC 
R: TCAGAGCATCAACGCAAAAG 
58°C 








CXCLi1 Y14971 F: CCACTGCTTACTGGCTTATCG 
R: CTTGGGATGGATGAACTTGG 
55°C 
CXCLi2 NM_205498 F: CTCGCTCTTCTCATCGCATC 
R: GGCAGCAGTGTCCCATCC 
58°C 
CCLi3 Y18692 F: AGCCTGCCATCATCTTCATC 
R: AAACAGCACCTGCCATGAG 
58°C 
IL-16 NM_204352 F: CTCAGCCCAAAACCATCAGT 
R: GGTGGCAGTAAGTGGAAAGC 
58°C 
    




TLR2  AB046533 F: CCTGGTGTTCCTGTTCATCC 
R: AGCGTCTTGTGGCTCTTCTC 
58°C 
TLR3 NM_001011691 F: GGCTAAACGACACTCAAGCA 
R: GGCGTCATAATCAAACACTCC 
58°C 
TLR4 NM_001030693 F: TGGCACCTACCCTGTCTTTC 
R: GGCTTGGAGTGGCTTGTATG 
58°C 
TLR5 NM_001024586 F: AACTCCCTTCCTTCCCACAT 
R: AACCTCTCTCCCACACAAGC 
58°C 
TLR7 NM_001011688 F: ATCAGCACAGGGATGGAAAG 
R: GGGGAACGGTAGTCAGAAGG 
58°C 
TLR21 NM_001030558 F: AGAAGCAACCACAGGGAGAA 
R: AAGCACTTTTGGGGTCCTTT 
58°C 
iNOS D85422 F: ACCCACCCAACAACTGCTAA 
R: GCCCTTGTCCATCTCTTGTC 
58°C 
Table III-1: Real-time quantitative RT-PCR primers and probes. F: forward primer; R: reverse primer; P: 5’-FAM 
(5-carboxyfluorescein) + 3’-TAMRA (6- carboxytetramethylrhodamine) probe. 
 
Total RNA from 1,5 x 106 infected HD11 cells (MOI 1) was prepared using the Total RNA Isolation 
Reagent (TRIR, ABgene, Westburg, Leusden, The Netherlands) according to the manufacturer’s 
protocol. RNA from uninfected cells served as negative controls. After RNA extraction, samples were 
treated with RNase-free amplification grade DNase I (Promega) following the manufacturer’s 
instructions and were confirmed to be DNA-free by performing a PCR for the C. psittaci 16S rRNA gene. 
One microgram of total RNA was reverse transcribed (reverse-ITTM 1st Strand Synthesis, Thermo 
Scientific) into host cell cDNA using the anchored oligo-dT molecule. Each RNA sample was spiked with 
5ng coliphage MS2 control RNA (RNA Control Kit, Thermo Scientific). All experiments were performed 
in duplicate, with replicates performed at different days.  
Following cDNA synthesis, cDNA amplification was performed for 6 cytokine genes, 4 chemokine 
genes, the caspase-1 gene, the GM-CSF gene, the iNOS gene, 6 TLR genes, the HD11 28S rRNA 
normalization gene and the MS2 spike. cDNA amplification was performed using the AbsoluteTM QPCR 
SYBR® Green Mix (Thermo Scientific). The DNA polymerase was initially activated for 15 min at 94°C. 
Then 40 cycles of amplification were carried out using the Rotor Gene RG-3000 cycler (Westburg) 
according to the following cycle profile: DNA was denatured at 95°C for 10 min and during 40 cycles of 
95°C for 30s, primers (Table III-1) annealed at 55-60°C for 30s and extended at 72°C for 30s. Program 
settings included acquisition on the FAM/Sybr channel in the extension step and a gain of six. 
Quantification was done as described by Beeckman et al. (2008), using standard graphs of the cycle 
treshold (Ct) values obtained by testing 10-fold serial dilutions (109 to 101 molecules/µl) of the purified 
PCR products. All samples and standards were tested in duplicate. Ct-values of the samples were 
automatically converted into initial template quantities (N0) by use of the RotorGene software 6.0 
(Westburg) using imported standard curves from previous runs. Quantification results of the coliphage 
MS2 RNA obtained were used to correct for inter-sample variability, while quantification results of the 




HD11 28S rRNA were used to correct for cell growth during the developmental cycle. No difference in 
mRNA level is therefore shown as a fold change of 1.  
2.4.    HD11 activation assay 
Activation of HD11 cells was determined by measurement of the accumulation of nitrite (NO2-) in the 
culture medium at 2h, 4h, 8h, 12h and 18h post infection with C. psittaci. One hundred microliter of 
the collected cell free supernatant was added to equal amount of Griess reagent (Sigma) and incubated 
for 15 minutes at room temperature. The amount of NO2- (NO) was determined by measuring the 
absorbance of the reaction product with a spectrophotometer (Tecan Genios Plus) at a wavelength of 
585 nm. A 10-fold NaNO2 dilution series ranging from 320 µM to 0.3125 µM (in triplicate) was created 
to generate a standard curve. This standard curve was used to determine the amount of NO2- (NO) in 
the samples. 
2.5.    Statistical analysis 
The experiment was performed twice, each time testing all samples in duplicate. Data were pooled for 
statistical analysis. The mean and standard error mean (SEM) for cytokine-, chemokine-, caspase-1-, 
GM-CSF-, iNOS-, and TLR-gene transcript levels were calculated. Statistically significant differences 
(p<0.05; p<0.005) between the results obtained to investigate the innate immune response elicited by 
C. psittaci was determined using an unpaired Student’s t-test (SPSS Inc., Chicago Illinois, US). Secondly, 
an analysis of variance (ANOVA, SPSS Inc.) with post-hoc analysis (both Tukey HSD and Tukey-b) was 
performed along the time axis to determine significant upregulation time points for cytokine-, 














3.      Results 
3.1.    Transcription analysis of the caspase-1 gene and cytokines 
genes 
Statistical differences were observed when comparing gene transcript levels of infected cells versus 
mock infected controls. The influence of an infection on gene expression by comparing gene transcript 
levels in infected cells versus mock infected controls was examined. The mRNA levels in mock infected 
controls were presented as an mRNA-fold change of 1. For the pro-inflammatory cytokines IL-1β and 
IL-6, gene expression upregulation was already noticed at 2h p.i., as compared to the mock infected 
controls. The upregulation continued, resulting in maximal upregulation of the IL-1β (1671-fold) and 
IL-6 (1195-fold) gene expression at 18h p.i. and 4h p.i., respectively. IL-1β and IL-6 gene upregulation 
was most significant from 8h to 12h p.i. The genes for LITAF, IL-12p35 caspase-1, MIF, IL-10 and GM-
CSF were all downregulated (mRNA-fold change < 1) during the first 4h p.i, as compared to the results 
of the mock infected controls. However, at 8h p.i., mRNA-levels for all these genes were comparable 
to the ones for the mock infected controls, as they were close to a mRNA-fold change of 1. A significant 
upregulation of the expression of the caspase-1, LITAF, GM-CSF, Caspase-1, MIF and IL-10 genes was 
observed towards 12h p.i., the beginning of the mid cycle period. Regarding the caspase-1, LITAF , MIF, 
IL-12p35, IL-10 and GM-CSF genes, upregulation of gene expression was most pronounced for LITAF  
(23-fold) and IL-12p35 (106-fold). Interestingly, during the mid cycle (from 12h to 18h p.i.), mRNA levels 
for all genes significantly declined towards the base line level of 1, except for IL-1β, GM-CSF and IL-10. 
The expression of those genes was significantly upregulated during mid cycle, resulting in a 1671-, 27- 
and 9.8-fold change in mRNA level, as compared to mock infected controls (Fig. III-1).  
 






Fig III-1. Cytokine gene expression by HD11 cells infected with C. psittaci (MOI=1)) at different time points 
(2h, 4h, 8h, 12h and 18h) p.i. Results are presented as fold changes in cytokine mRNA levels compared to 
mock infected controls. Significant differences between C. psittaci infected and mock infected HD11 cells, 
determined by an unpaired student t test, are indicated by **P< 0.005 and *P<0.05.  Significant upregulation 
or downregulation for every cytokine, determined by an ANOVA test, is indicated by a letter. Error bars in 











3.2.    Transcription analysis of chemokine genes 
We compared the expression of the pro-inflammatory chemokine genes CXCLi1 (K60), CXCLi2 (IL-8), 
CCLi3 (K203) and IL-16 in C. psittaci infected HD11 cells versus mock infected controls. Statistical 
differences were observed when comparing gene transcript levels for infected cells versus mock 
infected controls.  All chemokine genes, except for the IL-16 gene, were significantly upregulated 
during the early phase of the bacterial reproduction cycle (85-fold for CXCLi1, 66-fold for CXCLi2 and 
89-fold for CCLi3). During mid-cycle, the gene expression upregulation continued (1493-fold for CXCLi1, 
471-fold for CXCLi2 and 767-fold for CCLi3). For the IL-16 gene, a significant, but rather moderate 
expression upregulation was noticed no earlier than mid-cycle (10-fold rise and 2.2-fold rise at 12 and 
18h p.i., respectively) (Fig. III-2).  
 
Fig III-2. Chemokine gene expression by HD11 cells infected with C. psittaci (MOI=1)) at different time points 
(2h, 4h, 8h, 12h and 18h) p.i. Results are presented as fold changes in cytokine mRNA levels compared to 
mock infected controls. Significant differences between C. psittaci infected and mock infected HD11 cells, 
determined by an unpaired student t test, are indicated by **P< 0.005 and *P<0.05.  Significant upregulation 
or downregulation  for every cytokine, determined by an ANOVA test, is indicated by a letter. Error bars in 









3.3.    Transcription analysis of TLR genes 
We compared the expression of six known avian TLR genes; TLR2, TLR3, TLR4, TLR5, TLR7 and TLR21 in 
C. psittaci infected HD11 cells versus mock infected controls. During the early phase of the 
developmental cycle, TLR gene expression was significantly downregulated, as compared to mock 
infected controls. TLR21 was significantly upregulated (3.6-fold rise) at 8h p.i. In contrast, the 
expression of all TLR genes, with the exception of the TLR2 gene, was significantly upregulated during 
mid-cycle (especially, at 12h p.i.). Gene expression upregulation was rather moderate for TLR3 (5.9-
fold rise), TLR4 (6.2-fold rise), TLR5 (5.2-fold rise) and TLR7 (4.5-fold rise) genes, whereas gene 
expression upregulation was more pronounced for the TLR21 gene (34-fold rise) (Fig. III-3).  
 
 





Fig III-3. TLR gene expression by HD11 cells infected with C. psittaci (MOI=1)) at different time points (2h, 
4h, 8h, 12h and 18h) p.i. Results are presented as fold changes in cytokine mRNA levels compared to mock 
infected controls. Significant differences between C. psittaci infected and mock infected HD11 cells, 
determined by an unpaired student t test, are indicated by **P< 0.005 and *P<0.05.  Significant upregulation 
or downregulation  for every cytokine, determined by an ANOVA test, is indicated by a letter. Error bars in 




3.4.    Transcription analysis of the iNOS gene and HD11 activation 
assay 
Activation of HD11 cells by C. psittaci was evaluated by comparing iNOS gene transcription and NO 
(NO2-) production in infected versus mock infected cells. The expression of the iNOS gene was 
significantly upregulated during mid-cycle resulting in a 344.6-fold rise of the mRNA level at 18h p.i. 
The same was observed for the NO production resulting in 91.02 µM  4.06 at 18h p.i. versus 1.32 µM 
 0.17 for the mock infected controls (Fig. III-4).  





Fig III-4. iNOS gene expression and NO production by HD11 cells infected with C. psittaci (MOI=1)) at 
different time points (2h, 4h, 8h, 12h and 18h) p.i. Results are presented as fold changes in cytokine mRNA 
levels compared to mock infected controls. Significant differences between C. psittaci infected and mock 
infected HD11 cells, determined by an unpaired student t test, are indicated by **P< 0.005 and *P<0.05.  
Significant upregulation or downregulation  for every cytokine, determined by an ANOVA test, is indicated 
by a letter. Error bars in all figures represent the standard error mean between two independent 
experiments performed in duplicate. 
 
4.      Discussion 
As a member of the obligate intracellular Chlamydiaceae family, Chlamydia psittaci engages in an 
intimate relation with respiratory epithelial cells and macrophages. Not much  is known of the innate 
immunity during a primary Chlamydia infection. Former studies on chlamydial immunology mainly 
focused on adaptive immunity against C. trachomatis, C. muridarum, C. pneumoniae, and C. caviae 
whereas it is becoming increasingly  clear that the innate immune response influences the migration 
and activation of immune cells, thereby directing the adapative immune response (Germain, 2004). 
Very few studies have investigated the innate immune system of the avian respiratory tract (Ariaans 
et al., 2008; Sarmento et al., 2008 and Wang et al., 2006) and only one study has examined innate 
immunity to C. psittaci in its natural host cell, the respiratory epithelial cell or avian macrophage 
(Beeckman et al., 2010), although knowledge on the innate immune mechanisms to C. psittaci 
infections and chlamydial antigens is crucial to understand the pathogenesis of, and immunity to this 
zoonotic pathogen. 




The objective of this study was to examine the innate immune response generated after an avian C. 
psittaci infection in a matched avian host cell line. The use of natural host cells in in vitro experiments 
is important, as earlier demonstrated by Roshick et al. (2006).  
The current study focused on activation and expression of cytokine and TLR genes by HD11 cells during 
the early phase (2-8h p.i.) and mid-cycle (12-18h p.i.) period of the developmental cycle of the highly 
virulent C. psittaci strain 92/1293 (ompA genotype D). We performed this study on avian macrophage-
like cells as it is well known that macrophages play a key role in directing the innate immune response 
during infection.  
First,  the expression of inflammatory cytokine genes in C. psittaci infected HD11 cells was investigated. 
Genes encoding the NF-B-regulated pro-inflammatory cytokines IL-1 and IL-6 were highly expressed 
during C. psittaci infections of avian macrophage-like cells. mRNA levels for both genes showed a 
significant upregulation at 4h post infection. The same mRNA-fold changes were obtained by 
Beeckman et al. (2010), using the same model, but inoculating C. psittaci at a multiplicity of infection 
(MOI) of 100 instead of 1 and monitoring cytokine production at 4h p.i. Thus, the expression of the IL-
1 and IL-6 genes early on during the C. psittaci developmental cycle seemed to be MOI independent. 
A continuously augmenting IL-1 and IL-6 gene expression upregulation was observed leading to the 
highest IL-1 and IL-6 gene expression levels during mid- (18h p.i.) and early-cycle (4h p.i.), 
respectively.Continuously augmenting IL-1 and IL-6 gene expression upregulation was also observed 
using other in vitro models, like for instance C. muridarum in primary mouse macrophages (Prantner 
and Nagarajan, 2009) and C. trachomatis in human monocytes/macrophages and THP-1 cells (Bas et 
al., 2008). In our study, the IL-1 mRNA levels continuously augmented in infected cells, but they were 
only accompanied by caspase-1 gene upregulation from mid-cycle onwards. IL-1 protein expression 
is controlled at the posttranslational level, since it requires cleavage of pro-IL-1 by the host protease 
caspase-1. The effector protein CopB (Fields et al., 2005) could play a role in caspase-1 activation 
because the homologous T3S translocator proteins in Shigella (IpaB) and Salmonella (SipB) (Hersh et 
al., 1999; Hilbi et al., 1998; Thirumalai et al., 1997) have been shown to co-localize with caspase-1 and 
are necessary and sufficient for its activation. Beeckman et al. (2008), examined the expression of C. 
psittaci T3S effector genes including copB1 (but not copB2). copB1 was expressed late (>24h p.i.) during 
the developmental cycle.  
Expression of the LITAF-gene, another NF-B-regulated pro-inflammatory cytokine, was not 
upregulated till the beginning of the mid-cycle period and this 23-fold upregulation corresponded with 
a 6.2-fold increase in TLR4 expression. This is in contrast with the study of Prantner and Nagarajan 




(2009) in murine macrophages, who observed the highest induction of LITAF  mRNA early during 
infection (8h p.i.) and ascribed this to dominant TLR2-MyD88 signaling.  
The importance of the contribution of TLR2 or TLR4 signaling in chlamydial inflammation is still a matter 
of debate. Joyee and Yang (2008) stated in their review on the role of TLRs in immune responses to 
chlamydial infections that, although chlamydial LPS and hsp are recognized by TLR4, intact organisms 
stimulate innate immune cells mainly through TLR2. Interestingly, the TLR2 gene is the only TLR gene 
in our study, which is not upregulated after internalization of C. psittaci, when comparing infected and 
mock-infected cells. The question rises whether this might present an immune evasion strategy, 
reducing early secretion of pro-inflammatory cytokines as they may aid in eradicating a chlamydial 
infection (Darville et al., 2003), or whether this is a crucial mechanism that exists to switch this pathway 
off to prevent over-amplification of the TLR-2-mediated signal.  The gene encoding the chicken 
macrophage migration inhibitory factor (MIF) was the least upregulated cytokine gene during a C. 
psittaci infection of HD11 cells. This might be beneficial for the pathogenesis of the infection, as high 
MIF levels could negatively influence the spreading of C. psittaci from the lungs to various tissues 
throughout the body Unlike mammalian MIF, avian MIF alone does not promote the expression of IL-
1, IL-6, IL-12 and IL-8 or NO production in HD11 cells. This only occurs in previously stimulated 
(primed) cells ([Bernhagen et al., 1994] and [Kim et al., 2010]). Thus, in our study MIF probably plays 
no role in enhancing cytokine and/or chemokine expression by HD11 cells. 
 IL-12 gene expression was actually downregulated in the early phase of the infection and it became 
highly (106.7-fold) upregulated during mid-cycle. A study of Agrawal et al. (2009) showed that IL-12 is 
involved in protection against C. trachomatis.  
C. psittaci infection downregulated the expression of the anti-inflammatory IL-10 gene during the early 
phase of the chlamydial developmental cycle. This is in contrast with our former study, examining IL-
10 expression only at 4h p.i. (Beeckman et al., 2010). Previously, we found a 581-fold upregulated IL-
10 mRNA level at 4h p.i. This can most likely be attributed to the MOI, which was 100 times higher in 
the former study.  
Similar with the downregulation of the IL-10 gene early in the infection, other genes like IL-12, GM-
CSF, LITAF , MIF, caspase-1, TLR-2, TLR-3, TLR-4, TLR-5, TLR-7 and TLR21 were also significantly 
downregulated, suggesting an immune evasion strategy induced by C. psittaci. 
The pro-inflammatory chemokines CXCLi1, CXCLi2 and CCLi3 were highly expressed, especially during 
mid-cycle. CXCLi1, CXCLi2 and CCLi3 mediate neutrophil, heterophil and monocyte attraction to the 
place of infection. Buchholz and Stephens (2008) revealed that the endogenous CXCLi2 response 
induced by C. trachomatis was dependent upon NOD-1 PRR signaling. As TLR-21 gene expression was 




significantly upregulated by C. psittaci, gene expression analysis for additional intracellular PRR, like 
NOD-1 will be performed in future experiments. Expression of IL-16 was upregulated by C. psittaci 
during mid-cycle. According to Ghigo et al. (2010) IL-16 promotes replication of Tropheryma whipplei 
by inhibiting phagolysosomal fusion. It is possible that IL-16 plays also a role in the inhibition of the 
fagolysosomal fusion of C. psittaci by activation of the T3SS. 
The expression of all examined TLR genes was down-regulated during the first 4h p.i. Gene 
upregulation was first observed for TLR21 (3.6-fold at 8h p.i.). The avian TLR21 is an intracellular 
endosomal nucleotide signaling receptor that senses and responds to bacterial genomic DNA (Keestra 
et al., 2010). Thus, C. psittaci is certainly recognized by intracellular signaling receptors. This might 
influence the expression of pathogen recognition receptors (PRRs) directly or their downstream 
signaling. Unfortunately, other intracellular receptors like RIG-I like receptors, NOD-like receptors and 
inflammasomes are not yet investigated.  
In conclusion, our results showed a clearer view on how C. psittaci is recognized by HD11 cells and its 
influence on the host innate immune response. High expression of cytokines, chemokines, iNOS, 
caspase-1 and GM-CSF genes with a peak during mid cycle of the developmental infection were  
observed. Further research on other pattern recognition receptors and their pathways is necessary to 














Biology and the elicited innate immune response of C. 















This chapter will be published as: 
Lagae S., Soen B., Saad N., and Vanrompay D. Biology and the elicited innate immune response of C. 
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Chlamydia psittaci is a Gram-negative obligate intracellular bacterium, causing respiratory infections 
in birds and humans. The bacterium can survive and even replicate within macrophages, which are 
phagocytes of the innate immune system involved in the phagocytosis, stimulation of host cell defense 
and presentation of antigens to activate the adaptive immune response. The development cycle, the 
T3SS and the innate immunity initiated by C. psittaci was investigated in THP1 cells. A rapid early entry 
was observed followed by an increase in the average area per inclusion between 24h and 48h p.i. 
resulting in the lyse of the host cell at 48h p.i. The study of the T3SS of C. psittaci revealed the 
continuous expression of IncA. Furthermore, the effector proteins SctW and SctC were also detected 
during the developmental cycle. The staining data indicate that the T3SS is continuously expressed and 
active during the infection cycle in THP1 cells. 
Less is known of the innate immunity elicited by C. psittaci. In this way, it was determined which 
pattern recognition receptors were involved during infection with C. psittaci in THP1 cells. A significant 
upregulation of TLR4, TLR6, TLR3, TLR9+, NLRP3, ASC, RIG-I, NOD-2 was noticed during infection. 
Moreover, different cytokines and chemokines such as IL-1β, TNF-α, IL-6, IL-8 and GM-CSF were 




















1.      Introduction 
Chlamydia psittaci infect a wide range of avian species. In addition, C. psittaci has a tremendous 
zoonotic potential and all genotypes can readily infect humans via inhalations of nasal and ocular 
secretions and/or faeces of infected animals (Cray, 2011). Symptoms in humans may vary from 
unapparent to severe and the infection can even cause death when untreated (Rohde et al., 2010). 
After inhalation, C. psittaci binds and enters epithelial cells and macrophages from the respiratory tract 
where it starts his unique biphasic developmental cycle alternating between the elementary body (EB) 
and the reticulate body (RB). In order to enter and survive in the host environment, C. psittaci 
translocate effector proteins into the host cell by using a sophisticated molecular syringe called the 
type III secretion system (T3SS) (Beeckman et al., 2008). The developmental cycle start with the 
attachment of EB to the host cell membrane, thereby on entry, translocating an actin-recruiting 
protein called tarp (translocated actin-recruiting phosphoprotein) into the host cell to induce 
recruitment and polymerization of actin at the attachment site, assisting the internalization of the 
bacteria (Carabeo et al., 2002; Subtil et al., 2004, Beeckman et al., 2007). Other effector proteins 
translocated into the host cell are the inclusion membrane proteins or Incs, in which IncA mediates 
homotypic fusion of inclusion probably through t_SNARE domains (Rockey et al., 2002; Delevoye et al., 
2004). Interestingly, the expression of  genes encoding components of the T3SS vary in the 
developmental cycle in agreement with the alternation between EBs and RBs, the replication of RBs, 
but it is also dependent on the Chlamydiae species, the strain and the host cell  used (Slepenkin et al., 
2003; Beeckman and Vanrompay, 2010). 
As monocytes and macrophages are part of the innate immune system, it is unique that Chlamydiaceae 
can enter and even replicate within those cells. However, multiple inclusions and metabolically active 
aberrant bodies were observed in monocytes infected with C. pneumonia (Airenne et al., 1999). So, 
Chlamydiae appear to become spontaneously persistent following infection of monocytes. 
Furthermore, the number of infectious progeny of EBs from macrophages was much lower when 
compared to EBs recovered from an epithelial cell line such as HeLa cells. As Chlamydiae has a lower 
ability to replicate and to generate new metabolically active EBs when compared to epithelial cells and 
the observation of aberrant RBs, lead to the assumption that monocytes/macrophages may rather 
serve as carriers for the bacteria to infect other organs and establish a systemic infection (Gaydos et 
al., 1996; Wolf et al., 2005).  
Macrophages are wide distributed throughout the body of the host and they will rarely be far away 
from infectious organisms introduced by any route. Macrophages are mobile scavenger cells capable 
of engulfing and killing microbes, but probably their most important function is to supervise through 




the elaboration of chemotactic cytokines and thereby recruiting other immune cells to place of 
infection. They can also activate the adaptive immune response through the presentation of antigens 
to T-cells via MHC molecules (Beuttler, 2004). Macrophages express a range of pattern recognition 
receptors (PRRs) such as Toll-like receptors (TLRs), Retinoic acid-inducible gene (RIG) -I-like and 
nucleotide-binding oligomerization domain (NOD) -like sensing receptors, on their surface and in 
vacuolar and cytosolic compartments capable of sensing PAMPs of Chlamydiaceae (Athman and 
Philpott, 2004). Researchers have observed that all those receptors do play a role in sensing 
Chlamydiaceae and are responsible for the evoked immune response mediated by several cytokines 
and chemokines. Several reports indicate an important role for NOD-like receptors, especially NOD1, 
leading to a high IL-8 production during chlamydial infection (Opitz et al., 2005; Shimada et al., 2009; 
Buchholz and Stephens, 2008). Furthermore, the NLRP3/ASC inflammasome is necessary for the 
induction of IL-1β through the activation of caspase-1 during chlamydial infection in macrophages and 
epithelial cells (Abdul-Sater et al., 2009; Shimada et al., 2009; He et al., 2010). However, to generate 
functional IL-1β proteins, pro-IL-1β must be first formed through the activation of TLRs before caspase-
1 can proteolytically cleaves this precursor to the pro-inflammatory cytokine IL-1β. Several studies 
have showed that different TLRs such as TLR2 and TLR4 are activated after infection with Chlamydiae 
(Prebeck et al., 2001; Bulut et al., 2002; Netea et al., 2002; Shimada et al., 2012).   
However, how C. psittaci is recognized by human macrophages and the innate immune response that 
is elicited is unknown. The aim of this study it to investigate the mode of action of the T3SS of C. psittaci 
in  THP1 cells and the macrophage response to the chlamydial infection. This study focused on the in 
vitro development of C. psittaci in THP1 cells and the elicited immune response by 1) the determination 
of the characteristics of the replication cycle of C. psittaci in THP1 cells, 2) clarifying the role of T3SS in 
the developmental cycle of C. psittaci in THP1 cells and 3) examination of the recognition and the 
evoked immune response of C. psittaci by THP1 cells. A better understanding of the pathogenesis of C. 
psittaci and the elicited innate immune response in human macrophages will lead to a better 











2.      Material and Methods 
2.1.    Chlamydia and cell lines 
The Chlamydia psittaci genotype B strain CP3 used in this study was isolated from a pigeon (Page and 
Bankowski, 1959). The bacteria were grown in Buffalo Green Monkey (BGM) cells using standard 
techniques. The EBs and RBs were purified by discontinuous gradient ultracentrifugation using four 
different concentrations of urografin (60 vol%, 54 vol%, 44 vol% and 32 vol%) mixed with Tris-KCl. 
Ultracentrifugation (Beckman Coulter, SW40 Ti) was performed at 50 000g for 60 minutes at 4°C. After 
ultracentrifugation, the 32/44 interphase contained the RBs and the 44/54 interphase contained the 
EBs. The EBs were collected and the tissue culture infective dose (TCID50) was determined by the 
method of Spearman and Kaerber (Mayer et al., 1974). 
THP1 cells, a human monocytic cell line derived from an acute monocytic leukemia patient, were 
cultured in RPMI1640 + glutamax (Gibcon) medium supplemented with 1% streptomycin and 2% 
vancomycin and were incubated in a humidified atmosphere at 37°C and 5% CO2. 
2.2.    Chlamydia psittaci infection in THP1 cells 
THP1 cells were seeded in Chlamydia trac bottles (Bibby Sterilin Ltd., Stone, UK) at a concentration of 
300 000 cells/ml and grown for 24h at 37°C and 5% CO2. To differentiate THP1 monocytes into 
adherent macrophages a concentration of 50 ng/ml phorbol 12-myristate 13-acetate (PMA) was added 
at the cell culture medium. After 24h, the medium was aspirated and 300 000 THP1 cells were infected 
with C. psittaci genotype B using different multiplicity of infections (MOIs). Irreversible attachment and 
cell entry was performed by centrifugation at 1300g for 15minutes at 4°C. After centrifugation, the 
inoculum was removed and cell culture medium enriched with 5.5 mg/l glucose (Sigma) was added to 
every trac bottle. The trac bottles were incubated at 37°C. 
2.3.    Replication, inclusion size and titration of the infectious 
progeny of C. psittaci in THP1 cells  
To determine the inclusion forming units per ml (IFU/ml) and the inclusion size (MFA: mean 
fluorescence area) of C. psittaci in human macrophages, the fluorescence-based digital titration 
technique described by Beeckman et al. (2009) was used. Different MOIs (MOI of 1, 2, 5, 10 and 20) 
were investigated at different time points (30min, 1h, 24h, 48h and 6 days) post infection. Every 
condition was 4 times repeated. Inclusion forming units on each glass slide were stained by a direct 
immunofluorescence staining (IMAGENTM Chlamydia, Oxoid, Drongen, Belgium) (Vanrompay et al., 
1995). The coverslides were examined under the microscope (Olympus BX41, magnification 600x) and 




fluorescence was visualized with a Mercury-lamp (EXFO X-cite, series 120 Q). Throughout the cover 
slip, 50 random fluorescent images were recorded (Olympus XC30 camera) with the CellF software. The 
images were digitally analyzed with an in-house developed ImageJ application and processed with 
programmed Microsoft Excell macros. The Microsoft Excell macros generated the  inclusion forming 
units per ml (IFU/ml)  and the mean fluorescent area (MFA) [pixels2]. 
Moreover, the infectious progeny of C. psittaci on human macrophages was also titrated. THP1 
macrophages were infected at a MOI of 1. At 12h, 18h, 24h and 72 post infection, the supernatant was 
aspirated. A tenfold dilution series of the supernatant was made and inoculated on BGM cells. After 6 
days, the BGM were fixed with methanol and stained with IMAGEN Chlamydia (Oxoid). The TCID50/ml 
was determined using the method of Spaerman and Kaerber (Mayer et al., 1974). 
2.4.    Immunofluorescence assay of the T3SS of C. psittaci 
We tested whether C. psittaci genotype B is capable to induce actin polymerization at the site of 
attachment and entry and whether different components of the T3SS are expressed during the 
developmental cycle. THP1 cells were seeded at a concentration of 300 000 cells/ml in Chlamydia Trac 
Bottles and subsequently inoculated at an MOI of 1, performing a centrifugation step at 1300g for 15 
minutes at 4°C in order to synchronize irreversible attachment and entry. After centrifugation, the 
inoculum was removed and 1 ml of culture medium with glucose was added  and the cells were 
incubated at 37°C.  The cells were fixated using fixative solution (4% paraformaldehyde in 120 mM 
sucrose solution) followed by permeabilization with saponin at 15 min, 1h, 4h, 8h, 24h and 48h p.i. 
(Beeckman et al., 2007). Colocalization between C. psittaci and actin polymerization was assessed 
using AlexaFluor 488 coupled phalloidin (Molecular Probes, Invitrogen) and an indirect staining for C. 
psittaci using a primary antibody which is a rabbit polyclonal antibody prepared against purified EBs, 
followed by an AlexaFluor 546 labeled goat anti-rabbit conjugate (Molecular Probes).  
As T3SS plays an important role in different phases of the chlamydial life cycle, we studied different 
T3S-related proteins such as SctC, SctW and IncA in THP1 cells using the expression of rabbit polyclonal 
anti-StC, SctW and IncA – antibodies, followed by an AlexaFluor 546 labeled goat anti-rabbit conjugate 
(Molecular Probes). C. psittaci staining was done using a direct immunofluorescence staining (IMAGEN 
Chalmydia, Oxoid, Drongen, Belgium). 
All dilutions and washing steps were performed with 1% BSA (Sigma) in PBS). The nuclei were visualized 
in all samples with DAPI or 4’,6’-diamidino-2-phenylindole. Coverslips were mounted using Mowiol 
(Calbiochem, VWR, Haasrode, Belgium) with 0.01% p-phenylenediamine (PPD, Sigma, Bornem, 




Belgium). The coverslips were examined under the microscope (Olympus BX41, magnification 600x). 
All images were recorded and merged with the CellF software. 
2.5.    Transcription analysis of different Pattern Recognition 
Receptors 
We determined the expression of different PRRs following C. psittaci infection (MOI = 1) of THP1 cells 
by examining gene transcript levels of TLR1, TLR2, TLR3, TLR4, TLR6, TLR9, NLRP3/ASC, RIG1 and NOD2 
in infected and control THP1 cultures during the early- (2h, 4h, 8h), mid- (12h, 18h 24h) and late- (36h, 
48h, 72h) phase of the developmental cycle. Specific primers for the different PRRs found in the 
literature were used (Table IV-1). 
Target Primer sequence 3’ – 5’ Ta Reference 
TLR1 F: CAGTGTCTGGTACACGCA TGGT 
R: TTTCAAAAACCGTGTCTGTTAAGAGA 
60°C Tamaki et al., 2011 
TLR2 F: GGCCAGCAAATTACCTGTGTG 
R: AGGCGGACATCCTGAACCT 
60°C Tamaki et al., 2011 
TLR3 F: TCCATAAAAGCCGAAAGGTG 
R: TTCCAGAGCCGTGCTAAGTT 
60°C Tamaki et al., 2011 
TLR4 F: TCCATAAAAGCCGAAAGGTG 
R: CTGAGCAGGGTCTTCTTCAC 
60°C Tamaki et al., 2011 
TLR6 F: GGATAGCCACTGCAACATCA 
R: TTGGTTTTCACGGGTAGGTC 
60°C Tamaki et al., 2011 
TLR9 F: GCTAGACCTGTCCCGCAATA 
R: ACACTTGGCTGTGGATGTTG 
60°C Tamaki et al., 2011 
NLRP3 F: CTTCCTTTCCAGTTTGCTGC 
R: TCTCGCAGTCCACTTCCTTT  
55°C Abdul-Sater et al., 2009 
ASC F: AGTTTCACACCAGCCTGGAA 
R: TTTTCAAGCTGGCTTTTCGT 
55°C Abdul-Sater et al., 2009 
NOD2 F: CATGTGCTGCTACGTGTTCTC 
R: CCTGCCACAATTGAAGAGGTG 
60°C Tang et al., 2011 
RIG1 F: TGTTCTCAGATGCCTTGGATG 
R: CACTGCTCACCAGATTGCAT 
55°C Conceicao et al., 2010 
β-actin F: TCACCCACACTGTGCCCATCTACGA 
R: CAGCGGAACCGCTCATTGCCAATGG 
60°C Tamaki et al., 2011 
Table IV-1: Real-time quantitative RT-PCR primers and probes. F: forward primer; R: reverse primer; Ta: 
annealing temperature. 
 
Total RNA was extracted from 300 000 cells using the Total RNA Isolation Reagent (TRIR, ABgene, 
Westburg, Leusden, The Netherlands) according to the manufacturer’s protocol. After RNA extraction, 
samples were treated with RNase-free amplification grade DNase I (Promega) following the 
manufacturer’s instructions and were confirmed to be DNA-free by performing a PCR for the β-actin 
gene. One microgram of total RNA was reverse transcribed (reverse-ITTM 1st Strand Synthesis, Thermo 
Scientific) into host cell cDNA using the anchored oligo-dT molecule. The experiment was performed 
three times and qPCR using SYBRGreen technology was performed in duplo on each sample. 




Quantification was done as described by Beeckman et al. (2008), using standard graphs of the cycle 
treshold (Ct) values obtained by testing 10-fold serial dilutions (109 to 101 molecules/µl) of the purified 
PCR products. Ct-values of the samples were automatically converted into initial template quantities 
(N0) by use of the RotorGene software 6.0 (Westburg) using imported standard curves from previous 
runs. Quantification results of the THP1 β-actin were used to correct for cell growth. No difference in 
mRNA level is therefore shown as a fold change of 0.  
2.6.    Protein analysis of human cytokines 
Different cytokines such as IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-17α, IFN-γ, TNF-α and GM-
CSF were investigated in the supernatans of C. psittaci infected THP1 cells (MOI=1) during the mid- 
(12h, 18h, 24h) and late- (36h, 48h and 72h) phase of the developmental cycle  using a Multi-Analyte 
ELISArray Kit (SABiosciences) according to the manufacturer’s protocol. The experiment was 
performed three times and standard curves were used to determine the concentration (ng/ml) for 
every cytokine. 
2.7.    Statistical analysis 
Every experiment was repeated three times, except the digital titration experiment which was 
repeated four times. The mean and standard error mean was calculated for every sample. Secondly, 
an analysis of variance (ANOVA, SPSS Inc.) with post-hoc analysis (both Tukey HSD and Tukey-b) and 
the non-parametric tests such as Mann-Whitney and Kruskal-Wallis with Bonferroni correction was 
used to determine significant differences between infected an non-infected THP1 cells and between 














3.      Results 
3.1.    Replication, inclusion size and titration of the infectious 
progeny of C. psittaci in THP1 cells  
The number of IFU/ml and the MFA was obtained using the digital titration technique in order to obtain 
information on the developmental cycle of C. psittaci in THP1 cells. 
Regarding at the IFU/ml, a significant decline was observed for all MOIs investigated from 30 min until 
48h p.i., followed by an increase from 48h until 6d p.i. However, the observed increase at 6d p.i. is not 
statistically significant different compared with the other time points investigated, except for a MOI of 
2 (Fig. IV-1). Interestingly, regarding at the MFA, a strong peak at 48h p.i. was noticed for all MOIs 
investigated. Moreover, the MFA of the inclusions at 48h showed significant difference compared with 
the MFA of the other time points investigated  Remarkably, how higher the MOI how smaller the MFA 
of the inclusions (Fig. IV-2). 
Furthermore, a titration was performed on the supernatant of infected THP1 cells (MOI=1) at 12h, 18h, 
24h, 36h, 48h and 72h p.i. through inoculation of dilution series of this supernatant on BGM cells. The 
TCID50/ml was the highest (14 600/ml) at 48h p.i., indicating that the developmental cycle last 48h in 
THP1 cells (Fig. IV-3). 
 
Fig. IV-3: Mean TCID50/ml in the supernatant at different time points p.i. (12h, 18h, 24h, 36h, 48h and 72h) of 
infected THP1 macrophages (MOI=1). Error bars represent the standard error mean between three 
independent experiments. Statistical significant differences between the different time points were analyzed 
with the non-parametric Mann-Whitney test. 




Fig. IV-1: Number of inclusion forming units (IFU)/ml are shown for given multiplicity of infection (MOI) at different time points p.i. (30 min, 1h, 24h, 48h and 6d). Error 
bars represent the standard error mean between four independent experiments. Statistical significant differences between the different time points were analyzed with 









Fig. IV-2: Mean fluorescence area per inclusion (pix2/IFU) are shown for given multiplicity of infection (MOI) at different time points p.i. (30 min, 1h, 24h, 48h and 6d). 
Error bars represent the standard error mean between four independent experiments. Statistical significant differences between the different time points were analyzed 
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3.2.    Immunofluorescence assay of the T3SS of C. psittaci 
In order to investigate the host cell reaction to infection with C. psittaci, THP1 cells were stained for 
host cell actin and different T3S-related proteins such as SctW, SctC and IncA, bacteria and the nucleus 
at 15 min, 1h, 4h, 8h, 24h and 48h p.i. 
Attachment for C. psittaci to the outer cell membrane of THP1 cells was noticed at 15 min p.i. As we 
used a MOI of 1, only the half of the THP1 cells were infected and the actin polymerization at the site 
of attachment was not very pronounced. Interestingly, the size and appearance of the cells changes 
between 1h and 4h p.i., larger and more elongated cells were noticed, which was very apparent at 8h 
p.i. At 24h p.i., the inclusions were observed at the periphery of the cell, near the cell membrane and 
at 48h p.i. the majority of the THP1 cells were ruptured, releasing a large numbers of EBs which can 
again attach and infect macrophages. Interestingly, at this time point it was noticed that the 
macrophages has a larger and more elongated form. A minority of the cells still has inclusions (Fig. IV-
4). 
IncA is a T3S effector protein localized into the inclusion membrane. The IncA protein was detected 
early during the infection (15 min p.i.) in the proximity of the nucleus. However, the majority of the 
chlamydial organisms did not translocate the effector IncA protein so early in the infection.  However, 
at 1h p.i., almost all chlamydial organisms express the IncA protein in very tight association with the 
nucleus. Again, at 24h p.i. the inclusion were observed at the cell periphery. Overall, IncA is 
continuously expressed along with C. psittaci throughout the whole developmental cycle (Fig. IV-5). 
SctC is essential in the assembly of a functional T3SS as it forms the secreton together with SctW in the 
bacterial outer membrane. The protein SctC is also very early  expressed in the developmental cycle 
(15 min p.i.). However, we could no longer detect the protein at 1h p.i. From 4h p.i. on the SctC signal 
reappeared and could be continuously observed until the end of the measurements (Fig. IV-6).  
The T3S effector protein SctW regulates the translocation of effector proteins by blocking the needle 
channel. At 15 min p.i., only one EB was observed showing a SctW signal. In addition, the SctW signal 
completely disappears from 1h p.i. until 8h p.i. From 24h p.i. on, the signal of SctW re-emerges along 
with the growth of the inclusion bodies of C. psittaci and at 48h p.i only a few inclusions were observed 








   
15 minutes p.i. Actin 15 minutes p.i. Chlamydia psittaci 15 minutes p.i. Merged 
   
8 hours p.i. Actin 8 hours p.i. Chlamydia psittaci 8 hours p.i. Merged 




   
24 hours p.i. Actin 24 hours p.i. Chlamydia psittaci 24 hours p.i. Merged 
   
48 hours p.i. Actin 48 hours p.i. Chlamydia psittaci 48h hours p.i. Merged 
 
Fig. IV-4: Fluorescent microscopy images of actin staining of THP1 cells infected with C. psittaci at MOI 1. Subfigures show C. psittaci (red), actin (green) and merged 
image with DAPI 




   
15 minutes p.i. Chlamydia psittaci 15 minutes p.i. IncA 15 minutes p.i. Merged 
   
1 hour p.i. Chlamydia psittaci 1 hour p.i. IncA 1 hour p.i. Merged 




   
24 hours p.i. Chlamydia psittaci 24 hours p.i. IncA 24 hours p.i. Merged 
 
Fig. IV-5: Fluorescent microscopy images of IncA staining of THP1 cells infected with C. psittaci at MOI 1. Subfigures show C. psittaci (green), IncA (red) and merged 
















   
4 hours p.i. Chlamydia psittaci 4 hours p.i. SctC 4 hours p.i. Merged 
   
48 hours p.i. Chlamydia psittaci 48 hours p.i. SctC 48 hours p.i. Merged 
 
Fig. IV-6: Fluorescent microscopy images of SctC staining of THP1 cells infected with C. psittaci at MOI 1. Subfigures show C. psittaci (green), SctC (red) and merged 
image with DAPI. 
 




   
48 hours p.i. Chlamydia psittaci 48 hours p.i. SctW 48 hours p.i. Merged 
 
Fig. IV-7: Fluorescent microscopy images of SctW staining of THP1 cells infected with C. psittaci at MOI 1. Subfigures show C. psittaci (green), SctW (red) and merged 















3.3.    Expression analysis of pattern recognition receptors 
It was determined which pattern recognition receptors were involved during the infection of C. psittaci 
(MOI =1) in THP1 cells during the early- (2h, 4h, 8h), mid- (12h, 18h, 24h) and late- (36h, 48h, 72h) 
phase of the developmental cycle. Statistical differences were observed when comparing gene 
transcript levels of infected THP1 cells versus mock infected THP1 cells. The mRNA levels for mock 
infected controls were presented as a mRNA fold change of 1. 
The PRRs investigated expressed on the surface cell membrane were TLR1, TLR2, TLR6 and TLR4. TLR1 
is significantly upregulated at 2h p.i. (118.83 fold) compared to the mock-infected controls. The 
upregulation continued, resulting in a maximal significant upregulation (237.73-fold) at 4h p.i, followed 
by a significant decline at 8h p.i. (21.89-fold). Also at later time points such as 18h and 72h p.i. was a 
significant upregulation noticed in infected THP1 cells compared with the mock-infected controls. 
Regarding TLR4 and TLR6, a significant upregulation was detected at 2h p.i. (respectively 119-fold and 
21.19-fold) followed by a significant downregulation at 8h p.i. (respectively 10.62-fold and 10.84 fold). 
Furthermore, a significant downregulation was also observed for TLR4 at later time points such as 24h 
p.i. (2.27-fold) and 72h p.i. (2.03-fold), whereas TLR6 showed a significant upregulation at 18h p.i. 
(3.92-fold). TLR2 was not expressed during infection with C. psittaci in THP1 cells (Fig. IV-8A).  
The transcript levels of the intracellular TLR3 and TLR9 were significant upregulated early in the 
infection cycle at 2h p.i. (3.99-fold and 5.94-fold respectively) and 4h p.i. (6.07-fold and 7.80-fold 
respectively) followed by a significant downregulation (9.77- fold and 14.13-fold respectively). 
Interestingly, TLR9 was also upregulated at later time points such as 18h p.i. (11.30-fold) and 24h p.i. 
(10-87-fold), although there was no significant difference at the latter time point between the infected 
and the mock-infected cells (Fig IV-8B). 
Similar with the intracellular TLR, the transcript levels of the NLRP3/ASC inflammasome was also 
significant upregulated early in the infection at 2h p.i. (18.54-fold and 17.24-fold respectively) and 4h 
p.i. (9.30-fold and 16.09-fold respectively). This upregulation was followed by a significant decline. 
However, at 18h and 72h p.i. the receptor NLRP3 was again significantly upregulated (2.8-fold and 
1.72-fold respectively) whereas ASC was significantly upregulated at 24h p.i. (8.58-fold) and 48h p.i. 
(13-fold) (Fig. IV-8C). 
The transcript levels of the intracellular receptors RIG-I and NOD2 were also investigated. NOD2 was 
together with RIG-I significantly upregulated early in the infection cycle at 2h p.i. (55.80-fold and 18.12-
fold respectively) and 4h p.i. (4.09-fold and 20.29-fold respectively) followed by a downregulation for 
NOD2 at 8h p.i. (6.33-fold) and 12h p.i. (34.81-fold), although the latter time point was not significantly 




downregulated in infected THP1 cells compared with mock-infected THP1 cells. Interestingly, a 
significant upregulation was observed at 18h p.i. (7.95-fold) and 72h p.i. (3.58-fold) for the transcript 
























Fig. IV-8: Transcript level gene expression of TLRs/RIG-I/NODs and inflammasome by THP1 cells infected with 
C. psittaci (MOI=1) at different time points (2h, 4h, 8h, 12h, 18h, 24h, 36h, 48h, 72h) p.i. Results are presented 
as fold changes in mRNA levels compared to mock infected controls.  Significant upregulation between the 
different time points for every gene, determined by an ANOVA test, is indicated by a letter (p<0.05). Significant 
differences between C. psittaci infected and mock infected HD11 cells, determined by a non-parametric Mann-
Whitney test, are indicated by *P<0.05. Error bars in all figures represent the standard error mean between 
three independent experiments performed in duplicate. 
 
 




3.3.    Protein analysis of human cytokines and chemokines 
The concentration of different cytokines and chemokines such as IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-
10, IL-12, IL-17α, IFN-γ, TNF-α and GM-CSF were determined in the supernatant of C. psittaci infected 
(MOI=1) and mock infected THP1 cells at 12h, 18h, 24h, 48h, 36h and 72h p.i.  
The cytokines IL-1α, IL-2, IL-4, IL-10, IL-12, IL-17α and IFNγ were not detected in the supernatant of 
infected cells, indicating that those cytokines were not expressed during infection with C. psittaci in 
human macrophages. In addition, high concentrations of the cytokines IL-1β and TNF-α and the 
chemokine IL-8 was noticed throughout all time points measured. Remarkably, mock-infected THP1 
cells also express the chemokine IL-8, indicating that there is a certain base level expression of this 
chemokine. The expression of the cytokine IL-6 and GM-CSF was rather late in the infection observed 
from 48h p.i. and 36h p.i. on, respectively (Fig. IV-9A/B/C). 
 
 






Fig. IV-9: Cytokine production of TNF-α, GM-CSF, IL-1β, IL-6 and IL-8 by THP1 cells infected with C. psittaci 
(MOI=1) at different time points (12h, 18h, 24h, 36h, 48h, 72h) p.i. Significant differences between C. psittaci 
(inf) and mock-infected (MOC) HD11 cells, determined by a non-parametric Mann-Whitney test, are indicated 









4.      Discussion 
As mentioned before, C. psittaci is endemic in the poultry industry and possesses a huge zoonotic 
danger for poultry workers, veterinarians, employees in poultry slaughtering, laboratory workers, 
workers in avian quarantine stations, wildlife rehabilitators, zoo workers and pet shop workers 
(Harkinezhad et al., 2007; Vanrompay et al., 2007).  A better understanding of the pathogenesis and 
the mechanisms associated with immune responses to C. psittaci is important to develop efficient 
therapeutic strategies. 
It has been demonstrated in experimental infected turkeys that C. psittaci infect eptithelial cells and 
macrophages of the respiratory tract, thereby inducing severe inflammation. Macrophages are used 
as a transport vehicle to spread to several organs throughout the body to establish a systemic infection 
as C. psittaci has been found in blood monocytes/macrophages recognized by the specific marker 
KUL01 (Vanrompay et al., 1995b). Because it is important to perform chlamydial research in a matched 
host cell system (Roshick et al., 2006), the human monocyte cell line THP1 was used to elucidate the  
interaction between C. psittaci and its human host. 
Similary with the study of Beeckman et al. (2010), a limited replication, or barely survival of C. psittaci 
was noticed in THP1 cells for all MOIs investigated.  In this study, looking at the mode of entry, C. 
psittaci induces actin recruitment and polymerization to the site of invasion within 15 min p.i. 
However, the observed polymerization was not very pronounced suggesting that the THP1 cells also 
actively has taken up the bacteria via phagocytosis. Normally, after phagocytosis, lysosomes fuses with 
pathogen-containing phagosomes, releasing his acidic hydrolases in the resulting phagolysosomes in 
order to eradicate the pathogen. But Chlamydiaceae have developed mechanisms to avoid this 
phagolysosomal fusion (Escalante-Ochoa et al., 1998).  However, Beeckman and Vanrompay (2010) 
have demonstrated by means of transmission electron microscopy experiments that after 2h p.i. 
lysosomal fusion takes place for C. psittaci genotype B (strain CP3). It could be that the significant 
decrease of IFU/ml from 30 minutes until 24h p.i. observed for all MOIs is the result of lysosomal fusion. 
A tremendous significant increase in mean fluorescence area per inclusion is observed between 24h 
and 48h p.i., suggesting the similarity with the developmental cycle in epithelial cells. Moreover, the 
microscopic images showed that chlamydiae were also released after 48h p.i. Interestingly, when a 
significant difference was observed at a certain time point between different MOIs then the smallest 
MOI value yields the largest mean fluorescence area per inclusion. These observations suggest that 
the bacteria are able to sense how many EBs are present in the neighborhood. This inter-bacterial 
communication is called quorum sensing which is used for cell-to-cell communication and as a sensor 
for population density (Bassler, 2002).  Up to now, there is no indication that Chlamydiae is able to 




sense or to communicate with other Chlamydiae in the inclusion. However, it is easy to imagine that 
detecting the number of other Chlamydiae bacteria or particular forms of Chlamydiae, especially the 
converting of RBs into EBs, inside the chlamydial inclusion might be useful. It could be that if C. psittaci 
senses that sufficient EBs are present, the inclusion is kept small in order to avoid disturbing the natur 
al host dynamics and subsequently consequent detection which result in host immune response in an 
attempt to eradicate the bacteria. In addition, recent studies have demonstrated that bacteria are able 
to control their degree of infection in order to prevent extensive activation of the immune host cell 
defense (Shames et al., 2010; Medzhitov, 2009). However, as Chlamydiae is released after 48h p.i. from 
THP1 cells, it is possible that the observed decrease in mean fluorescnece area per inclusion is the 
result of lysis of the host cell. 
As the C. psittaci replication is limited within macrophages, man could wonder why Chlamydiae infect 
these cells in the first place. Of course, macrophages can actively take up the EBs by pahgocytosis, but 
the presence of the actin recruitment to the site of invasion showed that the bacteria forced entry by 
the use of its T3SS. Former studies demonstrate that C. pneumoniae also infect macrophages to 
transmigrate through the mucosal barrier present in the lungs and subsequently have access to the 
lymphatic system and the systemic circulation to spread to the other tissues present throughout the 
body (Moazed et al., 1998; Gieffers et al., 2004). As C. psittaci was already demonstrated in blood 
monocytes/macrophages of turkeys (Vanrompay et al., 1995b), it is suggested that C. psittaci also uses 
these cells as a vector to disseminate by hematogenous and lymphatic routes and establish a systemic 
infection. 
At 15 min p.i., several proteins of the T3SS such as tarp, IncA and SctW were detected, which supports 
the hypothesis that C. psittaci have a preloaded T3SS. SctW – an effector soluble protein blocking the 
transmembrane channel – is present at 15 min p.i. with is in concordance with the observations of 
Beeckman et al. (2008) who detected also SctW of C. psittaci at 15 min p.i in HD11 cells. From 1h to 8h 
p.i., the effector protein SctW remains undetectable which is logical as EBs are converted to RBs and 
the inclusion start the develop, no blocking of the T3SS by SctW is needed. At 24h and 48h p.i., SctW 
re-emerges, indicating the asynchronous RB to EB differentiation and the arming of the T3SS of EBs 
with effector proteins in order to ensure rapid entry of the host cell. The staining data indicate that 
the T3SS is continuously expressed and active during the replication cycle in THP1 cells. However, a 
limited number of T3SS proteins were investigated at a relatively small number of time points p.i. In 
order to obtain a more accurate view on the role of the T3SS of C. psittaci in human macrophages more 
robust and accurate techniques will be necessary such as electron microscopy along with an overview 
of the complete replication cycle using live cell imaging to capture the developmental cycle in real 
time. 




Little is known on how C. psittaci is recognized by its host cell, the macrophage. In this study, 
intracellular and membrane-bound PRRs were investigated at several time points p.i. at a MOI of 1. 
Looking at the membrane-bound TLRs investigated, a significant upregulation of TLR1, TLR4 and TLR6 
was noticed early in the infection followed by a significant decrease during the mid- en late-cycle of C. 
psittaci. Remarkably, no significant upregulation for TLR2 on the membrane of THP1 cells was detected 
early in the infection with C. psittaci. Commonly, TLR2 and TLR4 are known as the primary PRRs 
involved in the detection of Gram-positive and Gram-negative bacteria respectively. However, as TLR2 
is involved in the recognition of a broad range of microbial products, including peptidoglycan from 
Gram-positive bacteria (Takeuchi et al., 1999), bacterial lipoproteins (Brightbill et al., 1999), 
mycobacterial cell wall lipoarabinomannan (Means et al., 1999) and yeast  cell walls (Underhill et al., 
1999), it is unique that several reports indicate a critical role for TLR2 for bacterial clearance and 
survival during an infection with Chlamydia pneumoniae in macrophages (Shimada et al., 2012; Beckett 
et al., 2012; Netea et al., 2002; Bas et al., 2008; Agrawal et al., 2011, Darville et al., 2003). The 
observations of Netea et al. (2002) showed the production of the pro-inflammatory cytokines TNFα 
and IL-1β, but not of the anti-inflammatory cytokine IL-10, through TLR-2 dependent mechanisms. 
These observations were confirmed by Agrawal et al. (2011), who demonstrated an inflammatory and 
thus pathogenic role for TLR2. Not only the cytokines TNFα and IL-1β are upregulated through TLR2, 
but also IL-6 and IFN-γ. In addition, TLR4 is responsible for the production of IL-12 in response to 
infection with Chlamydiae and in the absence of a functional TLR4, IL-12 secretion is attenuated. These 
data suggest that TLR4 plays an important role in the initiation of the innate immune response and 
maintains a balance between pro- and anti-inflammatory responses (Prebeck et al., 2001; Agrawal et 
al., 2011). Thus, it most likely that TLR2 and TLR4 are both important to orchestrate cytokine and 
chemokine responses and host defense against Chlamydiae infections. However, several reports also 
indicate that TLR4 also has no role for the effective host defense against Chlamydiae infections (Netea 
et al., 2002; Beckett et al., 2012). In conclusion, it has been shown that whole bacteria or Chlamydia 
Hsp60 induce TLR-mediated activation, but signaling receptor differed among studies from both TLR2 
and TLR4 (Vabulas et al., 2001), only TLR4 (Sasu et al., 2001; Bulut et al., 2002), only TLR2 (Netea et al., 
2002), to largely TLR2 and to a minor extent TLR4 (Prebeck et al., 2001). In our study, TLR4 was 
significant upregulated early during the infection but no IL-12 was detected in the supernatans of the 
infected cultured THP1 cells. Other cytokines such as IL-1β and IL-6 were also produced after infection 
but not through the TLR2, suggesting that other PRRs are responsible for the induction of this pro-
inflammatory cytokines. Remarkably, the anti-inflammatory cytokine IL-10 was not detected, which is 
in concordance with earlier mRNA results of C. psittaci infected avian HD11 cells (Lagae and 
Vanrompay, 2015). A study of Bas et al. (2008) demonstrated that MIP (Macrophage Infectivity 
Potentiator) –a bacterial lipoprotein exposed at the surface of EBs- was able to induce TNF-α and IL-8 




secretion through the signaling pathways of TLR2/TLR1/TLR6 with the help of CD14. Our data showed 
the significant upregulation of TLR1 and TLR6 but not TLR2 after infection with C. psittaci in THP1 cells. 
As TLR1 and TLR6 need to form a heterodimer with TLR2 to be functional, it is clear that the observed 
TNF-α and IL-8 production is not derived from those signaling receptors. The cytokine TNF-α was 
constantly secreted at the time points p.i. investigated, which is in concordance with the results of 
Shemer-Avni et al. (1989) who observed secretion of TNF-α after infection of Mono Mac 6 cells (human 
monocytic cell line) with C. pneumonia, peaking at 8h p.i.  
Not only the membrane-bound TLRs, but also intracellular PRRs such as TLR3, TLR9, NLRP3, NOD2 and 
RIG-I were investigated during this study after infection with C. psittaci in THP1 cells. Remarkably, all 
intracellular PRRs investigated were significant upregulated early in the infection (2h and 4h p.i.). The 
intracellular TLR9 recognize bacterial DNA containing unmethylated CpG motifs and is significant 
upregulated at 2h, 4h and 18h p.i. The early upregulation of TLR9 suggest the presence of chlamydial 
CpG DNA in the endosomes early after inoculation, supporting the hypothesis that Chlamydiae is also 
phagocytosed by macrophages followed by lysosomal fusion. These results are in concordance with 
the results described in the study of Lagae and Vanrompay (2015) where TLR21 – a homolog of TLR9- 
is significantly upregulated in avian HD11 cells after infection with C. psittaci.  It is quite remarkable 
that TLR3 is also significant upregulated after infection with C. psittaci as TLR3 recognize viral dsRNA. 
However, a recent study of Derbigny et al. (2010) demonstrated that oviduct epithelial cells infected 
with C. muridarium secreted IFN-β in a TLR3-dependent manner. But the observations of our study and 
the study of the research group of Derbigny could not be readily explained by the current 
understanding of the TLR3 biology. As ssDNA or dsDNA could not stimulate TLR3, we should perhaps 
focused on identifying the Chlamydia TLR3 PAMP which would represent a significant contribution to 
a better understanding of the TLR3 biology. Possibilities could be a nonnucleic acid Chlamydia 
component or it could be that after infection with Chlamydiae a cellular response is induced resulting 
in the generation of cellular dsRNA.  
The inflammasome containing caspase-1, apoptosis-associated speck-like protein containing a caspase 
recruitment domain (ASC) and a nucleotide-binding oligomerization domain-like protein such as NLRP3 
was investigated during a C. psittaci infection. The NLRP3/ASC complex was significant upregulated at 
2h, 4h and 24h p.i., suggesting a role for the inflammasomse for the production of mature IL-1β during 
infection with C. psittaci in THP1 cells. IL-1β production is a thightly regulated process that requires 
two distinct signals: 1) a pro-inflammatory signal that leads to NF-κB activation an synthesis of pro-IL-
1β and 2) activation of caspase-1 via the inflammasome that cleaves pro-IL-1β into its biologically 
active form. Our findings demonstrate that C. psittaci infection of THP1 cells leads to caspase-1 
activation and IL-1β secretion through a process requiring the NLRP3 inflammasome. We can 




hypothese that the first signal could be derived from activation of the TLR4 to generate pro-IL-1β. 
These observations were also demonstrated for C. trachomatis, C. pneumoniae and C. muridarium 
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It has since long been reported that Chlamydia psittaci is endemic in the poultry industry in Belgium 
as well as in other European countries. Nowadays, expensive antibiotic treatments are necessary to 
reduce mortality rate but this can lead to antibiotic resistance. Moreover, C. psittaci can easily be 
transmitted from birds to humans through the inhalation of pathogen-containing aerosols derived 
from faeces and eye and nostril secretions. Therefore, the need for an efficient vaccine against C. 
psittaci is augmenting. However, more research is needed to develop such a vaccine. Knowledge on 
the immune mechanisms of C. psittaci infections is crucial to understand the pathogenesis of, and 
immunity to this zoonotic pathogen and to act as a basis for vaccination studies. This study has 
investigated the in vivo immune response evoked by C. psittaci in his natural host, the chicken. 
Excretion of C. psittaci, chlamydial antibody detection in sera, blood immune cells and the mRNA 
expression levels of different cytokines, chemokines and one Toll-like receptor  were investigated in 
different organs (conchae, lungs, airsacs, harderian gland, bursa fabricius and spleen) at different time 
points post infection (6h, 24h, 48h, 4d, 6d, 8d, 10d, 14d and 21d). A higher frequency of cytotoxic CD8+  
T cells and monocytes/macrophages expressing the MHC II molecule were observed in the infected 
group. Several cytokines and chemokines are significantly upregulated during infection but remarkably 
also significantly downregulated, especially at late time points. Furthermore, the only Toll-like receptor 
investigated, TLR4, was also significant upregulated in several organs. This study can contribute on the 
elucidation on how C. psittaci interact with his host, leading to the developing of targets for effective 

















1.      Introduction 
Chlamydia (C.)  psittaci causes respiratory infections in poultry. Transmission of this pathogen occurs 
through inhalation of Chlamydia-bearing dust particles and aerosol from faeces and respiratory, nostril 
and eye excretions. After inhalation, primary replication takes place in the epithelial cells of the upper 
respiratory tract. Following this initial replication, the infection spreads to epithelial cells and 
macrophages of the lower respiratory tract. Subsequently, the bacteria appear in blood plasma and 
monocytes leading to a systemic infection affecting various tissues throughout the body. Symptoms 
vary from inapparent to severe, depending on the chlamydial strain, stress and condition of the avian 
host (Vanrompay et al., 1995a).  
The pathology of chicken-derived C. psittaci strains in SPF chickens has been examined by Yin et al. 
(2013a). Symptoms started at 2 days post infection and included anorexia, conjunctivitis, rhinitis, 
dyspnoea and intermittent diarrhea. Macroscopic lesions, observed at necroscopy, showed congestion 
of the lungs with grey inflammatory foci, conjunctivitis, sinusitis, rhinitis, pneumoniae, air sacculitis, 
pericarditis, enlargement of the spleen and liver, inflammation of the gastro-intestinal tract and 
congestion of kidneys and reproductive organs (Yin et al., 2013a).  
However, little is known about the interaction with the host in terms of the immune response. Former 
studies on chlamydial immunology mainly focused on adaptive immunity against C. trachomatis, C. 
muridarum, C. pneumoniae, and C. caviae, whereas it is more and more clear that the very early innate 
immune response influences migration and activation of immune cells (Germain, 2004), so directing 
the adaptive immune response. Very few studies have investigated the innate immune system of the 
avian respiratory tract (Ariaans et al., 2008; Sarmento et al., 2008; Wang et al., 2006) and only two 
studies have examined innate immunity to C. psittaci in its natural host cell, the avian macrophage 
(Beeckman et al., 2010; Lagae et al., 2014). Those two studies showed a significant upregulation of 
mRNA expression of IL-1β, IL-6, LITAF (lipopolysaccharide-induced tumor necrosis alpha factor), IL-
12p35, caspase-1, MIF, IL-10, CXCLi1, CXCLi2, CCLi3, TLR-4 and TLR-21.  
Interestingly, a recent study by Kalmar et al. (2015), investigated the immune response in SPF chickens 
at 1, 3, 7 and 14 days post infection (dpi) after aerosol infection with a non-avian C. psittaci strain 
(DC15 isolated from an aborted calve foetus) or with C. abortus (sheep strain S26/3). They investigated 
the expression of immune related genes in the thoracic airsac at 1, 3, 7 and 14 days post infection. 
Their results showed that the stronger replication of the non-avian C. psittaci strain also evoked a more 
intense immune response than in the case of a C. abortus infection, as IFN-γ, IL-1β, IL-6, IL-17, IL-22, 
LITAF and iNOS genes were significantly stronger upregulated in C. psittaci infected animals as 




compared to C. abortus infected chickens. Moreover, antibody responses and lymphocyte proliferative 
responses were significantly higher in C. psittaci infected chickens. 
However, it would be interesting to use an avian C. psittaci strain and to examine the expression of 
immune related genes at additional (earlier and later) time points during infection in its natural host. 
Moreover, sampling tissues of the upper and lower respiratory tract and of additional immune tissues 
throughout the body of the chickens could provide additional knowledge. Therefore, this study was 
designed to investigate the innate and adaptive immune response in SPF chickens (Gallus domesticus) 
towards the highly virulent avian C. psittaci genotype D strain 92/1293. The expression of the following 
cytokine genes (IL-1β, IL-12p35, IL-6, LITAF, IL-10, Caspase-1) and chemokines genes (CXCLi2, CCLi3) 
were examined, as well as the expression of toll-like receptor 4 (TLR4). Gene expression was examined 
at early and late points during the infection focusing at several immune and non-immune tissues 
throughout the body. In addition, C. psittaci antibody responses were examined as well as peripheral 
blood mononuclear cell (PBMC) phenotypes at different time points following infection.  
2.      Materials  and Methods 
2.1.    Chlamydia psittaci 
The C. psittaci genotype D strain 92/1293, used in this study, was isolated from a pooled homogenate 
of the lung, a cloacal swab and the spleen of a diseased turkey. The strain originated from a severe 
outbreak of respiratory disease on a commercial turkey broiler farm in The Netherlands (Vanrompay 
et al., 1993). Bacteria were grown in Buffalo Green Monkey (BGM) cells as previously described 
(Vanrompay et al., 1992) and the 50% tissue culture infective dose (TCID50) was determined by the 
method of Spearman and Kaerber (Mayr et al., 1974). 
2.2.    Study Concept 
Experiments were performed in negative pressure isolators (IM 1500, Montair, Sevenum, The 
Netherlands). The experimental design (Table V-1) was evaluated and approved by the Ethical 
Committee for Animal Experiments of Ghent University (EC 2010/054). Seventy-two Specific Pathogen 
Free (SPF) chickens (VALO BioMedia GmbH, Germany) were randomly divided into two groups. At one 
week of age, group 1 was aerosol infected during one hour using a CirrusTM nebulizer (5 µm aerosol 
particle size, Laméris, Aartselaar, Belgium). Chickens were infected with 106 TCID50 of the C. psittaci 
genotype D strain 92/1293 in phosphate buffered saline (PBS). Group 2 was aerosol mock-infected 
using PBS.  




Eight chickens of each group were sequentially euthanized at 6 hours (h), 24h, 48h, 4 days (d), 6d, 8d, 
10d, 14d and 21d post infection (p.i.). Before euthanasia, blood was taken. Sera were examined for the 
presence of C. psittaci antibodies using a recombinant major outer membrane protein MOMP-based 
ELISA (Verminnen et al., 2006). During necropsy, the conchae, lungs, thoracic and abdominal airsacs, 
harderian gland, bursa Fabricius and spleen were collected for gene expression analysis. Tissues were 
snap frozen in liquid nitrogen and stored at -80°C until RNA extraction. Pharyngeal and cloacal 
excretion of viable C. psittaci was also monitored at euthanasia. Sampling was performed using rayon-
tipped, aluminium shafted swabs (Copan, Fiers, Kuurne, Belgium) provided with transport medium 
(Vanrompay et al., 1992). Swabs were stored at -80°C until examined by culture in BGM cells. At 7d, 
14d and 21d p.i., heparinized peripheral blood samples were collected for flow cytometric 
identification of monomorphonuclear cells.  
Table V-1: Experimental set-up 





Observations, manipulations, sampling 
  Pharyngeal +  
cloacal swabs 
8 birds [dpi]a 
Blood  
 
8 birds [dpi]b 
Blood 
 
8 birds [dpi]c 
Euthanasia  
 
8  birds [dpi]d 
1 
(n = 36) 
C. psittaci 
92/1293 
⅓, 24, 48, 4, 6, 8, 10, 
14, 21 
⅓, 24, 48, 4, 6, 8, 10, 
14, 21 
7, 14, 21 ⅓, 24, 48, 4, 6, 8, 10, 
14, 21 
2 
(n = 36) 
PBS ⅓, 24, 48, 4, 6, 8, 10, 
14, 21 
⅓, 24, 48, 4, 6, 8, 10, 
14, 21 
7, 14, 21 ⅓, 24, 48, 4, 6, 8, 10, 
14, 21 
a: Chlamydia cell culture b: Antibody determination (ELISA) c: Flow cytometric phenotyping of PBMCs d: 
Quantitative real-time PCR of different organs 
 
2.3.    Chlamydia psittaci excretion 
Swabs were shaken for 1 h at 4°C, centrifuged and Chlamydia excretion was monitored using standard 
procedures for culture and bacterial identification (IMAGENTM immunofluorescence staining kit; 
ThermoFisher, Aalst, Belgium). The presence of C. psittaci on the whole microscopic slide was 
enumerated (600x, BX41 Olympus, Aartselaar, Belgium) and results were scored from 0 to 8. (Table V-










Table V-2: Culture scores 
 
Score Meaning 
0 No EB’s or inclusions  
1 1-3 EBs  
2 3-10 EBs and 1-2 IPCs  
3 10-30 EBs and 3-10 IPCs  
4 30-50 EBs and 11-20 IPCs  
5 50-70 EBs and 21-30 IPCs  
6 70-100 EBs and 31-50 IPCs  
7 > 100 EBs and 51-70 IPCs  
8 All of the  fields EBs and IPCs  
EB = elementary body, IPC = Inclusion with replicating C. psittaci 
 
2.4.    Flow cytometric phenotyping of PBMC  
Peripheral blood mononuclear cells (PMBC) to be used for flow cytometric phenotyping were purified 
from heparinized peripheral blood (v. ulnaris) by lymphoprep density gradient centrifugation. PBMC 
were cryopreserved in liquid nitrogen until analysis. 
For analysis, PBMC were washed and resuspended in staining medium consisting of RPMI 1640 
supplemented with 1% bovine serum albumin (BSA) and 0,1% NaN3. PBMC were stained using the 
following monoclonal antibodies (Southern Biotech, Birmingham, AL): Panel 1: CD4-RPE, CD3-SPRD, 
CD8α-Cy5, TCR1-biotin (TCRγδ), streptavidin-APC-Cy7. Panel 2: CD45-FITC, CD44-APC. Panel 3: KUL01-
FITC, MHC Class II-PE. Staining was done by adding the monoclonal antibodies in combination or as 
single-color staining for compensation to 3 x 105 cells. Cells were incubated at 4°C for 30 min and 
washed three times with washing buffer. Subsequently (only panel 1) streptavidin-APC-Cy7 was added 
and cells were incubated at 4°C for 30 min. Cells were washed three times with washing buffer. All 
flow cytometric analyses were conducted using a BD FACSCantoTM (Beckton Dickinson, Erembodegem, 
Belgium) equipped with a 488 nm blue laser and a 633 nm red laser. A minimum of 40 000 lymphocytes 
were collected from each sample and analyzed using the FACSDiva software. 
 
 




2.5.    Chlamydial antibody detection 
The sera were analyzed using a previously developed recombinant MOMP-based ELISA (Verminnen et 
al., 2006). Serum antibody titres were determined in 2-fold dilution series stating at a dilution of 1/40. 
Anti-MOMP immunoglobulin titers were determined as the highest serum dilution that gave an optical 
density (OD405) above the cut-off value. The cut-off value was the mean of the OD values of negative 
chicken sera plus two times the standard deviation. Titers were presented as the reciprocal of the 
highest serum dilution with an absorbance above the cut-off value. Negative control sera were 
obtained from 1-week-old Specific Pathogen Free (SPF) chickens. Positive control sera originated from 
a former experimental infection (Yin et al., 2013a). 
2.6.    Quantitative Real-Time PCR 
Frozen tissues were thawed and homogenized for total RNA extraction using TRIzol (Invitrogen, 
Merelbeke, Belgium) according to the manufacturer’s protocol. After RNA extraction, samples were 
treated with RNase-free amplification grade DNase I (Promega) following the manufacturer’s 
instructions and were confirmed to be DNA-free by performing a PCR for the presence of the C. psittaci 
16S rRNA gene. One microgram of total RNA was reverse transcribed (reverse-ITTM 1st Strand Synthesis, 
Thermo Scientific) into host cell cDNA using the anchored oligo-dT molecule. Specific primers (Table V-
3) were designed using primer 3 (http://frodo.wi.mit.edu/primer3/) and DINA melt 
(http://www.bioinfo.rpi.edu/ applications/hybrid) software programs. Specificity of all qRT-PCR 
primers was initially checked by conventional PCR, cloning (pGEM-T Easy Vector System, Promega, 
Leiden, The Netherlands) and DNA sequencing of the inserts (LGC Genomics, Berlin, Germany). As we 
were not able to design specific primers for IL-10 and IL-12p35, probes labeled with the fluorescent 
reporter dye 5-carboxyfluorescein (FAM) at the 5’ end and the N,N,N,N’-tetramethyl-6-
carboxylrhodamine (TAMRA) quencher at the 3’end (designed by P. Kaiser and L. Rothwell; Institute 
for Animal Health, Compton, Berkshire, UK) were needed to verify the specificity of the amplified 











Table V-3: Real-time quantitative PCR primers and probes.  
 
Target Accession No. Primer and probe sequence (5’-3’) Ta 
28S rRNA X59733 F: TTTGGGTTTTAAGCAGGAGGT                                  
R: TTGCGACAACACATCATCAGT 
58°C 
IL-1β Y15006.1 F: CACAGAGATGGCGTTCGTT                                        
R: GTGACGGGCTCAAAAACCT 
58°C 
IL-6 NM_204628 F: AGAAATGCCTGACGAAGCTCT                                  
R: CACGGTCTTCTCCATAAACGA 
58°C 




IL-10 AJ621254 F: CATGCTGCTGGGCCTGAA                                                 
R: CGTCTCCTTGATCTGCTTGATG                                     
P: CGACGATTCGGCGCTGTCACC 
55°C
TNF-α AY765397 F: TCCTCACCCCTACCCTGTC                                           
R: TCAGAGCATCAACGCAAAAG 
58°C 
IL-12p35 AJ262751 F: TGGCCGCTGCAAACG                                                      
R: ACCTCTTCAAGGGTGCACTCA                                    
P: CCAGCGTCCTCTGCTTCTGCACCTT 
55°C 
CXCLi2 NM_205498 F: CTCGCTCTTCTCATCGCATC                                         
R: GGCAGCAGTGTCCCATCC 
58°C 
CCLi3 Y18692 F: AGCCTGCCATCATCTTCATC                                      
R: AAACAGCACCTGCCATGAG 
58°C 
TLR4 NM_001030693 F: TGGCACCTACCCTGTCTTTC                                              
R: GGCTTGGAGTGGCTTGTATG 
58°C 
F: forward primer; R: reverse primer; P: 5’-FAM (5-carboxyfluorescein) + 3’-TAMRA (6- 
carboxytetramethylrhodamine) probe. 
 
Following cDNA synthesis, cDNA amplification was performed for IL-1β, IL-12p35, IL-6, TNF-α, CXCLi2, 
CCLi3, Caspase-1, IL-10, TLR4 and the 28S rRNA normalization gene using the AbsoluteTM QPCR SYBR® 
Green Mix (Qiagen) or the Absolute QPCR mix (Thermo Scientific). RNA expression of selected genes 
was determined by quantitative real-time PCR (qRT-PCR) with the Rotor Gene Q (Qiagen) using the 
following cycle profile: one cycle of 95°C for 15 min and 45 cycles of 95°C for 30s, 55-58°C for 30s and 
72°C for 30s. Quantification was performed as described by Beeckman et al., (2008), using standard 
graphs of the cycle treshold (Ct) values obtained by testing 10-fold serial dilutions (109 to 101 
molecules/µl) of the purified PCR products. Ct-values of the samples were automatically converted 
into initial template quantities (N0) by use of the RotorGene software Q (Qiagen) using imported 
standard curves from previous runs. No difference in mRNA level is shown as a fold change of 1. 
 




2.7.    Statistical analysis 
To compare between the infected and the mock-infected group, standard error means were calculated 
and an unpaired student’s t-test was used. Secondly, an analysis of variance (ANOVA, SPSS Inc., 
Chicago, IL, USA) with post-hoc analysis was performed to determine significant differences (p < 0.05) 

























3.      Results 
3.1.    Chlamydia psittaci pharyngeal and cloacal excretion 
Cultures scores for the pharyngeal and cloacal swabs are presented in Fig V-1. Negative control 
chickens did not excrete C. psittaci. At 6h p.i. C. psittaci was detected in pharyngeal swabs with a mean 
culture score of 2. The same amount of C. psittaci was also present in swabs taken at 24h and 48h p.i. 
From 4 days post infection (dpi) onwards pharyngeal shedding significantly increased (mean culture 
score of 3.1)  with the highest amount of C. psittaci found at 6 dpi (mean culture score of 6.6). From 6 
dpi onwards, pharyngeal excretion gradually decreased but it remained statistically the same till 14 
dpi. 
Cloacal shedding of C. psittaci was observed from 4 dpi. onwards. Cloacal excretion was the highest at 
6d p.i. (mean score of 3.2) followed by a significant decline at 10d p.i. (mean score 2.25). However, at 
14 dpi, cloacal excretion again increased significantly to a level comparable to the one observed at 6 
dpi. At 21 dpi, cloacal excretion was significantly lower than on all previous time points. Throughout 
the infection, cloacal excretion was lower than pharyngeal excretion. 
Fig. V-1: Pharyngeal and cloacal shedding of C. psittaci at different time points p.i.  
 
Each value represents a mean of 8 infected chickens. Significant differences between the time points post 
infection is indicated by a letter (p<0.05). The error bars represent the standard error of the mean. 
 
 




3.2.    Phenotyping of PBMC 
Immunophenotyping of peripheral blood lymphocytes subpopulations was performed by flow 
cytometry using three different staining panels. When analyzing the samples stained with antibody 
panel 1, first the lymphocyte population was located in a FCS/SSC dot plot, next T cells were identified 
as being CD3+. T cells were divided into γδ T cells (TCR1+) and non-γδ T cells and analyzed for their 
expression of the surface markers CD4 and CD8α. When examining the samples stained with antibody 
panel 2, first the lymphocyte population was located in a FCS/SSC dot plot, next thrombocytes were 
excluded as being CD45low. Subsequently, CD44 and CD45 expression was analyzed on the lymphocyte 
population. When analyzing samples stained with antibody panel 3, first the granulocyte and monocyte 
population was located in a FCS/SSC dot plot, next monocytes/macrophages were identified as being 
KUL01+. Finally MHC Class II expression was analyzed on the monocytes/macrophages (FIg. V-2). The 
results of the phenotyping analyses are presented in Table V-2. 
 No significant differences between the percentage of non-γδ T cells of the infected and mock-infected 
chickens were noticed. Within the non-γδ T cell population, the frequency CD4 and CD8α cells was 
determined. No significant differences between the frequency of CD4 cells of the infected and mock-
infected chickens were observed. However, the infected group had a significant higher frequency of 
CD8α cells compared with the mock-infected group at all time points p.i. investigated.  
 It was noticed that the percentage of γδ T cells from the infected animals was significantly higher than 
the values from the mock-infected controls at 7d p.i. Within the γδ T cell population the frequency of 
CD4 and CD8α cells was determined. No CD4+ cells were observed but CD8α frequencies are presented 
in table V-4. No significant differences between the infected and mock-infected group were detected.  
The expression of CD44 and CD45 was determined on peripheral lymphocytes (CD45hi) and presented 
as mean fluorescence intensities (MFI). At 21d p.i., the mock-infected group has a significant higher 
expression of CD45 on their peripheral lymphocytes compared with the infected group.  
Regarding at the monocytes/macrophages, presented as being KUL01+, no significant differences in 
the frequency between the infected and mock-infected group was observed. However, at 7d p.i. a 
significant higher frequency of monocytes/macrophages presenting the MHC Class II molecule on their 
surface was noticed in the infected group compared with the mock-infected control group. At 21d p.i., 
the mock-infected control group showed a significant higher percentage of MHC Class II+ 
monocytes/macrophages compared with the infected group.  
 

































































































Fig. V-2: Immunophenotyping  staining profiles of chicken mononuclear cells from peripheral 
blood. (A) A representative sample stained with antibody panel 1 (CD3, TCR1, CD4, CD8α). The 
staining strategy was: lymphocytes, CD3+ cells, TCR1+ cells. CD3+TCR1+ and CD3+TCR1-cells were 
analyzed for CD4 and CD8α expression. (B) A representrative sample stained with antibody panel 
2 (CD45, CD44). The gating strategy was to identify the lymphocytes in a SSC/FSC plot and 
subsequently to exlude thrombocytes as being CD45low. CD45high cells were analyzed for their CD44 
expression. (C) A representative sample stained with antibody panel 3 (KUL01, MHCII). KUL01+ 














Table V-4: PBMC from mock-infected and C. psittaci infected chickens were subjected to immunophenotyping by flow cytometry at different time points 
(7d, 14d and 21d) p.i. Each value represents a mean of 8 chickens.  
 





















 7 A 80.5 ± 3.8 76.1 ± 3.6 11.0 ± 1.7b 20.8 ± 2.7b 15.5 ± 4.9 19.5 ±13.5 26.4 ± 6.2b 104 350 ± 15630 9 746 ± 452 
 B 80.5 ± 5.3 71.8 ± 10.7 4.9 ± 1.8b 17.0 ± 1.2b 18.1 ± 6.5 21.4 ±12.9 15.3 ± 3.1b 92 138 ± 23594 10 173 ± 493 
 14 A 77.7 ± 6.3 69.2 ± 8.3 10.5 ± 2.8a 22.5 ± 6.3 18.2 ± 7.7 69.2 ± 4.7 14.6 ± 4.9 128 517 ± 12 828 7 868 ± 907 
 B 81.5 ± 5.9 68.7 ± 13.9 7.9 ± 1.7a 18.7 ± 6.1 13.8 ± 4.7 71.5 ±13.8 15.3 ± 3.0 119 533 ± 13 642 7 696 ± 1158 
21 A 75.4 ± 4.9 76.0 ± 5.2 14.2 ± 5.7a 23.7 ± 4.2 3.4 ± 1.3 33.7 ± 9.8 14.3 ± 1.8b 80 918 ± 1 827 5 050 ± 278a 
 B 72.4 ± 4.9 79.8 ± 3.1 8.4 ± 3.2a 27.6 ± 4.7 2.8 ± 0.9 33.4 ± 8.4 17.9 ± 2.7b 80 915 ± 4 104 5 295 ± 225a 
 
 
* CD3+TCR1- cells: the proportion of T cells (CD3+) that does not express the γδ T cell receptor (TCR1-); CD3+TCR1-CD4+ cells: the proportion of non-γδ T cells 
(CD3+TCR1-) that express CD4; CD3+TCR1-CD8α+ cells: the proportion of non-γδ T cells (CD3+TCR1-) that express CD8α; CD3+TCR1+ cells: the proportion of T cells 
(CD3+) that expresses the γδ T cell receptor (TCR1+); CD3+TCR1+CD8α+ cells: the proportion of γδ T cells (CD3+TCR1+) that express CD8α; KUL01+ cells: the 
proportion monocytes/macrophages (KUL01+); KUL01+MHCII+ cells: the proportion monocytes/macrophages (KUL01+) that express MHCII; CD44: the surface 
expression of CD44 on lymphocytes; CD45: the surface expression of CD45 on lymphocytes. a P<0.05 for a comparison of the control group and the infection 
group determined by an unpaired student t test. b P<0.005 for a comparison of the control group and the infection group determined by an unpaired student 
t test. 
 




3.3.    Serological analysis of chicken sera 
Negative control chickens remained seronegative during the experiment. From 4 days p.i. onwards, 
low C. psittaci antibody titers were found in infected chickens (mean titer: 45 ± 11.8) with the highest 
mean antibody titer found at 6d p.i. (titer: 775 ± 313) (Fig. V-3). Between 6d p.i. and 10d p.i. (titer: 700 
± 221), a plateau phase was observed, followed by a decline of the mean antibody titer towards 21 d 





Fig. V-3: Mean MOMP-specific serum antibody titers of the infected group ± standard deviation at different 
time points following infection with C. psittaci 92/1293. Each value represents a mean of 8 infected chickens. 
The error bars represent the standard error of the mean. 
 
3.4.    Quantitative Real-Time PCR 
Presented in figure V-3, the first initiation of the innate immune response was seen at 24h p.i. in the 
conchae with a significant upregulation of the pro-inflammatory genes IL-1β, TNF-α, CXCLi2, CCLi3 and 
caspase-1. At 48h p.i., mRNA expression levels of all genes investigated were significantly upregulated 
in the conchae , except for CCLi3 and IL10 whereas the latter was never significantly up- or 
downregulated during the infection in the conchae. (Fig. V-4).  
Later in the infection, at 4d p.i. a significant upregulation in the mRNA expression levels of IL-1β, IL-


















reaches a significant peak at 6d p.i. Again, the expression levels of the regulatory cytokine IL-10 were 
unchanged during the infection in the lung tissue (Fig. V-5). 
Interestingly, the airsacs, a tissue which is anatomically in close contact with the lungs, showed also a 
significant upregulation of the expression levels of pro-inflammatory cytokines like IL-1β, IL-12p35, IL-
6, TNF-α and caspase-1 at 4d p.i., followed by a significant downregulation of IL-12p35 and IL-6 at 6d 
p.i. (Fig. V-6). At 14d p.i., the mRNA expression levels of caspase-1 and CXCLi2 was significantly 
upregulated whereas the latter gene was significantly downregulated at 21d p.i. in the airsacs. The 
anti-inflammatory cytokine IL-10 was significantly downregulated at 21d p.i. (Fig. V-6). 
Figure V-8 shows a significant upregulation of the mRNA expression of all genes investigated at 8d, 10d 
and 14d p.i. in the bursa fabricius. Remarkably, TLR4 was already significantly upregulated from 48h 
p.i. onwards with a significant peak at 14d p.i. This peak correlates well with a significant upregulation 
of all the pro-inflammatory cytokines and chemokines genes investigated. Furthermore, the mRNA 
expression level of the anti-inflammatory cytokine IL-10 was also significantly upregulated at 10d and 
14d p.i. in the bursa fabricius (Fig. V-8).  
In the spleen, mRNA expression of IL-1β was not observed (data not shown). Nevertheless, all the other 
pro-inflammatory cytokines (IL-12p35, IL-6 and TNF-α) were significantly upregulated at 8d p.i., 
indicatinging that a systemic infection is established from 8d p.i. onwards (Fig. V-8). Interestingly, TLR4 
was significantly very high upregulated at 6d p.i. in the spleen followed by a decline whereas the mRNA 
expression level remains unchanged from 14d p.i. onwards until the termination of the experiment 
(Fig. V-9).  
This fact was also seen in the harderian gland with a significant high upregulation of TLR4 at 6d p.i. 
(Fig. V-7). Expression levels of IL-1β mRNA were significantly upregulated at 48h and 10d p.i. in the 
harderian gland which correlates well with the upregulation of caspase-1 at 48h and 8d p.i. 
Furthermore, a significant upregulation of TNF-α at 6d and 10d p.i., of IL-6 and IL-12p35 at 14d p.i. was 
observed in the harderian gland. Remarkably, no significant upregulation of the mRNA expression 
levels of the pro-inflammatory chemokines CXCLi2 and CCLi3 was seen, only a significant 
downregulation of CCLi3 at 24h p.i. Expression levels of IL-10 mRNA were significantly upregulated at 












Fig. V-4: Expression of cytokine or chemokine or toll-like receptors in the conchae of chickens following 
infection with C. psittaci. Results are presented as fold changes in mRNA compared with age-matched mock-
infected controls based on samples from four chickens for each time determined by quantitative RT-PCR. 
Significant differences between C. psittaci infected and mock-infected chickens, determined by an unpaired 
student t test, are indicated by **P< 0.05 and *P<0.1. The error bars in all figures represent the standard 
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Fig. V-5:  Expression of cytokine or chemokine or toll-like receptors in the lungs of chickens following 
infection with C. psittaci. Results are presented as fold changes in mRNA compared with age-matched mock-
infected controls based on samples from four chickens for each time determined by quantitative RT-PCR. 
Significant differences between C. psittaci infected and mock-infected chickens, determined by an unpaired 
student t test, are indicated by **P< 0.05 and *P<0.1. The error bars in all figures represent the standard 
error of the means. 
 
 








Fig. V-6:  Expression of cytokine or chemokine or toll-like receptors in the airsacs of chickens following 
infection with C. psittaci. Results are presented as fold changes in mRNA compared with age-matched mock-
infected controls based on samples from four chickens for each time determined by quantitative RT-PCR. 
Significant differences between C. psittaci infected and mock-infected chickens, determined by an unpaired 
student t test, are indicated by **P< 0.05 and *P<0.1. The error bars in all figures represent the standard 
error of the means. 
 








Fig. V-7:  Expression of cytokine or chemokine or toll-like receptors in the harderian gland of chickens 
following infection with C. psittaci. Results are presented as fold changes in mRNA compared with age-
matched mock-infected controls based on samples from four chickens for each time determined by 
quantitative RT-PCR. Significant differences between C. psittaci infected and mock-infected chickens, 
determined by an unpaired student t test, are indicated by **P< 0.05 and *P<0.1. The error bars in all figures 
represent the standard error of the means. 
 
 








Fig. V-8:  Expression of cytokine or chemokine or toll-like receptors in the bursa fabricius of chickens 
following infection with C. psittaci. Results are presented as fold changes in mRNA compared with age-
matched mock-infected controls based on samples from four chickens for each time determined by 
quantitative RT-PCR. Significant differences between C. psittaci infected and mock-infected chickens, 
determined by an unpaired student t test, are indicated by **P< 0.05 and *P<0.1. The error bars in all figures 
represent the standard error of the means. 
 








Fig. V-9:  Expression of cytokine or chemokine or toll-like receptors in the spleen of chickens following 
infection with C. psittaci. Results are presented as fold changes in mRNA compared with age-matched 
mock-infected controls based on samples from four chickens for each time determined by quantitative RT-
PCR. Significant differences between C. psittaci infected and mock-infected chickens, determined by an 
unpaired student t test, are indicated by **P< 0.05 and *P<0.1. The error bars in all figures represent the 
standard error of the means. 
 




4.      Discussion 
The present study is one of few studies that shed light on the underlying immune response evoked by 
C. psittaci in his natural host, the chicken. Understanding the mechanisms associated with immune 
responses to C. psittaci respiratory infection in early life is important in developing targets for effective 
vaccination and therapeutic strategies for infection. Identification of the pitoval components of 
inflammation induced by C. psittaci will also facilitate the elucidation of its role in the pathogenesis of 
acute and persistent infection. 
 Aerogenous infection with C. psittaci is followed by systemic dissemination of the bacteria, probably 
mediated by monocytes/macrophages, as Vanrompay et al. (1995b) showed the presence of C. psittaci 
in blood monocytes recognized by KUL01 in experimentally infected SPF turkeys. C. pneumoniae 
infected monocytic cells are able to activate the integrin adhesion receptor system to invade 
noninflamed subendothelium and initiate inflammatory processes (May et al., 2003). Interestingly, at 
7d p.i. a higher frequency of monocytes/macrophages expresses the MHC class II molecule on their 
surface in the infected group compared to the mock infected group was observed, indicating that 
chlamydial antigens entered the monocytes/macrophages through endocytosis. This is in agreement 
with the results of Ojcius et al. (1997), who showed that most Chlamydia-containing vacuoles in THP1 
cells fuse with lysosomes and compartments expressing MHC class II molecules, suggesting that THP1 
cells might present antigens to Chlamydia-specific CD4+ T cells. However in this study, no significant 
difference in the frequency of CD4+ T cells between the infected and the mock-infected group was 
observed. Remarkably, at 21d p.i. a significant lower frequency of monocytes/macrophages expressing 
the MHC class II molecule was observed in the infected group compared to the mock infected group. 
Since only a proportion of monocytes/macrophages and epithelial cells will be infected by C. psittaci 
during an in vivo exposure, immune evasion could happen through downregulation of both MHC class 
I  and class II expression evoked by a chlamydia-specific protease called chlamydial protease activity 
function (CPAF)  (Ibana et al., 2011).  At every time point investigated, a significant higher frequency 
of CD8+ T cells in the infected group compared to the mock infected group was observed. As C. psittaci 
is an intracellular pathogen, CD8+ T cells could play a significant role in the protection against this 
bacterium. However, the role CD8+ cytotoxic T lymphocytes in immunity to Chlamydiae have been the 
subject of less study. Cytotoxic T lymphocytes (CTLs) recognize peptide antigens in the context of MHC 
class I, expressed on all nucleated cells which direct lyse of the infected cell and production of cytokines 
such as IFN-γ. The peptides presented to CTLs are derived from the cytoplasmic compartment of the 
cell (Monaco, 1992). Looking at chlamydial infections, it is unknown if any chlamydial antigens escape 
from or traffic across the vacuolar membrane. Such antigens could be likely candidates for processing 
and presentation to CTLs. However, the role of CTLs during Chlamydiae infections is in question.  During 




a C. trachomatis infection, both CD4+ and CD8+ T cells are stimulated and secrete IFN-γ (Gondek et al., 
2009; Johansson et al., 1997). However, elimination of CD8+ T cells does not compromise protection 
against a C. trachomatis genital infection (Morrison et al., 2000; Frankhauser and Starnbach, 2014). A 
recent study of Nogeuira (2015) showed that intranasal priming with C. trachomatis engages both CD4+ 
and CD8+ T cells, which are necessary for protection against a genital infection. The protection is largely 
dependent on IFN-γ secretion by T cells. Another study convincingly showed that in vivo depletion of 
CD8+ T cells in mice abrogates protection upon infection with C. psittaci, whereas depletion of CD4+ T 
cells did not affect protection (Buzoni et al., 1992). The precise role of CD8+ T cells during a C. psittaci 
infection in his natural host must be investigated more in detail.  The mucosal surfaces of the 
respiratory system serve as both entry and transmission route for most pathogens. Therefore, a crucial 
aspect in designing effective vaccines against C. psittaci is the stimulation of immunity at the mucosal 
sites of the respiratory system. Moreover, T cell migration among the mucosal surfaces is tightly 
regulated by the interaction of adhesion molecules and chemokine receptors that are differentially 
expressed on T cells and their target tissues. So, investigating how the immune system respond on 
infection with C. psittaci is of great importance to be able to develop effective therapeutic strategies. 
A few recent studies already investigated the immune response elicited by C. psittaci in his natural 
host. A study of Lagae et al. (2015) investigated the chicken macrophage activation and expression of 
cytokine, chemokine, caspase-1, iNOS and TLR genes during the early phase and mid-cycle period of 
the developmental cycle of C. psittaci. Another study examined the pathology and host immune 
response following aerogenous infection with C. psittaci or C. abortus in chickens (Kalmar et al., 2015). 
Yin et al. (2013a) investigated the presence of C. psittaci in different organs at various time points 
during a pathogenicity study of low and highly virulent C. psittaci isolates in chickens. At a given time 
point post infection, the presence of this bacterium corresponds well with the observed immune 
response in this study. In this study, the first host response was examined which is an acute 
inflammatory or polymorphonuclear leukocyte response, probably initiated by activation of the Toll-
like receptor pathway and by other still undefined mechanisms. During the first four days p.i., a 
significant upregulation of pro-inflammatory cytokines, chemokines and TLR-4 was noticed in the 
conchae, lungs and airsacs. This aerogenous infection with C. psittaci is followed by a systemic 
dissemination of the infection, as from 6 days p.i. on, a significant immune response is observed in the 
harderian gland, bursa fabricius and spleen. This systemic infection is mediated by peripheral blood 
mononuclear cells as alveolar macrophages could migrate through the mucosal barrier and gain access 
to the systemic circulation. It is possible that C. psittaci infection induces rolling and adhesion of 
macrophages to the non-inflamed vessel wall as previously reported for C. pneumonia (May et al, 
2003). 




Interestingly, the anti-inflammatory cytokine IL-10 was not significant upregulated in the conchae, 
lungs and airsacs; yet well in the lymphoid organs like the harderian gland, bursa fabricius and spleen. 
Although, Il-10 suppresses a broad range of inflammatory responses and is an important factor in 
maintaining homeostasis of overall immune responses (Stober et al, 2005 and Villalta et al, 2011). 
Unfortunately, little is known about the anti-inflammatory effect of IL-10 during a C. psittaci infection. 
Beeckman et al. (2009) observed exceptionally high levels of IL-10 in C. psittaci infected HD11 
macrophages at a MOI of 100 after 4h p.i. A study of Yilma et al. (2012) showed that IL-10 inhibits 
inflammatory mediators in human epithelial cells and mouse macrophages exposed to C. trachomatis. 
Additionally, Gao et al. (2013) reported that IL-10 suppresses expression of inducible co-stimulator-
ligand (ICOS-L), an activator of T lymphocytes, on DC in an animal model with C. muridarum lung 
infection. It is possible that other immunoregulatory molecules like IL-1 receptor antagonist, IL-4, IL-
11 and IL-13 act in the conchae, lungs and airsacs to control the pro-inflammatory cytokine response. 
A recent study has demonstrated that CD4+ Th17 responses are also induced by Chlamydia infections 
(Bai et al., 2009; Scurlock et al., 2011). Th17 cells are differentiated from conventional αβ CD4+ T cells 
under the influence of different cytokines such as TGF-β, IL-1β, IL-6 and IL-23 (Korn et al., 2009). The 
pro-inflammatory cytokines secreted by Th17 cells, IL-17A and IL-17F, stimulate the production of 
cytokines and chemokines involved in neutrophil generation, maturation and mobilization to sites of 
inflammation. The role of Th17 responses in Chlamydia infections is complex; it can promote bacterial 
clearance but also potentially damage host tissue when improperly controlled (Bai et al., 2009; Zhang 
et al., 2009; Zhou et al., 2009). Kalmar et al. (2015) also investigated the mRNA expresiion of IL-17 after 
infection with C. psittaci in chickens and noticed a rapid upregulation of this cytokine at 3d p.i. 
Furthermore, several studies demonstrated an expansion of Foxp3+ T regulatory cells (Tregs) during 
Chlamydia infections (Faal et al., 2006; Gall et al., 2011; Marks et al., 2007). Intriguingly, infection with 
C. muridarum subverted the suppressive role of Tregs on the immune systems into the promotion of 
Th17 differentiation from conventional CD4+ T cells but also converted themselves into pro-
inflammatory Th17 cells. Further elucidating of the immune mechanisms that effectively regulate Th17 
response may help to understand the pathogenesis of Chlamydia. 
Remarkably, during the C. psittaci infection several cytokines and chemokines are significant 
downregulated in various organs. It has been previously shown that several effector molecules, 
translocated by the type III secretion system (T3SS) of many Gram-negative bacterial pathogens inhibit 
or subvert PAMP-directed innate immune reponses to promote infection. For example, four effector 
molecules of Yersinia, YopH, YopE, YopT and YpkA antagonize phagocytosis. YopJ inhibits nuclear factor 
kappa B (NF-κB) and mitogen-activated protein (MAP) kinase signaling pathways and can induce a pro-
inflammatory mode of cell-death associated with caspase-1 activation. (Viboud and Bliska, 2005; Philip 




and Brodsky, 2012). The effector molecule IpaH4.5 of Shigella flexneri is an E3 ubiquitin ligase capable 
of directly regulating the host inflammatory response by inhibiting the NF-κB signaling pathway (Wang 
et al. 2013). How the effector molecules of C. psittaci regulate the host immune response during 
infection has not yet been uncovered. A study of Prantner and Nagarajan (2009) showed that inhibition 
of the T3SS of C. muridarium led to decreased IL-6, IL-1β and CXCL10 levels. In comparison, inhibition 
of the T3SS of C. psittaci evoked a significant lower mRNA expression of IL-1β, IL-6, LITAF, IL-12p35, 
caspase-1, macrophage inhibitory factor (MIF), IL-10, CXCLi1, CXCLi2, CCLi3, IL-16, TLR-2, TLR-3, TLR-4, 
TLR-5, TLR-7 and TLR-21 in chicken macrophages during the mid-phase of the developmental cycle. 
Intriguingly, during the early-phase a significant upregulation was noticed for CXCLi1, IL-16 and TLR-4 
genes (unpublished results). The T3SS is also required to initiate inflammation via activation of caspase-
1 or NF-κB-dependent genes. For example, the Pseudomonas aeruginosa T3S effector ExoS activates 
both TLR2 and CD14/TLR4 signaling (Epelman et al. 2004). Shigella IpaB and Salmonella SipB 
(homologous to the chlamydial CopB) colocalize with caspase-1 and are necessary for its activation 
(Prantner and Nagarajan, 2009). 
Only one pattern recognition receptor (PRR), TLR4, was investigated in this study with a significant 
upregulation in the conchae, lungs, harderian gland, bursa fabricius and spleen during infection. 
However in the airsacs, TLR4 was significant downregulated at 8d p.i.  Contrary, Kalmar et al. (2015) 
reported a significant upregulation of TLR4 at 7d and 14d p.i. in the thoracic airsacs. Chlamydial LPS 
and chlamydial heat-shock proteins are ligands for the TLR4 receptor. Recent studies describe that 
TLR2 plays a significant role as a pattern recognition receptor for and is involved in early secretion of 
pro-inflammatory mediators, while TLR4 has a protective role (Agrawal et al., 2011; Massari et al., 
2013; Prebeck et al., 2001; Beckett et al. 2012). In this study, TLR4 is significant upregulated in every 
organs examined except the airsacs, but it is possible that TLR4 is not responsible for the observed 
production of pro-inflammatory mediators. To our knowledge, only two studies has yet investigated 
the role of the pattern recognition receptors during a C. psittaci infection (Lagae et al., 2015; Kalmar 
et al., 2015). Different studies revealed not only a role for TLRs but also for NOD-like receptors (NLRs) 
and inflammasomes during a chlamydial infection (Shimada et al., 2012). 
In conclusion, to our knowledge, this is one of the few studies wherein in vivo immune response during 
a C. psittaci infection was studied in his natural host, the chicken. However, a comprehensive 
understanding about the vital mechanisms controlling C. psittaci-caused pathological sequelae 
remains lacking. It will be an important future goal to identify the mediators, the PRRS and the cells 
involved in the host immune response during a C. psittaci infection and better define how these factors 























































General discussion and perspectives 
Chlamydia psittaci is an obligate intracellular bacterium causing  respiratory disease and mortality in 
birds. The disease is endemic in many species of wild birds, but also in poultry like chickens, turkeys, 
ducks and geese (Newman et al., 1992; Vanrompay et al., 1997; Verminnen et al., 2008). Recently, C. 
psittaci has been found more often in chickens (Yin et al., 2013a; 2013b). In order to prevent mortality, 
reduced feed intake and carcass condemnation at slaughter, antibiotic treatments are still being used 
in farms to control these infections. 
C. psittaci is also a zoonotic pathogen. It causes parrot fever or psittacosis in humans after aerogenic 
transmission of the bacteria from diseased birds (Andersen and Vanrompay, 2000). Several reports 
described the transmission of C. psittaci from birds to humans, particularly in high-risk individuals such 
as veterinarians, poultry workers, ped bird owners, bird breeders, taxidermists or traders (Hinton et 
al., 1993; Vanrompay et al., 1995a; Heddema et al., 2006; Harkinezhad et al., 2007; Verminnen et al., 
2008; Beeckman and Vanrompay, 2009; Larouceau et al., 2009). However, reports on C. psittaci 
zoonotic transmission from chicken farms are rare (Gaede et al., 2008; Dickx and Vanrompay, 2011). 
Recently, we examined the prevalence of C. psittaci, atypical Chlamydiaceae and their possible 
zoonotic transmission on 19 Belgian chicken farms. ACC were not detected in the chickens or in the 
human samples. However, 18 out of 19 farms were positive for C. psittaci by both culture and PCR. C. 
psittaci ompA genotypes A and D were discovered among the chickens. Looking at the humans, 29 out 
of 31 (93.5%) were positive for C. psittaci by culture and PCR. Genotypes A, D and a mixed infection 
with genotypes C and D were found. This study shows that C. psittaci infections in chickens are, at least 
in Belgium, more prevalent than originally thought but it also emphasizes the importance of C. psittaci 
as a zoonotic pathogen. About 86.2% of the positive farmers reported yearly medical complaints 
potentially related to psittacosis and four of them currently experienced respiratory disease. About 
12.5% of the farmers mentioned that they had pneumonia after starting to keep chickens. It has been 
described that established workers gained a certain level of protection against clinical disease. New 
employees more often become ill after contact with C. psittaci (Newman et al., 1992; Hinton et al., 
1993). However, specific measures for controlling C. pittaci infections are recommended for all persons 
at risk. People should be adequately informed about the risk and on protective procedures. They 
should be trained how to use protective equipment which include suitable clothing, gloves, disinfecting 
soap and a full-face mask or at least mask that covers mouth and nose as a full face mask is not always 
easy to wore during work. Collective protective measures such as ventilation and frequent cleaning to 
prevent aerosol accumulation and cross-contamination between the different barns or different 
rooms in a slaughterhouse are also needed (Deschuyffeleer et al., 2012). Accurate diagnostic 
monitoring in poultry and reporting of infections by physicans is required. In this respect, an increased 




awareness of occupational physicians is also crucial. Despite the European Union’s obligation to assess 
any biohazard in the workplace, knowledge on C. psittaci is still relatively undeveloped and a specific 
risk assessment has not been composed yet. So, there is still room for improvement. 
C. psittaci is endemic in the poultry industry causing economic damage, although specific calculations 
of economic losses are unavailable. Large epidemiological studies have been performed but they can 
never prove the economic impact of C. psittaci in poultry. Intervention studies are needed for this 
purpose. During such an intervention study, one is able to calculate the economic benefit obtained by 
using a specific preventive strategy. However, we have no C. psittaci preventive strategies, as there is 
no vaccine and the currently used antibiotics are also effective against other respiratory pathogens. As 
this bacterium has an important zoonotic potential, a way to control or even eradicate  this bacterium 
must be found. Currently, antibiotics are the only weapon against chlamydiosis. Tetracyclines are the 
drugs of choice for avian chlamydiosis. Enrofloxacin might also be used but it is less effective and more 
expensive. Moreover, it belongs to the fluoroquinolones and some countries (like for instance The 
Netherlands and Belgium) forbid the use of these antibiotics in farm animals as they are frequently 
used in human medicine. Prophylactic use of antibiotics is out of the question because the risk of 
creating tetracycline resistant C. psittaci strains and the risk of antibiotic residues in poultry meat. 
Antibiotics have also become environmental contaminants, which might have a negative impact on 
our ecosystem (Pouliquen et al., 2008). So far, tetracycline resistant C. psittaci strains have not been 
described in the literature. However, tetracycline resistant Chlamydia suis strains have been found in 
pigs, probably as an undesirable consequence of the long term use of antibiotics as growth promoters 
(in feed) in these animals. The latter has been forbidden since 1997 (Lenart et al., 2001; Dugan et al., 
2004). 
Vaccination would be a good strategy to prevent C. psittaci infections as it could lead to a better control 
of respiratory disease and to reduction of related financial losses (cost of antibiotics, reduced economic 
performance). Moreover, it could reduce of the use of antibiotics (less antibiotics residues in 
environment and meat). At present, a vaccine against C. psittaci is not yet commercially available, 
although there are already several commercial vaccines against C. abortus in ruminants and C. felis in 
cats. These vaccines are based on the use of killed or live attenuated bacteria. Especially, the live 
vaccines offer good protection and significantly reduce the shedding of infective organisms. However, 
concerns remain over the safety of using live-attenuated vaccines, particularly for zoonotic pathogens. 
Moreover, immunopathology can occur when using whole organism based chlamydial vaccines 
(Mabey et al., 2014). 




Vaccination studies on the development of a protective DNA vaccine, based on the major outer 
membrane protein (MOMP) of C. psittaci have been performed in turkeys. These studies revealed good 
results, as the vaccine was able to significantly prevent severe clinical signs and lesions and significantly 
reduced bacterial replication and excretion. Unfortunately, full protection could not be achieved, if 
albeit possible (Verminnen et al., 2005; Loots et al., 2006). The major outer membrane protein 
(MOMP) is an immunodominant protein which represents the majority of the surface exposed proteins 
and contains serovar-specific neutralizing epitopes. It has been shown that this protein is the most 
protective antigen (Caldwell et al., 1981; Hatch et al., 1981), so vaccine studies focused on MOMP. 
However, major efforts have been made to develop an effective vaccine with MOMP, although no 
vaccine is yet commercially available. 
During this thesis, a recombinant C. psittaci vaccine was developed and evaluated. Results will be 
presented later on, as the patent filing is not yet completed. 
Another approach to combat C. psittaci is ovotransferrin which is anti-microbial protein capable of 
binding iron needed by bacteria to survive in the host (Valenti et al., 1982; Valenti et al., 1983). A study 
of Beeckman et al. (2007)  demonstrated that ovotransferrin was able to inhibit actin polymerization 
and internalization of C. psittaci into chicken macrophages. To further explore the possible role of 
ovotransferrin as a prophylactic use, Van Droogenbroeck et al. (2008, 2011) set up two different in vivo 
experiments in turkeys. These experiments show that two administration rounds of ovotransferrin by 
aerosol based on the C. psittaci infection waves protect turkeys against C. psittaci infection and other 
respiratory infection outbreaks. However, the use of ovotransferrin cannot avoid the occurrence of 
these infections but clinical signs were not observed and antibiotics weren’t administered during the 
experiment. Moreover, such mild infections could stimulate the immune system in such a way that 
clinical signs are not present. It is worthwhile to invest in both approaches (vaccine and ovotransferrin) 
to reduce the use of antibiotics in the poultry industry. 
Developing knowledge on the protective immune mechanisms to C. psittaci infections is crucial for 
vaccine development. 
Therefore, in this thesis, the in vitro and the in vivo immune responses elicited by C. psittaci in the host 
were examined as well as the role of the T3SS in this complex mechanism. Upon entry in the host, C. 
psittaci infects and colonizes the epithelial cells and the macrophages of the respiratory tract. C. 
psittaci is able to invade and even replicate within macrophages, which are part of the innate immune 
system.  
Former studies mainly focused on the adaptive immune response against C. trachomatis, C. 
muridarum, C. pneumoniae, and C. caviae, whereas it is the early innate immune system that provides 




the first stage of defence against those bacteria upon entering the mucosal lining and establishing a 
productive infection. Very few studies have investigated the innate immune system of the avian 
respiratory tract (Ariaans et al., 2008; Sarmento et al., 2008; Wang et al., 2011) and only one study has 
examined innate immunity to C. psittaci in its natural host cell, the respiratory epithelial cell or avian 
macrophage (Beeckman et al., 2010). However, the use of natural host cells in in vitro experiments is 
important, as earlier demonstrated by Roshick et al. (2006). They evaluated the growth of C. 
trachomatis and C. muridarum in various human and mouse cell lines and concluded that the role of 
different antichlamydial effector mechanisms are best performed in matched host/chlamydial sets 
(Roshick et al., 2006). In this thesis, we therefore focused on the innate immune response elicited by 
C. psittaci in vitro in chicken and human macrophages, but also in vivo.  
For the in vitro studies, matched host cell lines were used, the avian monocyte/macrophage HD11 cell 
line and the human monocyte/macrophage THP1 cell line. C. psittaci actively infect macrophages by 
inducing actin recruitment at the site of invasion by using the sophisticated T3SS. C. psittaci can also 
enter the macrophage through phagocytosis. Phagocytosis of bacteria is a normal function of 
macrophages. They patrol the tissues of the body and ingest and destroy unwanted pathogens. Some 
pathogens such as Chlamydiae, have acquired the ability to survive and replicate within macrophages 
after they have been phagocytosed. According with other infection studies using 
monocytes/macrophages, a limited replication or a barely survival of C. psittaci was observed 
(Beeckman et al., 2010). Our observation suggest that C. psittaci  might use the macrophage as a 
vehicle to transmigrate through the mucosal barrier present in the lungs and subsequently have access 
to the lymphatic system and the systemic circulation to spread to the other tissues present throughout 
the body and establish a systemic infection (Moazed et al., 1998; Gieffers et al., 2004). 
The macrophage senses the presence of the bacteria through his pattern recognition receptors located 
extracellular and intracellular of the cell. In chapter III, it was for the first time observed that the avian 
intracellular receptor TLR21 was significant upregulated after infection with C. psittaci in avian 
macrophages. Moreover, a significant upregulation of TLR3, TLR4, TLR5 and TLR7 was also observed. 
This activation of several PRRs leads to the activation of signaling cascades, resulting in the production 
of several chemokines, pro- and anti-inflammatory cytokines. However, the precise immune 
mechanisms involved in pathogenesis to C. psittaci infection, especially in the receptor signaling and 
downstream activation and suppression during the innate phase of infection initiating the adaptive 
immune responses remains largely unknown. In this thesis, it is clear that the pro-inflammatory 
cytokines IL-1β and IL-6 are strong upregulated after infection. This two cytokines and are part of the 
acute phase response which maintain the inflammation localized to the site of infection, clear cellular 
debris and has a role in the chemotaxis (Schneider et al., 2001; Kaiser et al., 2004). Nevertheless, 




different chemokines such as CXCLi1, CXCLi2, CCLi3 and IL-16 were investigated. CXCLi1 and CXCLi2 
binds with the cognate receptor CXCR1 but have different roles. CXCLi1 and CXCLi2 induce the 
migration of heterophils and monocytes, respectively (Poh et al., 2008). According to the study of 
Beeckman et al. (2010) the CXCLi1 mRNA expression was upregulated to a higher level than CXCLi2 
following infection with C. psittaci. Furthermore, CCLi3 was also high upregulated which also attracts 
heterophils to the place of infection. Elevation of these chemokines support the presence of C. psittaci 
in heterophils which could be the result of active phagocytosis by heterophils once they arrive, or 
because C. psittaci actively invades those cells (Johns et al., 2009) (Fig. VI-1).  
 
Fig. VI-1:  Schematic overview of the investigated innate immune response in C. psittaci infected HD11 cells. 
Red and blue arrows indicate the up- or downregulation of several genes investigated during the early- and 
mid developmental cycle of C. psittaci, respectively. The thickness of the arrows shows the relative 
expression of each gene investgated.  
 
However, only chemo attractants such as CXCLi1, CXCLi2, CCLi3 and IL-16 were investigated after C. 
psittaci infection of macrophages. It would be interesting to examine the leukocyte extravastion or 
diapedesis in  vivo during infection with C. psittaci. This process involves several steps like 
chemoattraction, rolling adhesion, tight adhesion and transmigration. Several studies indicate that C. 
pneumoniae is recognized as a causative agent of respiratory tract infections and implicated as a 
potential risk factor or a cause of several extrapulmonary diseases such as multiple sclerosis, 
atherosclerosis and Alzheimer disease (Grimaldi et al., 2003; Janczak and 2015; Shima et al., 2010). C. 





















via VLA-4, LFA-1 and MAC-1 to invade noninflamed subendothelium and initiate inflammatory 
processes. Thus, C. pneumoniae has the potential to activate the integrin adhesion receptor system in 
monocytic cells and can actively contribute to the monocyte recruitment to sites of atherosclerotic 
lesions (May et al., 2003). Moreover, the disease atherosclerosis is known as the most common 
pathological change observed in blood vessels of captive psittacine birds (Pees et al., 2006). A recent 
study of Pilny et al. (2012) indicated that infection of C. psittaci and high plasma cholesterol 
concentration may be risk factors for developing atherosclerosis in pet psittacine birds. However, how 
C. psittaci contribute to the disease atherosclerosis must be elucidated. This outcome will also be very 
relevant for the public health as C. psittaci is a zoonotic agent. 
Chlamydiales have developed different mechanisms on the molecular and cellular level to circumvent 
recognition and activation of the innate immunity. Because of their need to dedifferentiate into RBs 
before replication, these bacteria need to control the immune system to have enough time to 
complete their biphasic lifecycle. The T3SS is a highly conserved multiprotein syringelike structure that 
translocate different bacterial effector proteins in the cytoplasm of the host cell. Many reports 
addressed the importance of the role of the T3SS in inflammation of different pathogens such as 
Salmonella spp. (Miao et al., 2006) Yersinia spp. (Shin and Cornelis, 2007), Shigella spp. (Suzuki et al., 
2007), Pseudomonas spp. (Franchi et al., 2007; Miao et al., 2008; Sutterwala et al., 2007), and 
Burkholderia spp. (Sun et al., 2005) through the activation of caspase-1 and NF-κB downstream genes 
such as IL-6, Mip-2 and monocyte chemoattractant protein 1. As the T3SS constitute an important 
virulence-associated mechanisms which is commonly spread among gram-negative bacteria, those 
small organic molecules such as INP0007 blocking the secretion of TTS system substrates have been 
proposed as a new class of antimicrobial agents called virulence blockers (Keyser et al., 2008). 
However, many of those virulence blockers tend to be toxic for the host cells. A study of Ur-Rehman 
et al. (2012) has screened a library of 58 salicylidene acylhydrazides to identify Chlamydia growth. Only 
twelve compounds were not toxic to the cell. At the end, two compounds were selected as promising 
treatment of Chlamydial infections. In the future, the specific role of the different effector proteins 
translocated by the T3SS on the innate immune response will be further elucidated. Therefore, C. 
psittaci mutants lacking an effector protein could be used (Wang et al., 2013). 
In chapter V, the in vivo immune response elicited by C. psittaci in chickens was investigated. During 
the first 48 hours, a significant pro-inflammatory response (IL-1β, IL-6, TNF-α, IL-12, CXCLi2, CCLi3, 
caspase-1, TLR-4) was observed in the conchae. A shift of the same pro-inflammatory response was 
observed to the lungs at 4 dpi. As the airsacs are anatomically closely related to the lungs, an immune 
response was also observed at 4 dpi. with the exception of IL-12, the chemokines and TLR4 which were 
not significantly upregulated. Later on in the infection (8 dpi, 10dpi, 14dpi and 21dpi), an initiating of 




the immune response was seen in the harderian gland, bursa fabricius and spleen, indicating the 
presence of a  systemic infection from 8 dpi. A significant upregulation of TLR4 was noticed in the 
spleen and the harderian gland. Again, no significant upregulation of the chemokines investigated 
were observed in the harderian gland. These results resembles well with the observations seen in HD11 
cells. But it must be noticed that in this study the innate immune response of not only macrophages 
but all cell types present in the respective organs  was investigated. 
In chapter IV, an elongated shape of some macrophages were observed after infection with C. psittaci. 
A study of McWhorter et al. (2013) showed that elongation of human macrophages induce polarization 
toward a M2 phenotype. Macrophages can polarize toward a spectrum of phenotypes which include 
the classical pro-inflammatory M1 and the alternative anti-inflammatory pro-healing M2 activation 
state (Mosser and Edwards, 2008). Those macrophages remain relatively plastic which mean that they 
are able to taken in multiple phenotypes depending on the environment. M1 macrophages possess 
bactericidal properties, especially against intracellular pathogens by releasing several pro-
inflammatory cytokines such as TNF-α, IL-1, IL-6, IL-12, chemokines and ROS, whereas M2 
macrophages support the growth of those pathogens (Kahnert et al., 2006). Francisella induce a M2 
polarization in macrophages by inducing the production of IL-4 and IL-13, which support their 
replication and survival (Shirey et al., 2008). However, a study of Gracey et al. (2013) showed that C. 
muridarum does not induce murine macrophage polarization during intracellular infection. 
Furthermore, the polarized macrophages have a different capacity to control this bacterium, with M2 
macrophages being permissive to Chlamydia growth and M1 macrophages being able to control C. 
muridarum through the induction of persistence. Intriguingly, M2 macrophages are more susceptible 
to Chlamydia infection than non-polarized macrophages, probably due to the increased expression of 
the mannose receptor on those macrophages facilitating the uptake of Chlamydia (Murray and Wynn, 
2011). In this way, it may take longer for M2 polarized macrophages to activate antimicrobial 
mechanisms than their unstimulated macrophages. Interestingly, a study of Jupelli et al. (2013) have 
demonstrated a shift in the numbers of M1 macrophages to M2 macrophages during C. pneumoniae 
lung infection. As we observed several elongated macrophages during intracellular infection with C. 
psittaci, it would be worthwhile to characterize macrophage – C. psittaci interactions in the context of 
macrophage polarization over a long period in vivo. However, we can already speculate about this 
polarization during C. psittaci infection as we have investigated several cytokines and chemokines 
during infection produced by macrophages. We observed a high pro-inflammatory cytokine production 
which is associated with M1 macrophages, which initiates adaptive immune T cell responses and tissue 
inflammation (Qin et al., 2012). However, looking at the in vivo study, a significant upregulation of the 




anti-inflammatory cytokine IL-10 is observed from 8 days post infection, suggesting a shift from some 
M1 macrophages to M2 macrophages. 
Remarkably, it was observed that the lowest MOI yields a significant larger inclusion when compared 
with other MOIs in THP1 macrophages. This indicates that C. psittaci is able to sense the neighborhood 
and the amount of EBs. This inter-bacterial communication is called quorum sensing which is a 
widespread phenomenon in the microbial world that has important implications in the coordination 
of population-wide responses in several bacterial pathogens (Bassler, 2002). This system allow bacteria 
to recognize the density of the bacterial population by sensing and measuring the accumulation of 
specific small signal molecules that bacteria of the community secrete. When the amount of the 
accumulated signals in the environment is sufficient, signaling pathways are activated that alter 
bacterial gene expression. Quorum sensing makes bacteria able to behave as a community and to 
perform tasks which would be impossible for individuals bacteria such as overcoming defense and 
immune system and establishing infections (Rutherford and Bassler, 2012; Fazli et al., 2014). 
Unfortunately, quorum sensing has not yet been investigated in Chlamydial species. 
In general, pro-inflammatory cytokines such as IL1-β, IL-6, TNF-α and IL-8 were detected in 
macrophages after a C. psittaci infection (Fig VI-2). Remarkably, the protein IL-12 was not found in the 
supernatant of activated THP1 macrophages. However, IL-12 bridges together with IL-18 the infection 
with the IFN-γ production in the innate immune response. Recognition of pathogens by macrophages 
normally induces secretion of chemokines and IL-12 and which attract NK cells to the site of 
inflammation and promotes IFN-γ synthesis in these cells  (Otani et al., 1999). Many reports indicate 
that dendritic cells and macrophages can produce IFN-γ (Frucht et al., 2001). However, no IFN-γ 
production was detected in the supernatant during a C. psittaci infection in human macrophages. 
Although, IFN-γ seems to be important during chlamydial infection as demonstrated by the enhanced 
bacterial levels IFN-γ-/- or IFN-γ receptor-/- mice, or mice treated with anti-IFN-γ antibodies, compared 
with controls (Cotter et al., 1997; Rottenberg et al., 1999; Johansson et al., 1997; Ito and Lyons, 1999). 
However, the mRNA products of IL-12 were detected in activated chicken macrophages and in the 
conchae, lungs, airsacs, bursa and spleen of infected chickens. It could be that this cytokine together 
with IL-18 induce the production of IFN-γ in T cells and NK cells in vivo during a C. psittaci infection in 
chickens. 
The human homologue TLR9 was also significant upregulated in the early- and mid-phase of the 
infection cycle of C. psittaci in THP1 macrophages (Fig. VI-2). TLR9 recognizes bacterial DNA containing 
unmethylated CpG motifs and an upregulation of TLR9 mRNA was also observed during an intranasal 
C. pneumonia infection (Han et al., 2004). However, a study of Rothfuchs et al. (2004) describes that 




TLR4 deficient bone marrow derived macrophages (BMDM) showed increased Chlamydial progeny 
concomitant with IFN-α expression, but that was not the case for TLR2-/-, TLR6-/-and TLR9-/- BMDM. 
Further investigation of the recognition by and the initiation of the signal cascade of TLR9 and its avian 
homologue TLR21 during C. psittaci infection would be interesting.  
In our study, TLR2 was not or significantly downregulated during infection, suggesting that TLR2 does 
not play a role during C. psittaci infection.  However, C. pneumoniae activates NF-κB in a TLR2 
dependent manner in 293HEK cells (Prebeck et al., 2001). Indeed, TLR2 seems to be important for 
bacterial clearance and survival during a C. pneumonia infection in vivo and in vitro (Rodriguez et al., 
2006; Beckett et al., 2012). In contrast to the study of Beckett et al. (2012) and Netea et al. (2002), 
TLR4 seems to be important in the battle against C. psittaci as it is significant upregulated in the human 
and avian macrophages as well as in the spleen, the bursa fabricius, the harderian gland, the lungs and 
the conchae during a C. psittaci infection in chickens. 
As TLR4 and MyD88 doubly deficient macrophages could still produce IFN-α/γ in response to C. 
pneumoniae infection, this implicates the existence of a TLR independent pathway in C. pneumoniae 
recognition (Rothfuchs et al., 2004). Therefore, several other PRRs such as NLRP3, ASC, RIG-I and NOD-
2 were investigated during C. psittaci infection in human macrophages. Remarkably, those intracellular 
receptors were significant upregulated during the early phase of the infection and not during the mid-
cycle (Fig. VI-2). The mechanisms behind this exceptionally observation must still be investigated. 
In our study NOD-2 was only significantly upregulated early in the infection cycle. Several studies 
report that both NOD-1 and NOD-2 play important roles during a C. pneumoniae infection (Opitz et al., 
2005; Shimada et al., 2009). Coordinated and sequential activation of TLRs and NODs signaling 
pathways will be necessary for an efficient immune response against chlamydial infections. It is likely 
that TLRs might be important for initial activation and NOD proteins for a sequential, prolonged 
activation of the target cells by intracellular Chlamydiae. 
Another important family investigated is the NLR family which are involved in the recognition of DAMP 
leading to the assembly of inflammasomes, which in turn leads to the generation of active caspase-1, 
a requirement for the production of mature IL-1β and IL-18. The mRNA expression of the 
inflammasome NLRP3/ASC was significantly upregulated during infection with C. psittaci in human 
macrophages (Fig. VI-2). Furthermore, the protein IL-1β was detected in the supernatant of the 
activated macrophages. In vivo, the mRNA expression of IL-1β and caspase-1 was significantly 
upregulated in different organs such as the conchae, lungs, airsacs, harderian gland and bursa fabricius, 
indicating an important role for the NLR family during Chlamydial infection.  





Fig. VI-2:  Schematic overview of the investigated innate immune response in C. psittaci infected THP1 cells. 
Red arrows indicate the upregulation of several genes and proteins investigated during the early-, mid- and 
late developmental cycle of C. psittaci. The thickness of the arrows shows the relative expression of each 
gene/protein investgated. 
 
In conclusion, we emphasized the endemic nature of C. psittaci in chickens and its zoonotic potential 
by describing the transmission of this bacteria from infected chickens to the farmers. Furthermore, the 
results presented in this thesis has led to a better understanding of the immunological mechanism 
mediated by C. psittaci in his natural host, indicating that C. psittaci initiates a pro-inflammatory 




































The focus of this thesis was on the avian Gram-negative obligate intracellular bacterium, Chlamydia 
psittaci. C. psittaci causes avian chlamydiosis and is mainly spread by inhalation of aerosols of nasal 
secretion or fecal material containing the infectious particle. It is known that C. psittaci can infect 400 
species, covering 30 different bird orders (Kaleta and Taday, 2003). In the poultry industry, C. psittaci 
causes a lowered egg production, higher mortality and carcass condemnation (Grimes and Wyrick, 
1991). The bacteria can be transmitted to humans resulting in psittacosis in which the symptoms can 
vary from inapparent to flu-like symptoms and even pneumonia (Harkinezhad et al., 2007; Harkinezhad 
et al., 2009; Van Droogenbroeck et al., 2009; Verminnen et al., 2006).  
After inhalation, primary replication of C. psittaci takes place in the epithelial cells and macrophages 
of the respiratory tract. Later on, the bacteria can be found in epithelial cells and macrophages of the 
lower respiratory tract. And in severe cases, the infection can become systemic whereby C. psittaci is 
present in blood macrophages spreading to various tissues throughout the body. Macrophages are an 
important part of the innate immune system and capable of engulfing and killing pathogens. But 
probably their most important function is to recruit other immune cells to the place of infection by the 
elaboration of chemokines. Macrophages can also activate the adaptive immune response by 
presenting the antigen. As macrophages play such an important role in clearing pathogens, it is rather 
unique that C. psittaci as well as other Chlamydiaceae are able to survive and even replicate within 
those cells. 
Besides illustrating that C. psittaci is endemic in the Belgian chicken industry and his zoonotic nature, 
this thesis focuses in the investigation of the innate immune response in vitro elicited by C. psittaci in 
chicken and human macrophages but also in vivo in his natural host, the chicken. This obtained 
knowledge was used to design and evaluate a recombinant C. psittaci vaccine. 
Chapter I of this thesis gives an overview of the history, classification and biology of C. psittaci in 
animals and humans. Furthermore, this chapter also focuses on immunology and chlamydial vaccine 
development. 
In Chapter II, the prevalence of C. psittaci and atypical Chlamydiaceae and their zoonotic transmission 
was investigated on 19 Belgian chicken farms. Pharyngeal swabs from chickens and farmers were 
investigated for the presence of C. psittaci using a combination of nested PCR, outer membrane protein 
A (ompA) genotype-specific quantitative real-time PCR and cell culture. The chickens of 18 out of 19 
farms were positive for C. psittaci by culture and PCR and genotype A and D were detected. Of the 
investigated farmers were 93.5% positive for C. psittaci by culture and PCR and genotypes A, D and a 
mixed infection with genotypes C and D were discovered. No atypical Chlamydiaceae were detected. 




This study shows that C. psittaci infections are endemic in the Belgian chicken industry and possess a 
huge zoonotic risk to all people in close contact. 
Chapter III was dedicated to studying the innate immunity initiated by C. psittaci in chicken 
macrophages (HD11 cells). C. psittaci engages an initimate relation with avian respiratory epithelia 
cells and macrophages. The mRNA expression of different cytokines (IL-1β, IL-6, MIF, TNF-α, IL-12p35, 
IL-10, GM-CSF), chemokines (CXCLi1, CXCLi2, CCLi3, IL-16), caspase-1, iNOS and toll-like receptors 
(TLRs) (TLR-2, TLR-3, TLR-4, TLR-5, TLR-7, TLR-21) were investigated during the early (2h-8h p.i.) and 
mid-cycle (12h-18h p.i.) phase of the developmental cycle of the highly virulent C. psittaci strain 
92/1293. In general, an augmentation of transcript levels for all genes investigated was detected, 
especially during mid-cycle.  
In chapter IV, we examined the relationship between C. psittaci and the human macrophage (THP-1 
cells), with the emphasis on internalization, survival, replication, T3SS and the innate immune system. 
The development of C. psittaci in human macrophages is very similar to the infection cycle in epithelial 
cells. Bacterial replication was quantified through titration of the cell culture supernatant and 
immunofluorescence assays were set up to examine the inclusion size and the inclusion forming units 
per ml. Rapid early entry was observed followed by an increase in the average area per inclusion 
between 24h and 48h p.i. which is likely to be the exponential growth of C. psittaci. At 48h p.i., lysis of 
the host cell was observed with the release of newly formed elementary bodies (EBs). At 15 min p.i., 
actin recruitment was observed and the continuous expression of the effector protein IncA was 
detected, supporting the assumption of a preloaded T3SS. During infection, the other effector proteins 
investigated, SctC and SctW were also observed. In addition, the gene expression level of a panel of 
pattern recognition receptors (TLR-1, TLR-2, TLR-3, TLR-4, TLR-6, TLR-9, NLRP3, ASC, RIG-I, NOD-2) were 
investigated during the early- (2h, 4h, 8h), mid- (12h, 18h, 24h) and late- (36h, 48h, 72h) phase of the 
developmental cycle of C. psittaci to evaluate how this bacterium is recognized by his host cell. Upon 
this recognition, a signal cascade is induced resulting in the production of several cytokines and 
chemokines. Different cytokines and chemokines such as IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, 
IL-17α, IFN-γ, TNF-α and GM-CSF were investigated in the supernatant of C. psittaci infected THP1 cells 
during the mid- and late-phase of the developmental cycle using a Multi-Analyte ELISArray Kit. The 
cytokines IL-1α, IL-2, IL-4, IL-10, IL-12, IL-17α and IFNγ were not detected, indicating that those 
cytokines were not expressed during infection with C. psittaci in human macrophages. In addition, high 
concentrations of the cytokines IL-1β and TNF-α and the chemokine IL-8 was noticed throughout all 
time points measured, whereas the cytokine IL-6 and GM-CSF was rather late in the infection observed 
from 48h p.i. and 36h p.i. on, respectively. 




The aim of chapter V was to elucidate the in vivo immune response evoked by C. psittaci in his natural 
host, the chicken. Excretion of C. psittaci, chlamydial antibody detection in sera, blood immune cells 
and the mRNA expression levels of different cytokines (IL-1β, IL-6, IL-10, IL-12, TNF-α, caspase-1), 
chemokines (CXCLi2 and CCLi3) and one Toll-like receptor (TLR-4) were investigated in different organs 
(conchae, lungs, airsacs, harderian gland, bursa fabricius and spleen) at different time points p.i.  (6h, 
24h, 48h, 4d, 6d, 8d, 10d, 14d and 21d). A higher frequency of monocytes/macrophages expressing 
the MHC II molecule and cytotoxic CD8+  T cells were observed in chickens infected with C. psittaci. 
Several cytokines, chemokines and TLR-4 were also significantly upregulated during infection in several 
organs. Remarkably several cytokines and chemokines were also significantly downregulated, 
especially at late time points. This study can contribute on the elucidation on how C. psittaci interact 
with his host, leading to the developing of targets for effective vaccination and therapeutic strategies 
for infection. 



































Deze doctoraatsthesis spitst zich toe op Chlamydia psittaci, een gram-negatieve obligaat intracellulaire 
bacterie voor vogels. C. psittaci veroorzaakt chlamydiosis bij vogels. Het wordt voornamelijk verspreid 
door inhalatie van besmette aerosols afkomstig van nasale secreties of fecaal materiaal. C. psittaci kan 
400 vogelspecies, behorend tot 30 verschillende ordes infecteren (Kaleta and Taday, 2003). Vooral in 
de pluimvee-industrie leiden C. psittaci infecties tot aanzienlijke verliezen ten gevolge van een 
verlaagde ei productie, verhoogd sterftecijfer en karkassen die niet geschikt zijn voor consumptie 
(Grimes and Wyrick, 1991). De bacterie kan ook mensen besmetten. Humane psittacosis heeft een 
heel divers klinisch beeld variërend van onbeduidend tot grieperige symptomen of longontsteking 
(Harkinezhad et al., 2007; Harkinezhad et al., 2009a; Van Droogenbroeck et al., 2009a; Verminnen et 
al., 2006).  
Na inhalatie van de bacterie treedt primaire replicatie op in de epitheliale cellen en macrofagen van 
de bovenste luchtwegen. Daarna kan de bacterie gedetecteerd worden in de epitheliale cellen en 
macrofagen van de onderste luchtwegen. In ernstige gevallen kan de infectie systemisch worden. 
Hierbij is C. psittaci aanwezig in bloed macrofagen die de bacterie verspreiden naar verschillende 
weefsels in het lichaam. Macrofagen zijn cellen die een belangrijk deel vormen van het aangeboren 
immuunsysteem. Deze cellen kunnen pathogenen fagocyteren. Maar hun belangrijkste taak is het 
aantrekken van andere immuuncellen naar de plaats van infectie door middel van chemokines. 
Daarnaast kunnen macrofagen het adaptief immuunsysteem activeren door antigenpresentatie. 
Doordat macrofagen een heel belangrijke rol spelen in het opruimen van pathogenen, is het uniek dat 
C. psittaci en andere leden van de Chlamydiacea familie in staat zijn om te overleven en zelfs te 
repliceren in deze cellen. 
Enerzijds toont deze doctoraatsthesis aan dat C. psittaci een zoönotisch karakter heeft en endemisch 
is in de Belgische kippenindustrie. Anderzijds ligt de focus ook op het verwerven van kennis omtrent 
de aangeboren immuunrespons tijdens een C. psittaci infectie. Dit werd zowel in vitro onderzocht in 
kippen- en humane macrofagen als in vivo in zijn natuurlijke gastheer, de kip. De verworven kennis 
werd gebruikt om een recombinant vaccin tegen C. psittaci te contstrueren en te avlueren. 
Hoofdstuk I van deze doctoraatsthesis geeft een overzicht weer van de geschiedenis, classificatie en 
biologie van C. psittaci in dier en mens. Daarnaast ligt de nadruk ook op immunologie en de 
ontwikkeling van een vaccine tegen Chlamydiae. 
In hoofdstuk II werd de prevalentie van C. psittaci en atypische Chlamydiaceae en hun zoönotische 
transmissie onderzocht op 19 Belgische kippenbedrijven. Faryngeale swabs van kippen en de 
pluimveehouders werden onderzocht op de aanwezigheid van C. psittaci door gebruik te maken van 




een combinatie van nested PCR, outer membrane protein A (ompA) genotype-specifieke kwantitatieve 
real-time PCR en celcultuur. De kippen van 18 bedrijven waren positief voor C. psittaci in celcultuur en 
nested PCR. In deze bedrijven werd genotype A en D gedecteerd. 93,5% van de pluimveehouders 
waren positief voor C. psittaci in celcultuur en nested PCR. Hierbij werd genotype A, D en een 
gemengde infectie met genotype C en D ontdekt. Atypische Chlamydiaceae werd niet gedecteerd op 
de kippenbedrijven. Deze studie toont aan dat C. psittaci endemisch aanwezig is in de Belgische 
kippenindustrie. Daarnaast bezit deze bacterie een groot zoönotisch karakter voor alle mensen die 
regelmatig dicht in contact komen met deze kippen. 
In hoofdstuk III werd de aangeboren immuunsysteem onderzocht gedurende een C. psittaci infectie 
in kippenmacrofagen (HD11 cellen). C. psittaci gaat een hechte verbintenis aan met hun eukaryote 
gastheercel, namelijk epitheelcellen en macrofagen. Verder gebruikt C. psittaci een T3SS om effector 
proteïnen te transloceren in het cytoplasma van zijn gastheercel. Hierdoor wordt de pathogenese van 
C. psittaci bevorderd. De mRNA expressie van verschillende cytokines (IL-1β, IL-6, MIF, TNF-α, IL-12p35, 
IL-10, GM-CSF), chemokines (CXCLi1, CXCLi2, CCLi3, IL-16), caspase-1, iNOS and toll-like receptors 
(TLRs) (TLR-2, TLR-3, TLR-4, TLR-5, TLR-7, TLR-21) werden onderzocht gedurende de vroege- (2h-8h p.i.) 
en de mid-fase (12h-18h p.i.) van de ontwikkelingscyclus van de hoge virulente C. psittaci stam 
92/1293. Algemeen werd een stijging van de transcriptieniveaus van alle genen waargenomen, 
voornamelijk tijdens de mid-fase van de ontwikkelingscyclus.  
In hoofdstuk IV werd de relatie tussen C. psittaci en de humane macrofaag (THP-1 cel) onderzocht met 
de nadruk op de internalisatie, overleving, replicatie, T3SS en het immuun systeem. De ontwikkeling 
van C. psittaci in humane macrofagen is sterk vergelijkbaar met de  ontwikkelingscyclus waargenomen 
in epitheliale cellen. Bacteriële replicatie werd gekwantificeerd door middel van titratie van het 
supernatans van geïnfecteerd cellen. Daarnaast werden immunofluorescence assays gebruikt om de 
inclusie grootte en de inclusie vormende units per ml te onderzoeken. Een snelle intrede werd gevolgd 
door een stijging in de grootte van de inclusie tussen 24h en 48h p.i. Deze observatie is 
hoogstwaarschijnlijk te wijten aan de exponentiële groei van C. psittaci. Lyse van de gastheercel werd 
geobserveerd 48h na de infectie. Hierdoor komen nieuw gevormde elementaire lichaampjes vrij (EBs). 
Actinpolymerisastie na 15 min na infectie en de continue expressie van de effector proteïne IncA 
werden gedecteerd. Deze observaties ondersteunen het vermoeden dat het T3SS reeds geladen is met 
een aantal effector proteïnen in het begin van de infectie. Gedurende de infectie werden nog andere 
effector proteïnen geobserverd zoals SctC en SctW. Daarnaast werd de genexpressie van een aantal 
pattern recognition receptors (TLR-1, TLR-2, TLR-3, TLR-4, TLR-6, TLR-9, NLRP3, ASC, RIG-I, NOD-2) 
onderzocht gedurende de vroege- (2h, 4h, 8h), mid- (12h, 18h, 24h) en late- (36h, 48h, 72h) fase van 
de ontwikkelingscyclus van C. psittaci om na te gaan hoe deze bacterie wordt herkend door zijn 




gastheercel. Na deze herkenning word een signal cascade geïnitieerd wat resulteert in de productie 
van verschillende cytokines en chemokines. Verschillende cytokines en chemokines zoals IL-1α, IL-1β, 
IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-17α, IFN-γ, TNF-α en GM-CSF werden onderzocht in het supernatans 
van geïnfecteerde THP1 cellen gedurende de mid- en late-fase van de ontwikkelingscyclus van C. 
psittaci door gebruik te maken van een Multi-Analyte ELISArray Kit. De cytokines IL-1α, IL-2, IL-4, IL-10, 
IL-12, IL-17α and IFNγ werden niet gedecteerd. Deze resultaten suggereren dat deze cytokines niet tot 
expressie komen tijdens een infectie met C. psittaci in humane macrofagen. Daarnaast werden wel 
hoge concentraties van de cytokines IL-1β en TNF-α en the chemokine IL-8 gedecteerd gedurende alle 
tijdspunten. Verder werden de cytokine IL-6 en GM-CSF ook gedecteerd laat in de infectie, namelijk 
vanaf 48h and 36h respectievelijk. 
Het doel van hoofdstuk V was om de in vivo immuunrespons tijdens een C. psittaci infectie in zijn 
natuurlijke gastheer, de kip te onderzoeken. Excretie van C. psittaci, detectie van antilichamen tegen 
Chlamydiae in het serum, bloed immuuncellen en de mRNA expressie van verschillende cytokines (IL-
1β, IL-6, IL-10, IL-12, TNF-α, caspase-1), chemokines (CXCLi2 and CCLi3) en één toll-like receptor (TLR-
4) werd onderzocht in verschillende organen (conchae, longen, luchtzakken, harderse klier, bursa 
fabricius en milt) op verschillende tijdspunten postinfectie (6h, 24h, 48h, 4d, 6d, 8d, 10d, 14d and 21d). 
Een hogere frequentie van monocyten/macrofagen die de MHC klasse II molecule tot expressie 
brengen en CD8+ T cellen werden geobserveerd in kippen geïnfecteerd met C. psittaci. Verschillende 
cytokines, chemokines and TLR-4 werden significant opgereguleerd gedurende de infectie in 
verscheidene organen. Daarnaast was het opmerkelijk dat verschillende cytokines en chemokines ook 
significant waren neergereguleerd, voornamelijk tijdens de late tijdspunten. Deze studie draagt bij tot 
het ontrafelen hoe C. psittaci interageert met zijn gast. Deze kennis kan leiden tot de ontwikkeling van 
een effectief vaccine en therapieën tegen een C. psittaci infectie. 
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jaartje werkzaam was in het labo, kwam Annelien Dumont het immuno front versterken. En wat een 
versterking was jij! Vanaf dan was jij voor mij een rots in de branding. We hebben uren en uren samen 
gesleten in het labo! Hoeveel ELISA’s, RNA-extracties, RT-PCRs, dissecties,… hebben wij wel niet samen 
gedaan? Bedankt dat ik altijd op jou kon rekenen. Dikwijls heb je samen met mij overuren geklopt of 
‘cachet’ gegeven. Jij was mijn labomaatje maar ook veel meer dan dat! Ik kon steeds rekenen op jouw 
mentale steun. Jij was er steeds om mij een oppeppertje of duwtje in de rug te geven!  Bedankt voor 
alle toffe babbels (ik mis ons ochtendbabbeltje enorm!), jouw super gezelschap tijdens ons uitjes naar 
Merelbeke, onze na-de-werkuren-sportieve-uitlatingen en al het plezier die we samen beleefden. We 
hebben toch heel wat afgebabbeld en afgelachen . Ook met Evelien De Clercq was de sfeer 
opperbest! Wat luisterde ik toch graag naar al jouw verhalen maar vooral naar de bizarre, grappige 
uitdrukkingen die daar mee gepaard gingen. Dikwijls deed mijn buik pijn van het lachen. Bedankt om 
de boel op te vrolijken (remember de google translate momenten en ik-show-mijn-jurk moment :-). 
Ook in het labo kon ik op jou rekenen. Bedankt om samen met mij tot in de late uurtjes T cel 
proliferatietesten te doen (jammer dat het karton tussen de deur toen niet gemarcheerd heeft ). 
Ook Leentje De Puysseleyr en Kristien De Puysseleyr zijn twee top madammen! Ik heb er een tijdje 
over gedaan om jullie koosnaampjes te weten te komen. Wat was ik dan ook blij toen jullie zich 
eindelijk versproken! Lootie en Wonske , bedankt voor alle goede babbels (zowel de serieuze als de 
minder serieuze), alle hulp, al mijn vragen te beantwoorden, alle plezier en de wijze raad! Jullie zijn 
een fantatstisch zussenteam! Na een jaartje in Amerika ‘Chlamydia-stuff’ te doen, kwam Sarah Van 
Lent in ons immuno team terecht. Meteen was duidelijk dat jij een doorzetter bent, ‘nen goander’ 
zoals ze bij ons zeggen! Ik sta nog steeds verteld hoe uitgebreid jouw kennis wel niet is. Als ik iets niet 
wist of twijfelde, stond ik nogal snel aan jouw bureau want ‘onze’ Sarah die wist wel raad! Daarnaast 
ben jij een echte tettergat, een eigenschap die goed scoorde bij de immuno’s. Bedankt voor de toffe 
middagpauzes, jouw verhalen en de buitenlabo-activiteiten (dankzij jou was ik net iets sportiever 
geworden ). Nog superveel succes met jouw doctoraat! Het einde is bijna in zicht! Ik duim mee! Ook 
Julie Geldhof voelde zich meteen thuis in ons Immuno-team. Jij behoort toch wel tot de top drie van 
de meest enthousiaste mensen die ik ken. Ik vraag mij nog steeds af waar jij al die energie vandaan 
haalt ! Het klikte dan ook meteen met jou! Als een echte dierenvriend was jij dan ook heel 
enthousiast om ons bureau-eiland te versterken met een aantal vissen. De uitstapjes met jou, Annelien 
en mezelf naar de eurotuin werden een feit want vissen hebben nu eenmaal veel verzorging nodig . 
Toen je na een jaartje besloot om ons te verlaten, was de spijt dan ook heel groot. Ik heb je zeker en 
vast gemist maar ik ben er van overtuigd dat je dat goed doet daar tussen de koeien! Cindy De Boeck, 
wij hebben maar een aantal maanden samen gewerkt maar het zou ook zeker geklikt hebben tussen 
ons. Ik wens je dan ook nog veel succes met jouw onderzoek! Lore Eggermont en Annelies Delporte, 




chauffage zal er misschien ook we voor iets tussen gezeten hebben ) en vice versa. Hoe dan ook, er 
werd toen wel wat afgebabbeld en afgelachen. Dankzij jullie kon ik eens mij gedachten verzetten. Ook 
al behoorden we tot een ander team, ik vond het steeds fijn om jullie dicht in mijn buurt te hebben! 
Bedankt voor alle steun en de mooie – soms hilarische- momenten! 
Ik wil ook graag mijn thesisstudenten Bert Persan, Neil Saad, Delphine De Sutter, Anoesjka Steenbeke, 
Bieke Soen, Ellen Audenaert en Eveline Jonckheere bedanken om hun steentje bij te dragen tot dit 
doctoraat! 
Ook een grote dank u wel aan Sofie De Schynkel en Fien De Block voor alle administratieve hulp en 
bestellingen.  Maar vooral bedankt voor jullie vriendelijkheid, jullie interesse, bemoedigende babbels 
en zoveel meer! Geert Meesen, ook jij stond steeds klaar om ons technisch te ondersteunen. Meer 
dan eens heb je mijn stalen tevoorschijn getoverd uit de ultracentrifuge. En de vele tips voor een goed 
wachtwoord ken ik nog steeds  Ook een dikke merci aan alle mobi-collega’s voor de toffe sfeer en 
de vlotte samenwerking! 
Voor het uitvoeren van onze dierexperimenten konden we altijd rekenen op het laboratorium voor 
Immunologie van Prof. Dr. E. Cox van de Faculteit Dierengeneeskunde in Merelbeke. Dank u wel dat 
de isolatoren steeds tot onzer beschikking stonden en dat we gebruik mochten maken van de labo-
infrastructuur. Verder wil ik ook graag Rudy Cooman bedanken. Dankzij jou stond er steeds eten en 
geautoclaveerd water klaar voor mijn kippetjes.  Maar ook bedankt voor het warme onthaal en de vele 
toffe babbels! 
 
Het laatste deel van mijn dankwoord is voorbehouden voor iedereen aan het thuisfront. Aan al mijn 
vriendinnetjes en vriendjes: bedankt voor alles!!! Sommige van jullie ken ik al van in de kleuterklas, 
maar in de ksj zijn we echt goede vrienden geworden. Samen hebben we al veel meegemaakt, van 
samen puberen met daartussen wilde feestjes, weekends, komen eten tot volwassenen (of althans iets 
dat erop lijkt ). Ik heb heel veel geluk dat ik mezelf mag rekenen tot zo een hecht vriendenteam! 
Bedankt om mij te steunen in alles, voor alle bemoedigende gesprekken, de dingen die we samen 
meemaakten, al het plezier dat we samen gekend hebben, de waslijst aan herinneringen,… m.a.w. dat 
ik deel van jullie leven mag zijn! Regelmatig kreeg ik dan ook de vraag hoe het met mijn doctoraat was. 
Het was niet altijd evident om uit te leggen waar ik precies mee bezig was, enfin het was iets met 
kippen en Chlamydia . Bedankt om steeds vol interesse regelmatig te vragen naar de vooruitgang. 
Maar vooral voor de vele duwtjes in de rug die ik heb gekregen! Het zinnetje: ‘je bent nu al zover, laat 
het nu niet schieten’ heeft echt wel geholpen!! Een dikke merci allemaal! XXX 
Een heel speciaal woordje van dank gaat naar mijn mama en papa. Ik evolueerde van een huilbaby 
naar een puber met alles erop en eraan ! Het moet niet altijd gemakkelijk geweest zijn maar toch 




hoeveel avonden heb jullie niet samen met mij samen gestudeerd in de lagere school? Jullie hebben 
mij geleerd wat het woord doorzetten echt betekent. Dankzij jullie sta ik waar ik vandaag sta! Bedankt 
voor alle kansen die ik steeds van jullie heb gekregen! Nu ik mijn eigen huisje, tuintje, boompje heb, 
blijven jullie bereid om bij te springen voor eender wat (babysitten is hoogstwaarschijnlijk jullie favoriet 
). Ik heb heel veel geluk om zulke fantatstische ouders als jullie te hebben! Bedankt voor alles!!! XXX 
Pieter Lagae, mijn kleine grote topbroer! Tijdens ons kindertijd, was er meestal geen ontsnappen aan 
mijn plagerijen . Toch leerde je mij ‘mario bros’ spelen als geen ander en kwam je mij steeds 
verwittigen als de sint was langs geweest  Telkens ik blok had of weer eens moest studeren, 
probeerde je zo stil mogelijk te zijn. En dankzij jou hebben we nu letterlijk een dak boven ons hoofd! 
Bedankt om zo een fantastiche broer te zijn!!! XXX 
Bart Vervaet, jij bent de man waar ik al veertien jaar lief en leed meedeel! Geen woorden kunnen 
beschrijven hoeveel ik van jou hou! Samen hebben we al zo veel meegemaakt en nog steeds trekken 
we aan hetzelfde zeil. Ik ben zo trots om jouw vrouw te zijn. Jij bent degene die mij hier helemaal heeft 
doorgesleurd! Dit doctoraat is ook jouw doctoraat, ook al versta je er geen snars van ! Bedankt voor 
alle liefde, alle steun, al het plezier,… kortom voor alles!! Love you XXX 
De grootste en dikste kussen zijn voorbehouden voor mijn dochtertje, Amber! Jij bent mijn alles! Het 
schrijven van dit doctoraat was een stuk draaglijker dankzij jouw trappelende voetjes in mijn buik. 
Amberke, geen woorden kunnen omschrijven hoeveel jij wel voor mij betekent! Jouw stralende ogen, 
jouw deugenieterij, wanneer je ‘mama’ zegt, jouw lach, jouw natte zoenen, ons keppemomentjes,… ik 
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OPLEIDINGSGEGEVENS 
 
2015-heden Leerkracht wetenschappen Sint-Barbaracollege Gent 
 
2014-2015 GON leerkracht op Sint-Lodewijk Kwatrecht (BuSo, opleidingsvorm 4) 
 
2009-2014 Assistente van de vakgroep Moleculaire Biotechnologie (Immunologie en 
Biotechnologie van de Dierlijke Cel) aan de Faculteit Bio-ingenieurswetenschappen 
van de Universiteit Gent 
 
2012-2013 Attest Specifieke Lerarenopleiding  
 
2007-2009   Master Biomedische Wetenschappen optie Immunologie en Infectie aan de Faculteit 
Geneeskunde en Gezondheidswetenschappen van de Universiteit Gent 
 
2004-2007     Academische Bachelor Biomedische Wetenschappen aan de Faculteit Geneeskunde en 
Gezondheidswetenschappen van  de Universiteit Gent 
 
2005-2007     Moderne Talen -Wetenschappen aan het Sint-Bernarduscollege te Oudenaarde 
 





Nederlands  Moedertaal 
Engels   Zeer Goed 
Frans   Basis 





Goede kennis van Microsoft Word, Excel, Powerpoint. 











Organiseren en begeleiden van practica (Ugent): 
 Immunologie: 1ste master Bio-ingenieurswetenschappen: optie Cel-en gentechnologie 
 Biotechnologie van de Dierlijke Cel: 1ste master Bio-ingenieurswetenschappen: optie Cel-en 
gentechnologie 
 Biochemische analysetechnieken: 1ste master Bio-ingenieurswetenschappen: optie Chemie en 
Bioprocestechnologie, optie levensmiddelenwetenschappen en voeding 
 Biochemie en Moleculaire Biologie: 2de bachelor Bio-ingenieurswetenschappen 
 
Theoretische lessen geven (Ugent): 
 Immunologie: 1ste master Bio-ingenieurswetenschappen: optie Cel-en gentechnologie 
 Biotechnologie van de Dierlijke Cel: 1ste master Bio-ingenieurswetenschappen: optie Cel-en 
gentechnologie 
 Biochemische analysetechnieken: 1ste master Bio-ingenieurswetenschappen: optie Chemie en 
Bioprocestechnologie, optie levensmiddelenwetenschappen en voeding 
 Chemie (2de graad) / Fysica (2-3de graad) / Biologie (3de graad) / Wetenschappelijk Werk (2-3de graad) 
 
Secundair onderwijs: 
 GON leerkracht 
  Sint-Lodewijkschool, Kwatrechtsesteenweg 168 te Wetteren.  
BuSO – type 4 – OV4 
 Leerkracht chemie, biologie, fysica, aardrijkskunde 
 Sint-Barbaracollege Gent; 2de graad 
 
 
ERVARINGEN – ONDERZOEKSSKILLS 
 
Vakgroep Moleculaire Biotechnologie (Faculteit Bio-Ingenieurswetenschappen, Universiteit Gent) 
 
- Schrijven van wetenschappelijke rapporten en artikels 
- Rapporteren en presenteren van behaalde resultaten 
- Laboratoriumervaring: cel- en weefselcultuur, bacteriecultuur, DNA en RNA extractie, PCR en (q)RT-
PCR, micro-arrays, kloneren, plasmide opzuivering, recombinante eiwit expressie (transfectie van 
eukaryote cellen), SDS-PAGE en immunobloting, ELISA, immunofluorescentie technieken, Flow 
Cytometrie, proefdieren experimenten (set-up, staalname), werkzaam in een bioveiligheid klasse 3 





2009-2010: Bert Persan. Epidemiologisch onderzoek naar Chlamydophila psittaci en invloed van het type III 
secretiesysteem op de immuunrespons. 
2010-2011: Neil Saad. The role of the type III secretion system of Chlamydia psittaci in human macrophages. 
Masterproef voorgedragen tot het behalen van de graad van Master in de Bio-ingenieurswetenschappen: Cel-en 
Gentechnologie 
2010-2011: Delphine De Sutter. Chlamydia psittaci vaccinatie bij kippen. Masterproef voorgedragen tot het 
behalen van de graad van Bachelor in de Chemie, afstudeerrichting Biochemie 
2010-2011: Anoesjka Steenbeke. Chlamydia psittaci vaccinatie bij kippen. 
2011-2012: Bieke Soen. Onderzoek naar de aangeboren immuunresposn van Chlamydia psittaci in humane 
macrofagen. Masterproef voorgedragen tot het behalen van de graad van Master in de Bio-
ingenieurswetenschappen: Cel-en Gentechnologie 
2011-2012: Ellen Audenaert. Detectie en epidemiologie van Chlamydia psittaci op Belgische kippenbedrijven. 
Masterproef voorgedragen tot het behalen van de graad van Master in de Bio-ingenieurswetenschappen: Cel-en 
Gentechnologie 
2011-2012: Eveline Jonckheere. Analyse van de immuunrespons bij SPF kippen na infectie met Chlamydia 








Schautteet K, De Clercq E, Jönsson Y, Lagae S, Chiers K, Cox E, Vanrompay D, 2012. Protection of pigs against 
genital Chlamydia trachomatis challenge by parenteral or mucosal DNA immunization. Vaccine. 30 (18) 2869-
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emerging Chlamydia psittaci infections in the chicken industry and pathology of Chlamydia psittaci genotype B 
and D strains in specific pathogen free chickens. Vet Microbiol. 162 (2-4) 740-49. 
 
Yin L, Lagae S, Kalmar I, Borel N, Pospischil A, Vanrompay D, 2013. Pathogenicity of low and highly virulent 
Chlamydia psittaci isolates for specific pathogen free chickens. Avian Diseases. 57 242-247. 
 
Lagae S, Kalmar I, Laroucau K, Vorimore F, Vanrompay D, 2014. Emerging Chlamydia psittaci infections in 
chickens and examination of transmission to humans. J Med Microbiol. 63 399-407. 
 
Lagae S, Vanrompay D, 2015. Innate immune response in avian macrophages eeicited by Chlamydia psittaci. 
Vlaams Dierengeneeskundig tijdschrift. 84 133-141. 
 
Lagae S, Dumont A, Vanrompay D, 2015. Examination of the in vivo immune response elicited by Chlamydia 





Met orale presentatie 
 
9th German Chlamydia Workshop. Ascona, Switzerland. 22-25 februari 2011. “Influence of the Chlamydia 
psittaci type III secretion system on the innate immune response of chicken macrophages.” 
8th Annual Amsterdam Chlamydia meeting (AACM). Hotel Mercure Amsterdam aan de Amstel, Amsterdam, 
Nederland. 9 december 2011. “Influence of the Chlamydia psittaci type III secretion system on the innate 
immune response of chicken macrophages.” 
 
 
Met poster presentatie 
 
25th Annual Meeting of the European Macrophage en Dendritic Cell Society (EMDS). Brussels, Belgium, 22-24 





Summer Course on Infection and Immunity. Faculty Veterinary Medicine, Ghent, Belgium. 29 en 30 september 
2009 
6th Annual Amsterdam Chlamydia meeting (AACM). Hotel  Mercure Amsterdam aan de Amstel, Amsterdam, 




Seminarie Welzijn en milieu, Gent, Belgium. 17 september 2009 
FACSAria III Operator Training, BD Erembodegem, Belgium. 31mei-4 juni 2010. 




Verenigingsleven:  Speelpleinwerking (Kruishoutem); 3 jaar leiding 
   KSJ – VKSJ –KSA Kruishoutem; 5 jaar leiding 
 
Andere: lezen, mountainbiken, naaien en reizen 
